Table of Contents
falseQ1--12-310001844817PA 0001844817 2023-10-01 2023-12-31 0001844817 2023-09-30 0001844817 2023-12-31 0001844817 2022-10-01 2022-12-31 0001844817 2021-08-16 2021-08-17 0001844817 2021-08-17 0001844817 2021-10-01 2021-10-02 0001844817 2021-08-16 2021-08-18 0001844817 2021-06-15 2021-06-16 0001844817 2023-06-26 2023-06-26 0001844817 2023-06-26 0001844817 2024-02-09 0001844817 2023-08-02 2023-08-02 0001844817 2023-08-04 0001844817 2021-10-01 2022-09-30 0001844817 2023-02-02 2023-02-02 0001844817 2022-11-10 2022-11-10 0001844817 2022-10-01 2023-09-30 0001844817 2022-09-30 0001844817 2022-12-31 0001844817 aaci:SponsorMember 2023-09-30 0001844817 aaci:PromissoryNotesMember aaci:SponsorMember 2023-09-30 0001844817 us-gaap:RelatedPartyMember 2023-09-30 0001844817 aaci:SponsorMember 2023-12-31 0001844817 aaci:SponsorMember aaci:SubscriptionAgreementWithPolarMember 2023-12-31 0001844817 aaci:PromissoryNotesMember aaci:SponsorMember aaci:WorkingCapitalLoanTrancheSeptemberTwoThousandAndTwentyThreeMember 2023-12-31 0001844817 aaci:PromissoryNotesMember aaci:SponsorMember aaci:WorkingCapitalLoanTrancheOctoberTwoThousandAndTwentyThreeMember 2023-12-31 0001844817 aaci:PromissoryNotesMember aaci:SponsorMember 2023-12-31 0001844817 aaci:PromissoryNotesMember aaci:SponsorMember aaci:WorkingCapitalLoanTrancheNovemberTwoThousandAndTwentyThreeMember 2023-12-31 0001844817 aaci:PromissoryNotesMember aaci:SponsorMember aaci:WorkingCapitalLoanTrancheAugustTwoThousandAndTwentyThreeMember 2023-12-31 0001844817 us-gaap:RelatedPartyMember 2023-12-31 0001844817 aaci:InitialBusinessCombinationMember aaci:BishopIrMember 2023-12-31 0001844817 aaci:TerminationOrClosingOfInitialBusinessCombinationMember aaci:IcrLlcMember 2023-12-31 0001844817 aaci:AdditionalLiabilitiesUponTheClosingOfTheInitialBusinessCombinationMember aaci:IcrLlcMember 2023-12-31 0001844817 aaci:HallumCapitalGroupLlcMember 2023-12-31 0001844817 aaci:DADavidsonAndCoMember 2023-12-31 0001844817 aaci:NonRedemptionAgreementsMember 2023-12-31 0001844817 aaci:NonredeemableCommonStockMember 2022-10-01 2022-12-31 0001844817 aaci:RedeemableCommonStockMember 2022-10-01 2022-12-31 0001844817 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001844817 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001844817 aaci:CommonStockSubjectToPossibleRedemptionMember us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001844817 aaci:CommonStockNotSubjectToRedemptionMember us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001844817 aaci:NonredeemableCommonStockMember 2023-10-01 2023-12-31 0001844817 aaci:RedeemableCommonStockMember 2023-10-01 2023-12-31 0001844817 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001844817 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001844817 aaci:SubscriptionAgreementMember aaci:SponsorMember us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001844817 aaci:SubscriptionAgreementMember aaci:SponsorMember us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001844817 aaci:SubscriptionAgreementMember aaci:SponsorMember 2023-10-01 2023-12-31 0001844817 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001844817 us-gaap:WarrantMember 2023-10-01 2023-12-31 0001844817 aaci:RepresentativeSharesMember 2023-10-01 2023-12-31 0001844817 aaci:FounderSharesMember 2023-10-01 2023-12-31 0001844817 srt:DirectorMember 2023-10-01 2023-12-31 0001844817 aaci:SponsorMember 2023-10-01 2023-12-31 0001844817 aaci:WarrantsEachExercisableForOneShareOfCommonStockFor11.50PerShareMember 2023-10-01 2023-12-31 0001844817 aaci:CommonStockParValue0.0001PerShareMember 2023-10-01 2023-12-31 0001844817 aaci:UnitsEachConsistingOfOneShareOfCommonStockAndOnehalfOfOneRedeemableWarrantMember 2023-10-01 2023-12-31 0001844817 aaci:CommonStockSubjectToPossibleRedemptionMember us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001844817 aaci:CommonStockNotSubjectToRedemptionMember us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001844817 aaci:NonRedemptionAgreementsMember 2023-10-01 2023-12-31 0001844817 us-gaap:RelatedPartyMember 2023-10-01 2023-12-31 0001844817 aaci:ExtensionNoteMember aaci:SponsorMember 2023-10-01 2023-12-31 0001844817 us-gaap:IPOMember 2023-10-01 2023-12-31 0001844817 aaci:UnitsMember us-gaap:IPOMember 2021-08-16 2021-08-17 0001844817 aaci:PrivateSharesMember us-gaap:PrivatePlacementMember 2021-08-16 2021-08-17 0001844817 aaci:PrivateMember us-gaap:PrivatePlacementMember aaci:PurchaseAggregateMember 2021-08-16 2021-08-17 0001844817 aaci:AmendedAndRestatedBusinessCombinationAgreementMember 2021-08-16 2021-08-17 0001844817 aaci:UnitsMember 2021-08-16 2021-08-17 0001844817 aaci:FounderSharesMember 2021-08-16 2021-08-17 0001844817 aaci:FounderSharesMember 2021-08-17 0001844817 aaci:UnitsMember us-gaap:IPOMember 2021-08-17 0001844817 aaci:PrivateSharesMember us-gaap:PrivatePlacementMember 2021-08-17 0001844817 aaci:NonRedemptionAgreementsMember 2023-02-02 2023-02-02 0001844817 aaci:ExtensionNoteMember aaci:PromissoryNotesMember aaci:SponsorMember us-gaap:CommonStockMember 2023-08-02 2023-08-02 0001844817 us-gaap:CommonStockMember 2023-08-02 2023-08-02 0001844817 aaci:ExtensionNoteMember aaci:TrancheOneMember 2023-08-08 2023-08-08 0001844817 aaci:FirstAmendmentToTheBusinessCombinationAgreementMember 2022-11-10 2022-11-10 0001844817 aaci:WorkingCapitalNeedsFundingMember 2022-11-10 2022-11-10 0001844817 aaci:TrustAccountContributionMember 2022-11-10 2022-11-10 0001844817 aaci:NonRedemptionAgreementsMember 2023-02-02 0001844817 aaci:AmendedAndRestatedBusinessCombinationAgreementMember 2023-06-16 2023-06-16 0001844817 aaci:PromissoryNotesMember aaci:SponsorMember 2023-08-02 0001844817 aaci:ExtensionNoteMember aaci:PromissoryNotesMember aaci:SponsorMember us-gaap:CommonStockMember 2023-08-02 0001844817 aaci:UnsecuredPromissoryNoteMember 2023-08-02 0001844817 us-gaap:CommonStockMember 2023-08-02 0001844817 aaci:FounderSharesMember 2021-06-15 2021-06-16 0001844817 srt:DirectorMember 2021-06-15 2021-06-16 0001844817 srt:PresidentMember 2021-06-15 2021-06-16 0001844817 srt:DirectorMember 2023-06-26 2023-06-26 0001844817 aaci:ThreeIndependentDirectorsMember 2023-06-26 2023-06-26 0001844817 srt:ExecutiveOfficerMember 2023-06-26 2023-06-26 0001844817 aaci:SponsorMember 2023-06-26 2023-06-26 0001844817 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-06-26 2023-06-26 0001844817 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-06-26 2023-06-26 0001844817 aaci:SponsorMember 2022-10-01 2023-09-30 0001844817 aaci:FounderSharesMember us-gaap:OverAllotmentOptionMember 2021-10-01 0001844817 aaci:FounderSharesMember 2021-02-02 2021-02-03 0001844817 aaci:FounderSharesMember 2021-02-03 0001844817 aaci:FounderShares1Member 2021-02-03 0001844817 aaci:FounderSharesMember 2021-06-16 0001844817 aaci:SponsorMember aaci:FounderSharesMember 2021-06-16 0001844817 aaci:FounderSharesMember 2021-07-22 2021-07-23 0001844817 aaci:FounderSharesMember 2021-07-23 0001844817 aaci:ChiefExecutiveOfficerPresidentAndIndependentDirectorsMember aaci:FounderSharesMember 2021-07-23 0001844817 srt:ChiefExecutiveOfficerMember 2021-07-23 0001844817 aaci:FounderSharesMember us-gaap:OverAllotmentOptionMember 2021-10-01 2021-10-02 0001844817 aaci:EarlyBirdCapitalIncMember aaci:RepresentativeSharesMember 2021-02-07 2021-02-08 0001844817 aaci:NorthlandSecuritiesIncMember aaci:RepresentativeSharesMember 2021-02-07 2021-02-08 0001844817 aaci:RepresentativeSharesMember 2021-02-07 2021-02-08 0001844817 aaci:RepresentativeSharesMember 2021-02-08 0001844817 aaci:NorthlandSecuritiesIncMember aaci:RepresentativeSharesMember 2021-05-28 2021-05-29 0001844817 aaci:PromissoryNotesMember us-gaap:RelatedPartyMember 2022-05-09 0001844817 aaci:SponsorMember 2022-05-09 0001844817 aaci:PromissoryNotesMember aaci:SponsorMember 2022-07-01 2022-07-31 0001844817 aaci:PromissoryNotesMember aaci:SponsorMember 2023-07-28 0001844817 aaci:ExtensionNoteMember aaci:TrancheTwoMember 2023-09-12 2023-09-12 0001844817 aaci:PromissoryNotesMember aaci:SponsorMember aaci:WorkingCapitalLoanTrancheAugustTwoThousandAndTwentyThreeMember 2023-08-08 0001844817 aaci:PromissoryNotesMember aaci:SponsorMember aaci:WorkingCapitalLoanTrancheSeptemberTwoThousandAndTwentyThreeMember 2023-09-08 0001844817 aaci:IcrLlcMember 2021-11-01 2022-12-31 0001844817 aaci:InitialBusinessCombinationMember aaci:BishopIrMember us-gaap:SubsequentEventMember 2023-06-21 2024-06-20 0001844817 srt:MaximumMember aaci:InitialBusinessCombinationMember aaci:BishopIrMember us-gaap:SubsequentEventMember 2023-06-21 2024-06-20 0001844817 aaci:NorthlandSecuritiesIncMember aaci:RepresentativeSharesMember 2021-05-29 2021-05-29 0001844817 aaci:NonRedemptionAgreementsMember 2023-01-20 2023-01-20 0001844817 aaci:SponsorMember aaci:NonRedemptionAgreementsMember 2023-01-20 2023-01-20 0001844817 aaci:SponsorMember aaci:NonRedemptionAgreementsMember 2023-01-20 0001844817 aaci:NonRedemptionAgreementsMember 2023-01-20 0001844817 aaci:YaIiPnLtd.Member aaci:PurchaseAgreementMember 2023-02-23 2023-02-23 0001844817 aaci:FounderShares1Member 2021-02-03 2021-02-03 0001844817 aaci:RepresentativeSharesMember 2021-02-08 2021-02-08 0001844817 aaci:ExtensionNoteMember aaci:TrancheFourMember 2023-10-11 2023-10-11 0001844817 aaci:ExtensionNoteMember aaci:TrancheFiveMember 2023-11-09 2023-11-09 0001844817 aaci:SubscriptionAgreementMember aaci:TrancheOneMember 2023-12-15 2023-12-15 0001844817 us-gaap:CommonStockMember 2023-08-01 2023-08-31 0001844817 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-02-09 2024-02-09 0001844817 aaci:SubscriptionAgreementMember aaci:TrancheOneMember 2023-12-19 2023-12-19 0001844817 aaci:SubscriptionAgreementMember us-gaap:SubsequentEventMember aaci:TrancheTwoMember 2024-01-16 2024-01-16 0001844817 aaci:SecondExtensionNoteMember aaci:SponsorMember us-gaap:SubsequentEventMember 2024-02-09 0001844817 aaci:SecondExtensionNoteMember us-gaap:SubsequentEventMember 2024-02-09 0001844817 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-02-09 0001844817 aaci:ApprovalToExtendTheLastDatePriorToWhichBusinessCombinationShallBeConsummatedMember us-gaap:SubsequentEventMember 2024-02-13 2024-02-13 0001844817 us-gaap:SubsequentEventMember aaci:PrepaidAdvanceAgreementMember 2024-02-02 0001844817 us-gaap:SubsequentEventMember aaci:PrepaidAdvanceAgreementMember 2024-02-02 2024-02-02 0001844817 aaci:SubscriptionAgreementMember aaci:PolarMultiStrategyMasterFundMember 2023-12-12 0001844817 aaci:SubscriptionAgreementMember aaci:PolarMultiStrategyMasterFundMember aaci:MarchTwoThousandAndTwentyFourMember 2023-12-12 0001844817 aaci:SubscriptionAgreementMember aaci:PolarMultiStrategyMasterFundMember aaci:DecemberTwoThousandAndTwentyThreeMember 2023-12-12 0001844817 aaci:SubscriptionAgreementMember aaci:PolarMultiStrategyMasterFundMember aaci:JanuaryTwoThousandAndTwentyFourMember 2023-12-12 0001844817 aaci:SubscriptionAgreementMember aaci:PolarMultiStrategyMasterFundMember aaci:FebruaryTwoThousandAndTwentyFourMember 2023-12-12 0001844817 aaci:SubscriptionAgreementMember aaci:PolarMultiStrategyMasterFundMember aaci:DefaultSharesMember 2023-12-12 0001844817 aaci:SubscriptionAgreementMember aaci:PolarMultiStrategyMasterFundMember aaci:AdditionalDefaultSharesMember 2023-12-12 0001844817 aaci:SubscriptionAgreementMember aaci:PolarMultiStrategyMasterFundMember aaci:DecemberTwoThousandAndTwentyThreeMember 2023-12-12 2023-12-12 0001844817 aaci:SubscriptionAgreementMember aaci:PolarMultiStrategyMasterFundMember 2023-12-12 2023-12-12 0001844817 aaci:SponsorMember us-gaap:SubsequentEventMember aaci:WorkingCapitalLoanMember 2024-01-16 0001844817 aaci:PromissoryNotesMember aaci:SponsorMember 2023-07-28 2023-07-28 0001844817 aaci:PromissoryNotesMember aaci:SponsorMember aaci:WorkingCapitalLoanTrancheOctoberTwoThousandAndTwentyThreeMember 2023-10-10 0001844817 aaci:PromissoryNotesMember aaci:SponsorMember aaci:WorkingCapitalLoanTrancheNovemberTwoThousandAndTwentyThreeMember 2023-11-20 0001844817 aaci:SponsorMember aaci:SubscriptionAgreementWithPolarMember 2023-12-19 0001844817 aaci:PolarMultiStrategyMasterFundMember aaci:ExtensionNoteMember 2023-12-19 0001844817 aaci:ExtensionNoteMember aaci:TrancheFourMember 2023-10-10 2023-10-10 0001844817 aaci:SubscriptionAgreementMember aaci:PolarMultiStrategyMasterFundMember aaci:MarchTwoThousandAndTwentyFourMember 2024-02-13 0001844817 aaci:ApprovalToExtendTheLastDatePriorToWhichBusinessCombinationShallBeConsummatedMember us-gaap:SubsequentEventMember 2024-02-15 2024-02-15 0001844817 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-02-15 2024-02-15 0001844817 aaci:UnsecuredPromissoryNoteMember us-gaap:SubsequentEventMember 2024-02-15 0001844817 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-02-15 0001844817 us-gaap:SubsequentEventMember 2024-02-17 2024-02-17 0001844817 aaci:SecondExtensionNoteMember aaci:SponsorMember us-gaap:SubsequentEventMember 2024-02-17 2024-02-17 0001844817 aaci:SubscriptionAgreementMember us-gaap:SubsequentEventMember aaci:TrancheTwoMember 2024-02-16 2024-02-16 0001844817 aaci:SponsorMember us-gaap:SubsequentEventMember aaci:WorkingCapitalLoanMember 2024-02-16 0001844817 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001844817 us-gaap:CommonStockMember 2022-09-30 0001844817 us-gaap:RetainedEarningsMember 2022-09-30 0001844817 us-gaap:RetainedEarningsMember 2022-12-31 0001844817 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001844817 us-gaap:CommonStockMember 2022-12-31 0001844817 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001844817 us-gaap:CommonStockMember 2023-09-30 0001844817 us-gaap:RetainedEarningsMember 2023-09-30 0001844817 us-gaap:RetainedEarningsMember 2023-12-31 0001844817 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001844817 us-gaap:CommonStockMember 2023-12-31 xbrli:shares iso4217:USD xbrli:pure utr:Day utr:Month iso4217:USD xbrli:shares aaci:Director aaci:Investor
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 10-Q
 
 
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 2023
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
   
to
   
Commission File
No. 001-40742
 
 
Armada Acquisition Corp. I
(Exact name of registrant as specified in its charter)
 
 
 
 
 
 
Delaware
 
85-3810850
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
1760 Market Street, Suite 602
Philadelphia,
PA
19103
(Address of Principal Executive Offices, including zip code)
(215)543-6886
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
 
 
 
 
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Units, each consisting of one share of Common Stock and
one-half
of one Redeemable Warrant
 
AACIU
 
The Nasdaq Stock Market LLC
Common Stock, par value $0.0001 per share
 
AACI
 
The Nasdaq Stock Market LLC
Warrants, each exercisable for one share of Common Stock for $11.50 per share
 
AACIW
 
The Nasdaq Stock Market LLC
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
 
 
 
 
 
 
 
Large accelerated filer      Accelerated filer  
       
Non-accelerated
filer
     Smaller reporting company  
       
         Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act): Yes  No ☐
At February 9, 2024, there
were 8,072,849 shares of Common Stock, $0.0001 par value per share (“Common Stock”), issued and outstanding, which are comprised of 13,965 shares of Common Stock underlying Units and 8,058,884 shares of Common Stock that trade separately.
 
 
 


Table of Contents

ARMADA ACQUISITION CORP. I

Quarterly Report on Form 10-Q

Table of Contents

 

PART I. FINANCIAL INFORMATION

 

Item 1.

  Financial Statements      1  
  Condensed Balance Sheets as of December 31, 2023 (Unaudited) and September 30, 2023      1  
  Condensed Statements of Operations for the three months ended December 31, 2023 and 2022 (Unaudited)      2  
  Condensed Statements of Changes in Stockholders’ Deficit for the three months ended December 31, 2023 and 2022 (Unaudited)      3  
  Condensed Statements of Cash Flows for the three months ended December 31, 2023 and 2022 (Unaudited)      4  
  Notes to Unaudited Condensed Financial Statements      5  

Item 2.

  Management’s Discussion and Analysis of Financial Condition and Results of Operations      18  

Item 3.

  Quantitative and Qualitative Disclosures About Market Risk      25  

Item 4.

  Controls and Procedures      25  

PART II. OTHER INFORMATION

 

Item 1.

  Legal Proceedings      26  

Item 1A.

  Risk Factors      26  

Item 2.

  Unregistered Sales of Equity Securities and Use of Proceeds      26  

Item 3.

  Defaults Upon Senior Securities      26  

Item 4.

  Mine Safety Disclosures      26  

Item 5.

  Other Information      26  

Item 6.

  Exhibits      26  

SIGNATURES

     28  


Table of Contents
P6M
PART I—FINANCIAL INFORMATION
Item 1. Financial Statements.
ARMADA ACQUISITION CORP. I
CONDENSED BALANCE SHEETS
 
    
December 31,
2023

unaudited
   
September 30,

2023
 
Assets
    
Cash
   $ 54,405     $ 60,284  
Prepaid expenses
     13,534       33,605  
  
 
 
   
 
 
 
Total current assets
     67,939       93,889  
Investments held in Trust Account
     25,871,565       25,324,028  
  
 
 
   
 
 
 
Total Assets
   $ 25,939,504     $ 25,417,917  
  
 
 
   
 
 
 
Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit
    
Current liabilities:
    
Accounts payable
   $ 5,132,351     $ 4,708,050  
Franchise tax payable
     23,919       12,100  
Income tax payable
     78,617       10,783  
Subscription agreement liability, net
     6,752        
Promissory Notes-Related Party
     2,776,600       2,564,439  
Excise tax payable
     1,291,751       1,291,751  
  
 
 
   
 
 
 
Total current liabilities
     9,309,990       8,587,123  
  
 
 
   
 
 
 
Commitments and Contingencies (Note 5)
Common stock subject to possible redemption, 2,363,349 shares at redemption value of approximately $10.91 and $10.71 per share at December 31, 2023 and September 30, 2023, respectively
     25,784,690       25,316,806  
Stockholders’ Deficit:
    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
            
Common stock, $0.0001 par value; 100,000,000 shares authorized, 5,709,500 shares issued and outstanding (excluding 2,363,349 and 2,363,349 shares subject to possible redemption) at December 31, 2023 and September 30, 2023, respectively
     570       570  
Additional
paid-in
capital
     159,034        
Accumulated deficit
     (9,314,780 )     (8,486,582
  
 
 
   
 
 
 
Total Stockholders’ Deficit
     (9,155,176 )     (8,486,012
  
 
 
   
 
 
 
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit
   $ 25,939,504     $ 25,417,917  
  
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
1

ARMADA ACQUISITION CORP. I
CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)
 
    
For the Three Months Ended
 
    
December 31,
2023
   
December 31,
2022
 
Formation and operating costs
   $ 571,529     $ 394,352  
Stock-based compensation
     50,400       27,963  
  
 
 
   
 
 
 
Loss from operations
  
 
(621,929
 
 
(422,315
  
 
 
   
 
 
 
Other income
    
Trust interest income
     334,836       1,289,673  
Interest expense
     (5,387      
  
 
 
   
 
 
 
Total other income
     329,449       1,289,673  
  
 
 
   
 
 
 
Income before provision for income taxes
     (292,480     867,358  
Provision for income taxes
     (67,834     (260,331
  
 
 
   
 
 
 
Net (loss) income
  
$
(360,314
 
$
607,027
 
  
 
 
   
 
 
 
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption
     2,363,349       15,000,000  
  
 
 
   
 
 
 
Basic and diluted net (loss) income per share
  
$
(0.04
 
$
0.03
 
  
 
 
   
 
 
 
Basic and diluted weighted average shares outstanding,
non-redeemable
common stock
     5,709,500       5,709,500  
  
 
 
   
 
 
 
Basic and diluted net (loss) income per share
  
$
(0.04
 
$
0.03
 
  
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
2

ARMADA ACQUISITION CORP. I
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
(Unaudited)
FOR THE THREE MONTHS ENDED DECEMBER 31, 2023
 
    
Common Stock
    
Additional
    
Accumulated
   
Total

Stockholders’
 
    
Shares
    
Amount
    
Paid-in Capital
    
Deficit
   
Deficit
 
Balance as of September 30, 2023
  
 
5,709,500
 
  
$
570
 
  
$
    
$
(8,486,582
 
$
(8,486,012
Stock-based compensation
     —         —         50,400              50,400  
Proceeds allocated to Sponsor Shares for subscription agreement liability (see note 4)
     —         —         108,634              108,634  
Subsequent remeasurement of common stock subject to possible redemption
     —         —                (467,884     (467,884
Net loss
     —                       (360,314     (360,314
  
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance as of December 31, 2023
  
 
5,709,500
 
  
$
570
 
  
$
159,036
 
  
$
(9,314,780
)
 
$
(9,155,176
)
  
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
FOR THE THREE MONTHS ENDED DECEMBER 31, 2022
 
    
Common Stock
    
Additional

Paid-in
    
Accumulated
   
Total

Stockholders’
 
    
Shares
    
Amount
    
Capital
    
Deficit
   
Deficit
 
Balance as of September 30, 2022 (audited)
  
 
5,709,500
 
  
$
570
 
  
$
941,796
 
  
$
(4,091,693
 
$
(3,149,327
Stock-based compensation
     —         —         27,963              27,963  
Subsequent remeasurement of common stock subject to possible redemption
     —         —                (2,479,343     (2,479,343
Net income
     —         —         —         607,027       607,027  
  
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance as of December 31, 2022
  
 
5,709,500
 
  
$
570
 
  
$
969,759
 
  
$
(5,964,009
 
$
(4,993,680
  
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
3

ARMADA ACQUISITION CORP. I
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)


 
  
For the Three Months Ended
 
 
  
December 31,
2023
 
 
December 31,
2022
 
Cash Flows from Operating Activities:
                
Net (loss) income
   $ (360,314   $ 607,027  
Adjustments to reconcile net (loss) income to net cash used in operating activities:
                
Interest earned on investments held in Trust Account
     (334,836     (1,289,673
Interest expense
     5,387        
Stock-based compensation
     50,400       27,963  
Changes in current assets and liabilities:
                
Prepaid expenses
     20,071       55,678  
Accounts payable
     424,300       24,344  
Income tax payable
     67,834       260,331  
Franchise tax payable
     11,819       50,000  
    
 
 
   
 
 
 
Net cash used in operating activities
  
 
(115,339
 
 
(264,331
    
 
 
   
 
 
 
Cash Flows from Investing Activities:
                
Principal deposited in Trust Account
     (212,701      
    
 
 
   
 
 
 
Net cash used in investing activities
  
 
(212,701
 
 
(1,500,000
    
 
 
   
 
 
 
Cash Flows from Financing Activities:
                
Proceeds from issuance of promissory notes to related party
     212,161       1,950,000  
Proceeds from subscription agreement
     110,000        
    
 
 
   
 
 
 
Net cash provided by financing activities
  
 
322,161
 
 
 
1,950,000
 
    
 
 
   
 
 
 
Net change in cash
  
 
(5,879
 
 
185,669
 
Cash, beginning of the period
     60,284       177,578  
    
 
 
   
 
 
 
Cash, end of the period
  
$
54,405
 
 
$
363,247
 
    
 
 
   
 
 
 
Supplemental disclosure of noncash investing and financing activities
                
Subsequent remeasurement of common stock subject to possible redemption
   $ 467,884     $ 2,479,343  
    
 
 
   
 
 
 
Cost of issuance of debt under Polar agreement
   $ 108,634     $  
    
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
4
ARMADA ACQUISITION CORP. I
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
DECEMBER 31, 2023
Note–1 - Organization, Business Operations and Going Concern
Armada Acquisition Corp. I (the “Company”) is a blank check company incorporated as a Delaware corporation on November 5, 2020.
The Company was incorporated for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). As more fully described in this Note 1, on December 17, 2021 the Company entered into a business combination agreement with a target business which was amended and restated on June 16, 2023, and further amended on August 4, 2023. The Company concentrated its efforts in identifying businesses in the financial services industry with particular emphasis on businesses that are providing or changing technology for traditional financial services. 
As of December 31, 2023, the Company had not commenced any operations. All activity for the period from November 5, 2020 (inception) through December 31, 2023, relates to the Company’s formation and the initial public offering (the “IPO”) described below, and since the closing of the IPO, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO.
The Company’s sponsor is Armada Sponsor LLC (the “Sponsor”).
The registration statement for the Company’s IPO was declared effective on August 12, 2021 (the “Effective Date”). On August 17, 2021, the Company commenced the IPO of 15,000,000 units at $10.00 per unit (the “Units”).
Simultaneously with the consummation of the IPO, the Company consummated the private placement of 459,500 shares of common stock (“Private Shares”) at a price of $10.00 per share for an aggregate purchase price of $4,595,000.
Transaction costs amounted to $3,537,515, consisting of $1,500,000 of underwriting commissions, and $2,037,515 of other offering costs.
Following the closing of the IPO, a total of $150,000,000 ($10.00 per Unit) was held in the Trust Account (“Trust Account”). The funds held in the Trust Account are required to be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule
2a-7
promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the Investment Company Act, on August 10, 2023 we instructed the trustee to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in an interest bearing demand deposit account until the earlier of the consummation of a Business Combination or our liquidation. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay tax obligations and up to $100,000 to pay dissolution expenses, the proceeds from the IPO and the sale of the Private Shares will not be released from the Trust Account until the earlier of the completion of a Business Combination or the Company’s redemption of 100% of the outstanding public shares if it has not completed a Business Combination in the required time period. The proceeds held in the Trust Account may be used as consideration to pay the sellers of a target business with which the Company completes a Business Combination. Any amounts not paid as consideration to the sellers of the target business may be used to finance operations of the target business.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.
The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (excluding deferred underwriting commissions and taxes payable) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully.
In connection with any proposed Business Combination, the Company will either (1) seek stockholders approval of the initial Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against the proposed Business Combination or do not vote at all, into their pro rata share of the aggregate amount then on deposit in the Trust Account (net of taxes payable), or (2) provide its stockholders with the opportunity to sell their shares to the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the Trust Account (net of taxes payable and less up to $100,000 of interest to pay dissolution expenses), in each case subject to the limitations described herein. The decision as to whether the Company will seek stockholders approval of a proposed Business Combination or will allow stockholders to sell their shares to the Company in a tender offer will be made by the Company, solely in its discretion.
The shares of common stock subject to redemption are recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination (unless the proposal amending the Company charter to remove the net tangible assets requirement in connection with the Business Combination is approved and implemented at the special meeting approving the Business Combination) and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.
 
5

The Company had until February 17, 2023 (or 18 months following the IPO) to consummate a Business Combination (the “Combination Period”). As further described in Note 1, on February 2, 2023, the stockholders approved an amendment to our certificate of incorporation to extend the Combination Period until August 17, 2023. On August 2, 2023, the stockholders approved a second amendment to our certificate of incorporation to extend the Combination Period for six monthly periods or until no later than February 17, 2024. On February 1
5
, 2024, the stockholders approved a third amendment to the Company’s certificate of incorporation to extend the Combination Period for up to
six
additional monthly periods or until no later than August 17, 2024.
On August 8, 2023, the Company deposited $70,900 into the Trust Account thereby extending the Combination Period until September 17, 2023, and on each of September 12, 2023, October 11, 2023, November 9, 2023, December 15, 2023 and January 16, 2024, the Company deposited $70,900 
into the Trust Account, thereby extending the Combination Period for five additional months or until February17, 2024.
However, if the Company is unable to complete the initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding public shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company but net of taxes payable (and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, liquidate and dissolve, subject (in the case of (ii) and (iii) above) to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
The Sponsor, officers and directors have agreed (i) to vote any shares owned by them in favor of any proposed Business Combination, (ii) not to redeem any shares in connection with a stockholder vote to approve a proposed initial Business Combination or sell any shares to the Company in a tender offer in connection with a proposed initial Business Combination, (iii) that the founders’ shares will not participate in any liquidating distributions from the Company’s Trust Account upon winding up if a Business Combination is not consummated.
The Sponsor has agreed that it will be liable to ensure that the proceeds in the Trust Account are not reduced below $10.00 per share by the claims of target businesses or claims of vendors or other entities that are owed money by the Company for services rendered or contracted for or products sold to the Company. The agreement to be entered into by the Sponsor specifically provides for two exceptions to the indemnity it has given: it will have no liability (1) as to any claimed amounts owed to a target business or vendor or other entity, which has executed an agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account, or (2) as to any claims for indemnification by the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has it independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company believes it is unlikely that the Sponsor will be able to satisfy its indemnification obligations if it is required to do so.
On December 17, 2021, the Company entered into a business combination agreement as amended on November 10, 2022, June 16, 2023, and August 4, 2023 with Rezolve Limited, a private limited company incorporated under the laws of England and Wales (“Rezolve”), Rezolve Group Limited, a Cayman Islands exempted company (“Cayman NewCo”), and Rezolve Merger Sub, Inc., (“Rezolve Merger Sub”) (such business combination agreement, the “Business Combination Agreement,” and such business combination, the “Business Combination”).
On November 10, 2022, the Company and Rezolve entered into a First Amendment to the Business Combination Agreement (the “Amendment,” and together with the Original Business Combination Agreement, the “Business Combination Agreement” and the business combination contemplated thereby, the “Business Combination”), to among other things, extend the date on which either party to the Business Combination Agreement had the right to terminate the Business Combination Agreement if the Business Combination had not been completed by such date to the later of (i) January 31, 2023 or (ii) fifteen days prior to the last date on which the Company may consummate a Business Combination, and change the structure of the Business Combination such that Cayman NewCo is no longer a party to the Business Combination Agreement or the Business Combination.
On February 2, 2023, the Company held its Annual Meeting. At the Annual Meeting, the Company’s stockholders approved an amendment to the Company’s Charter to extend the date by which the Company must consummate a Business Combination or, if it fails to do so, cease its operations and redeem or repurchase 100% of the shares of the Company’s common stock issued in the Company’s IPO, from February 17, 2023 for up to six additional months at the election of the Company, ultimately until as late as August 17, 2023 (the “Extension”). In connection with the Extension, the holders of 11,491,148 shares of Common Stock elected to redeem their shares at a per share redemption price of approximately $10.19. As a result, $117,079,879 was removed from the Company’s Trust Account to pay such holders.
On June 16, 2023, the Company, Rezolve, Rezolve AI Limited, a private limited liability company incorporated under the laws of England and Wales (“Rezolve AI”) and Rezolve Merger Sub amended and restated the Business Combination Agreement (the “Amended and Restated Business Combination Agreement”) by way of a Deed of Release, Amendment and Restatement to, among other things, amend (a) the enterprise value of Rezolve by which the aggregate stock consideration is calculated to $1.60 billion, and (b) provide for (i) a
pre-Closing
demerger (the
“Pre-Closing
Demerger”) of Rezolve pursuant to UK legislation under which (x) part of Rezolve’s business and assets (being all of its business and assets except for certain shares in Rezolve Information Technology (Shanghai) Co Ltd and its wholly owned subsidiary Nine Stone (Shanghai) Ltd and Rezolve Information Technology (Shanghai) Co Ltd Beijing Branch and certain other excluded assets) are to be transferred to Rezolve AI in exchange for the issue by Rezolve AI of shares of the same classes of capital stock as in Rezolve for distribution among the original shareholders of Rezolve in proportion to their holdings of shares of each class of capital stock in Rezolve as at immediately prior to the
Pre-Closing
Demerger, (y) Rezolve AI will be assigned, assume and/or reissue the secured convertible notes currently issued by Rezolve pursuant to the Loan Agreements (as defined in the Amended and Restated Business Combination Agreement) and (z) Rezolve will then be wound up, and (ii) the merger of the Company with and into Rezolve Merger Sub, with the Company continuing as the surviving entity (the “Merger”) such that after completion of the
Pre-Closing
Demerger and Merger, the Company will become a wholly owned subsidiary of Rezolve AI.
Concurrently with the execution and delivery of the Amended and Restated Business Combination Agreement, the Company and the Key Company Shareholders (as defined in the Amended and Restated Business Combination Agreement) have entered into the Transaction Support Agreement, pursuant to which, among other things, the Key Company Shareholders have agreed to (a) vote in favor of the Company Reorganization (b) vote in favor of the
 
6

Amended and Restated Business Combination Agreement and the agreements contemplated thereby and the transactions contemplated thereby, (c) enter into the Investor Rights Agreement (as defined in the Amended and Restated Business Combination Agreement) at Closing and (d) the termination of certain agreements effective as of Closing.
On August 2, 2023, the Company held a special meeting of its stockholders to approve an amendment to its Charter (the “Charter Amendment”) to extend the date (the “Termination Date”) by which Armada has to consummate a Business Combination from August 17, 2023 (the “Original Termination Date”) to September 17, 2023 (the “Charter Extension Date”) and to allow Armada, without another stockholder vote, to elect to extend the Termination Date to consummate a Business Combination on a monthly basis up to five times by an additional one month each time after the Charter Extension Date, by resolution of Armada’s board of directors, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until February 17, 2024, or a total of up to six months after the Original Termination Date, unless the closing of a Business Combination shall have occurred prior thereto (the “Second Extension Amendment Proposal”). The stockholders of Armada approved the Second Extension Amendment Proposal at the special meeting and on August 3, 2023, Armada filed the Charter Amendment with the Delaware Secretary of State.
In connection with the vote to approve the Charter Amendment, the holders of 1,145,503 public shares of Common Stock of Armada exercised their right to redeem their shares for cash at a redemption price of approximately $10.56 per share, for an aggregate redemption amount of approximately $12,095,215.
In connection with the approval of the Second Extension Amendment Proposal, the Company issued an unsecured promissory note in the principal amount of up to $425,402 (the “Extension Note”) to the Sponsor. The Extension Note does not bear interest and matures upon closing of the Business Combination. In the event that Armada does not consummate a Business Combination, the Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The proceeds of the Extension Note will be deposited in the Trust Account in connection with the Charter Amendment as follows: $70,900 to be deposited into the Trust Account within five business days following approval of the Charter Amendment by the Company’s stockholders, and up to $354,502 in five equal installments to be deposited into the Trust Account for each of the five
one-month
extensions. On August 8, 2023, the Company borrowed $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to September 17, 2023, and on September 12, 2023, October 11, 2023, November 9, 2023, December 19, 2023 and January 16, 2024 the Company borrowed $70,900 under the Extension Note on each such date and deposited the funds into the Trust Account thereby extending the Combination Period for five additional months or until February 17, 2024. Payments made on December 19, 2023 and January 16, 2024 were funded under the terms of the Subscription Agreement with Polar (see Note 4 below).
On August 4, 2023, the Company, Rezolve, Rezolve AI, and Rezolve Merger Sub amended the Business Combination Agreement to remove the requirement that after giving effect to the transactions contemplated by the Business Combination Agreement, Rezolve shall have at least
$5,000,001 of net tangible assets (as determined in accordance with
Rule 3a51-1(g)(1)
of the Exchange Act) immediately after the closing of the Business Combination.
On February 15, 2024, the Company held a special meeting of its stockholders to approve an amendment to its Charter (the “Charter Amendment”) to extend the date (the “Termination Date”) by which the Company has to consummate a Business Combination from February 17, 2024 (the “Termination Date”) to March 17, 2024 (the “Charter Extension Date”) and to allow the Company, without another stockholder vote, to elect to extend the Termination Date to consummate a Business Combination on a monthly basis up to five times by an additional one month each time after the Charter Extension Date, by resolution of the Company’s board of directors, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until August 17, 2024, or a total of up to six months after the Original Termination Date, unless the closing of a Business Combination shall have occurred prior thereto (the “Third Extension Amendment Proposal”). The stockholders of the Company approved the Third Extension Amendment Proposal at the special meeting and on February 15, 2024 the Company filed the Charter Amendment with the Delaware Secretary of State.
In connection with the vote to approve the Charter Amendment, the holders of
945,662
shares of Common Stock of the Company exercised their right to redeem their shares for cash at a redemption price of approximately
 $10.98
per share, for an aggregate redemption amount of $10,384,496.
In connection with the approval of the Third Extension Amendment Proposal, the Company issued an unsecured promissory note in the principal amount of up to $297,714 (the “Second Extension Note”) to the Sponsor. The Second Extension Note does not bear interest and matures upon closing of the Business Combination. In the event that the Company does not consummate a Business Combination, the Second Extension Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The proceeds of the Second Extension Note will be deposited in the Trust Account in connection with the Charter Amendment as follows: $49,619
to be deposited into the Trust Account within three business days following February 17, 2024, and up to
 $
248,095
 
in five equal installments to be deposited into the Trust Account for each of the five
one-month
extensions.
Liquidity and Going Concern
The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business.
As of December 31, 2023, the Company had approximately $54,000 of cash in its bank operating account and a working capital deficiency of approximately $9.1 million (excluding income tax payable and franchise tax payable).
Following the completion of our IPO, the Sponsor has from time to time provided loans to the Company in order to assist the Company to fund its working capital needs and to provide funds to pay for the extensions of the Combination Period, all as more fully described in Note 3.
The aggregate balance outstanding under all promissory notes, including the Extension Note,
 
was $
2,776,600
 and $
2,564,439
as of December 31, 2023
,
and September 30, 2023, respectively.
 
The
 
balance of subscription agreement liability
 
(net of debt discount)
was $6,752 as of December 31, 2023, and $0 as of September 30, 2023.
In connection with the Company’s assessment of going concern considerations in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management determined that the liquidity condition and date for mandatory liquidation and dissolution raise substantial doubt about the Company’s ability to continue as a going concern through August 17, 2024, the scheduled liquidation date of the Company if it does not complete a Business Combination prior to such date. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
 
7

Risks and Uncertainties
Management is continuing to evaluate the impact of the
COVID-19
pandemic on the industry, the geopolitical conditions resulting from the recent invasion of Ukraine by Russia and subsequent sanctions against Russia, Belarus and related individuals and entities, as well as the war between Israel and Hamas, and the possibility of these conflicts spreading in the surrounding region, the status of debt and equity markets, and protectionist legislation in our target markets. Management has concluded that while it is reasonably possible that any of the foregoing could have a negative effect on the Company’s financial position, results of its operations and/or that of Rezolve’s or any other target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.
Inflation Reduction Act of 2022
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.
Any redemption or other repurchase that occurs on or after January 1, 2023, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of the Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with the Business Combination (or otherwise issued not in connection with the Business Combination but issued within the same taxable year of the Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. The Company has agreed that any such excise taxes shall not be paid from the interest earned on the funds held in the Trust Account.
As discussed above, during February 2023, holders of 11,491,148 shares of Common Stock elected to redeem their shares in connection with the Extension. As a result, $117,079,879 was removed from the Company’s Trust Account to pay such holders. During August 2023, holders of 1,145,503 shares of Common Stock elected to redeem their shares in connection with the Second Amendment Extension Proposal. As a result, $12,095,215 was removed from the Company’s Trust Account to pay such holders. During February 2024, holders of 945,662
shares of Common Stock elected to redeem their shares in connection with the Third Amendment Extension Proposal at a redemption price of approximately
 $10.98
per share, for an aggregate redemption amount of $10,384,496.
Management has evaluated the requirements of the IR Act and the Company’s operations, and has determined that $1,291,751 is required to be recorded as a liability on the Company’s balance sheet as of December 31, 2023. This liability will be reevaluated and remeasured at the end of each quarterly period.
Note 2 — Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by US GAAP. In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows for the period presented in the unaudited condensed financial statements. Operating results for the three months ended December 31, 2023, are not necessarily indicative of the results that may be expected through September 30, 2024.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on
Form10-K,
as filed with SEC on December 4, 2023.
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart the Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any
 
8

such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This
may
make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $54,405 and $60,284 in cash as of December 31, 2023 and September 30, 2023, respectively.
Investments Held in Trust Account
As of both December 31, 2023 and September 30, 2023, the assets held in the Trust Account were held in an interest bearing demand deposit account. To mitigate the risk that the Company may be deemed an investment company for purposes of the Investment Company Act, on August 10, 2023, the Company instructed the trustee of the Trust Account to liquidate the investments held in the Trust Account and thereafter to hold all funds in the Trust Account in an interest bearing demand deposit account until the earlier of consummation of a Business Combination or liquidation. Furthermore, such cash is held in bank accounts which exceed federally insured limits as guaranteed by the Federal Deposit Insurance Corporation.
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
   
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
   
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
   
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
The fair value of certain of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheets.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At December 31, 2023 and September 30, 2023, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Offering Costs Associated with IPO
The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A— “Expenses of Offering”. Offering costs consist of legal, accounting, underwriting and other costs incurred through the balance sheet date that are related to the IPO. The Company incurred offering costs amounting to
 
$3,537,515 as a result of the IPO consisting of a $1,500,000 underwriting commissions and $2,037,515 of other offering costs.
Common Stock Subject to Possible Redemption
The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ deficit. The Company’s shares of common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly,
2,363,349 shares of common stock as of September 30, 2023 and December 31, 2023 subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.
 
9

The Company recognizes changes in redemption value as they occur. Immediately upon the closing of the IPO, the Company recognized the remeasurement adjustment from initial carrying amount to redemption book value. The change in the carrying value
of
common stock subject to possible redemption resulted in charges against additional
paid-in
capital and accumulated deficit.
At December 31, 2023 and September 30, 2023, the common stock reflected in the balance sheets are reconciled in the following table:
 
 
 
 
 
 
Gross Proceeds
   $ 150,000,000  
Proceeds allocated to Public Warrants
     (11,700,000
Issuance costs related to common stock
     (3,261,589
Remeasurement of carrying value to redemption value
     14,961,589  
Subsequent remeasurement of carrying value to redemption value – Trust interest income (excluding the amount that can be withdrawn from Trust Account for taxes)
     548,862  
Common stock subject to possible redemption – September 30, 2022
  
 
150,548,862
 
Redemptions
     (129,175,094
Remeasurement of carrying value to redemption value
     3,943,038  
Common stock subject to possible redemption – September 30, 2023
  
$
25,316,806
 
Remeasurement of carrying value to redemption value
     467,884  
Common stock subject to possible redemption – December 31, 2023
  
$
25,784,690
 
 
10

Net (Loss) Income Per Common Stock
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per common stock is computed by dividing net (loss) income by the weighted average number of common stock outstanding for the period. Remeasurement adjustments associated with the redeemable shares of common stock are excluded from earnings per share as the redemption value approximates fair value.
The calculation of diluted (loss) income per share does not consider the effect of the warrants issued in connection with the IPO because the warrants are contingently exercisable, and the contingencies have not yet been met. The warrants are exercisable to purchase 7,500,000 shares of common stock in the aggregate. As of December 31, 2023 and 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net (loss) income per common stock is the same as basic net loss per common stock for the periods presented.
Accretion of the carrying value of common stock subject to redemption value is excluded from net (loss) income per common stock because the redemption value approximates fair value.
 
 
  
For the Three Months Ended December 31,
 
 
  
2023
 
  
2022
 
 
  
Common
Stock
Subject to
Possible
Redemption
 
  
Non-Redeemable
Common
Stock
 
  
Common
Stock
Subject to
Possible
Redemption
 
  
Non-Redeemable
Common
Stock
 
Basic and diluted net (loss) income per share
                                   
Numerator:
                                   
Allocation of net (loss) income
   $ (105,483    $ (254,831    $ 439,673      $ 167,354  
Denominator
                                   
Weighted-average shares outstanding
     2,363,349        5,709,500        15,000,000        5,709,500  
Basic and diluted net (loss) income per share
   $ (0.04    $ (0.04    $ 0.03      $ 0.03  
Stock-Based Compensation
The Company accounts for share-based payments in accordance with FASB ASC Topic 718, “Compensation—Stock Compensation,” (“ASC 718”), which requires that all equity awards be accounted for at their “fair value.” The Company measures and recognizes compensation expense for all share-based payments on their estimated fair values measured as of the grant date. These costs are recognized as an expense in the statements of operations upon vesting, once the applicable performance conditions are met, with an offsetting increase to additional
paid-in
capital. Forfeitures are recognized as they occur.
On June 16, 2021, the Sponsor transferred 50,000 shares to each of its Chief Executive Officer and to its President and 35,000 shares to each of its three independent directors. The aforementioned transfer is
with
in the scope of ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The aggregate fair value of these shares was $509,552 at issuance. A total of 100,000 shares vested upon consummation of the Initial Public Offering. The remaining 105,000 shares vest in equal quarterly installments until the second anniversary of the consummation of the Company’s Initial Public Offering, or August 17, 2023. At December 31, 2023, all shares under the June 16, 2021 grant were vested.
On June 26, 2023, the Sponsor allocated 270,000 shares to its three independent directors (90,000 each) and 100,000 shares to an executive officer. The aforementioned transfer is
with
in the scope of ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the transfer date. The aggregate fair value of these shares was $207,200 at the date of the transfer. A total of 190,000 shares vested upon the transfer date. The remaining 180,000 shares will vest as follows: 90,000 upon the 6 month anniversary of the transfer date; and 90,000 upon the one year anniversary of the transfer date
,
provided that all unvested shares would become vested upon consummation of initial business combination. The Company recognized $50,400 of stock-based compensation related to this grant for the three months ended December 31, 2023.
The Company recognized $50,400 and $27,963
of stock-based compensation for the three-month periods ended December 31, 2023 and December 31, 2022, respectively. 
Income Taxes
The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
 
11

As of December 31, 2023, and September 30, 2023, the Company’s deferred tax asset had a full
valuation
allowance recorded against it. Our effective tax
 
rate
 
was 23.19%
 
and 30.01% for the three months ended December 31, 2023 and 2022. The effective tax rate differs from the statutory tax rate of 21% for three months ended December 31, 2023, and 2022, due to the valuation allowance on the deferred tax assets and permanent differences related to the business acquisition and stock-based compensation expenses.
Debt discounts
Debt discounts relate to the issuance costs of some of the promissory notes to related parties, and are included in the condensed consolidated balance sheets as a direct deduction from the face amount of the promissory notes. Debt discounts are amortized over the term of the related promissory notes and included in the interest expense.
Recent Accounting Pronouncements
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its consolidated financial statements and disclosures.
Note 3 — Related Party Transactions
Founder Shares
On February 3, 2021, the Sponsor paid $
25,000
, approximately $
0.006
per share, to cover certain offering costs in consideration for
4,312,500
shares of common stock, par value $
0.0001
. On June 16, 2021, the Sponsor purchased an additional
700,000
shares of common stock at a purchase price of $
0.006
per share, or an aggregate $
4,070
, and transferred
50,000
shares to its Chief Executive Officer and to its President and
35,000
shares to each of its
three
independent directors. On July 23, 2021, the Sponsor purchased an additional
1,200,000
shares of common stock at a purchase price of $
0.006
per share, or an aggregate $
6,975
, resulting in the Sponsor holding an aggregate of
6,007,500
shares of common stock and the Chief Executive Officer, President and independent directors holding an aggregate of
205,000
shares of common stock (such shares, collectively, the “Founder Shares”). The Founder Shares included an aggregate of up to
1,125,000
shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part. On October 1, 2021 the underwriters’ over-allotment option expired unused resulting in
1,125,000
Founder Shares forfeited to the Company for no consideration.
The Sponsor, officers and directors have agreed not to transfer, assign or sell any Founder Shares held by them until the earliest of (A)180 days after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, the date on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the public stockholders having the right to exchange their public shares for cash, securities or other property (except with respect to permitted transferees). Any permitted transferees would be subject to the same restrictions and other agreements of the Sponsor, officers, and directors with respect to any Founder Shares.
Additionally, upon consummation of the IPO, the Sponsor sold membership interests in the Sponsor to 10 anchor investors that purchased 9.9% of the units sold in the IPO. The Sponsor sold membership interests in the Sponsor entity reflecting an allocation of 131,250 Founder Shares to each anchor investor, or an aggregate of 1,312,500 Founder Shares to all 10 anchor investors, at a purchase price of approximately $0.006 per share. The Company estimated the aggregate fair value of these founder shares attributable to each anchor investor to be $424,491, or $3.23 per share. The Company has offset the excess of the fair value against the gross proceeds from these anchor investors as a reduction in its additional
paid-in
capital in accordance with Staff Accounting Bulletin Topic 5A.
Representative Common Stock
On February 8, 2021, EarlyBirdCapital, Inc. and Northland Securities, Inc. (“Northland”) purchased 162,500 and 87,500 shares of common stock (“representative shares”), respectively, at an average purchase price of approximately $0.0001 per share, or an aggregate purchase price of $25.00. On May 29, 2021, Northland returned 87,500 shares of common stock to the Company, for no consideration, which were subsequently cancelled.
The representative shares are identical to the public shares included in the Units being sold in the IPO, except that the representative shares are subject to certain transfer restrictions, as described in more detail below.
The holders of the representative shares have agreed not to transfer, assign or sell any such shares until 30 days after the completion of an initial Business Combination. In addition, the holders of the representative shares have agreed (i) to waive their redemption rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of an initial Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete an initial Business Combination.
Promissory
Notes-to
Related Party
On May 9, 2022, the Sponsor loaned the Company the aggregate amount of $483,034 in order to assist the Company to fund its working capital needs. The loan is evidenced by two promissory notes in the aggregate principal amount of $483,034 from the Company, as maker, to the Sponsor, as payee. During July 2022, the Company fully repaid one of the promissory notes in the amount of $187,034, which represented monies loaned to the Company for the payment of Delaware franchise taxes. The Company utilized the interest earned on the Trust Account to repay the promissory note. The Company also paid $0 and $4,300 on behalf of the Sponsor for tax services in period ended December 31, 2023 and September 30, 2023, respectively. These amounts were applied against the balance owing to the Sponsor under the remaining promissory note. As of December 31, 2023 and September 30, 2023, the net amount outstanding under the promissory note was $247,454 and $247,454, respectively.
On November 10, 2022, the Sponsor loaned the Company $1,500,000 in order to cover the additional contribution to the Trust Account in connection with the Company’s exercise of the extension of the Combination Period until February 17, 2023, and $450,000 to fund its working capital needs. The promissory notes are
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time.
 
12

On July 28, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $125,245. The promissory note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. The amount outstanding under this promissory note was $125,245 as of December 31, 2023.
On August 2, 2023, the Company entered into a promissory note to the Sponsor in the amount of up to $425,402. The Extension Note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. Upon consummation of a Business Combination, the Sponsor shall have the option, but not the obligation, to convert up to $425,402 of the total principal amount of this note, in whole or in part at the option of the Sponsor, into common stock of the Company at a price of $10.00 per share (the “Common Stock”). The Common Stock shall be identical to the private placement shares issued to the Sponsor at the time of the Company’s IPO. On August 8, 2023, the Company borrowed $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to September 17, 2023. On September 12, 2023, the Company borrowed an additional $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to October 17, 2023. On October 10, 2023, the Company borrowed an additional $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to November 17, 2023. On November 9, 2023, the Company borrowed an additional $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to December 17, 2023. On December 19, 2023, the Company borrowed an additional $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to January 17, 2024. As of December 31, 2023, $354,502 was drawn and outstanding under this note. Management has determined that the conversion feature described above should not be accounted for separately from its host instrument. The December 19, 2023 draw of $70,900 under the Extension Note was attributable to a draw down under the Subscription Agreement with Polar as described in the Note 4 below.
On August 8, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $20,840 to be used for working capital. The promissory note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. The amount outstanding under this promissory note was $20,840 as of December 31, 2023.
On September 8, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $79,099 to be used for working capital. The promissory note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. The amount outstanding under this promissory note was $79,099 as of December 31, 2023.
On October 10, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $59,099 to be used for working capital. The promissory note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. The amount outstanding under this promissory note was $59,099 as of December 31, 2023.
On November 20, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $12,510 to be used for working capital. The promissory note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. The amount outstanding under this promissory note was $12,510 as of December 31, 2023.
On December 19, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $39,100 to be used for working capital. The promissory note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. This promissory note is attributable to a draw down under the Subscription Agreement with Polar as described in the Note 4 below.
The aggregate balance outstanding under all promissory notes, excluding the funding under the Subscription Agreement with Polar (as described in the Not 4 below) was $2,776,600 and $2,564,439 as of December 31, 2023 and September 30, 2023, respectively.
Administrative Service Fee
Commencing on the date of the IPO, the Company will pay the Sponsor $10,000 per month for office space, utilities and secretarial support. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the three months ended December 31, 2023, the Company incurred $30,000 in administrative service fees which were not paid and which were recorded in the accounts payable and accrued liabilities in the Company’s balance sheet, and for the three months ended December 31, 2022, the Company incurred and paid $30,000 in administrative service fees.
Note 4 — Subscription Agreement Liability
Effective December 12, 2023, the Company and the Sponsor, entered into a subscription agreement (the “Subscription Agreement”) with Polar Multi-Strategy Master Fund (“Polar”), an unaffiliated third party of the Company, pursuant to which Polar agreed to make certain capital contributions (the “Investor Capital Contribution”) from time to time, at the request of the Sponsor, subject to the terms and conditions of the Subscription Agreement, to the Sponsor to meet the Sponsor’s commitment to fund the Company’s working capital needs and extension payments. In exchange for the commitment of Polar to provide the Investor Capital Contribution, (i) the Sponsor will transfer shares of common stock, par value $0.0001 per share, to Polar at the closing of its initial business combination, as further described below; and (ii)
 
the
Company and the Sponsor have agreed jointly and severally to return the Investor Capital Contribution to the Investor at the closing of an initial business combination. The maximum aggregate Investor Capital Contribution is $440,000, with an initial Investor Capital Contribution of $110,000 available for drawdown within five (5) business days of the Subscription Agreement and the remaining amount to be available for drawdown in three equal tranches of $110,000 during January, February and March 2024. The initial Investor Capital Contribution of $110,000 has been funded to the Sponsor
,
 on January 16, 2024, the second Investor Capital Contribution of $110,000
was funded to the Sponsor, and on February 13, 2024, the third Investor Capital Contribution of $110,000 was funded to the Sponsor. In exchange for the foregoing commitment of Polar to make the Investor Capital Contributions to the Sponsor, the Company agrees to, or cause the surviving entity following the closing of the Company’s initial business combination to, issue
 
880,000
shares of Company common stock
 
13

currently held by the Sponsor in consideration for the amount that has been funded by Polar as of or prior to the closing of an initial business combination (the “Subscription Shares”). The Company or the surviving entity of the business combination shall promptly file a registration statement for resale to register the Subscription Shares after the closing of an initial business combination, but no later than 45 calendar days after the closing of business combination, and cause the registration statement to be declared effective by 150 calendar days after the closing of an initial business combination. The Subscription Shares shall be free from the lockup provisions currently applicable to these shares (for a period of 180 days following the closing of the business combination), provided that the stockholders of the Company shall have approved a proposal to such effect at the stockholders meeting held to approve the initial business combination.
In the event that Sponsor or the Company defaults in its obligations under the terms of the Subscription Agreement and in the event that such default continues for a period of five (5) business days following written notice to the Sponsor and Company (the “Default Date”), the Company (or the surviving entity following the
De-SPAC
Closing) shall immediately issue to Investor 220,000 shares of Company’s Common Stock (the “Default Shares” and together with the Subscription Shares, the “Investor Shares”) on the Default Date and shall issue an additional 220,000 Default Shares on each monthly anniversary of the Default Date thereafter, until the default is cured.
If the Company liquidates without consummating an initial business combination, neither the Company nor the Sponsor shall have any further obligation under the Subscription Agreement other than distributing to the Investor any available cash balances in their operating accounts up to the amount of the Investor Capital Contribution (subject to applicable law) excluding any funds held in the Trust Account.
The Company accounts for the subscription agreement liability as a bundled transaction with allocation of individual items based on their relative fair values. The fair value of shares issuable under the Subscription Agreement is considered cost of borrowing of the funds lent by the Sponsor upon receipt of the Contributions from the Investor and the net amount is recorded as subscription agreement liability in the Company’s balance sheet. The Company recognized $108,634 of cost of borrowing attributable to the draw under the Subscription Agreement in December 2023. Such cost of borrowing is amortized over the term of the Subscription Agreement and is included in the Company’s statement of operations as interest expense. For the three months ended December 31, 2023, the Company recorded $5,384 of interest expense attributable to the previously recognized cost of borrowing. The net amount of subscription liability is presented as a separate line item in the Company’s balance sheet as of December 31, 2023.
Note 5 — Commitments and Contingencies
Registration Rights
The holders of the Founder Shares issued and outstanding on the date of the IPO, as well as the holders of the representative shares, Private Shares and any shares the Sponsor may receive in payment of the Extension Note, will be entitled to registration rights pursuant to an agreement signed on the effective date of the IPO. The holders of a majority of these securities (other than the holders of the representative shares) are entitled to make up to two demands that the Company registers such securities.
The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private Shares and shares issued to the Sponsor in payment of the Extension Note can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The underwriters were paid a cash underwriting discount of 1.0% of the gross proceeds of the IPO, or $1,500,000 (and are entitled to an additional $225,000 of deferred underwriting commission payable at the time of an initial Business Combination if the underwriters’ over-allotment is exercised in full). On October 1, 2021 the underwriters’ over-allotment option expired unused resulting in the $225,000 deferred underwriting commission to be not payable to the underwriter.
Financial Advisory Fee
The Company has engaged Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC (“CCM”), an affiliate of a member of the Sponsor, to provide consulting and advisory services in connection with the IPO, for which it received an advisory fee equal to one (1.0) percent of the aggregate proceeds of the IPO, or $1,500,000, upon closing of the IPO. Affiliates of CCM have and manage investment vehicles with a passive investment in the Sponsor. On August 18, 2021, the Company paid to CCM
a
n aggregate of $1,500,000. The Company engaged CCM as a capital markets advisor in connection with the initial Business Combination for which it will earn an advisory fee of $3,000,000 payable only upon closing of the Business Combination. The Company also engaged CCM as a financial advisor in connection with the initial Business Combination for which it will earn an advisory fee of $8,750,000 payable only upon closing of the Business Combination.
The Company has engaged D.A. Davidson & Co. as a financial advisor and investment banker in connection with the initial Business Combination for which it will earn an advisory fee of $600,000, payable only upon closing of the Business Combination.
The Company has engaged Craig Hallum Capital Group LLC as a financial advisor in connection with the initial Business Combination for which it will earn an advisory fee of $500,000, payable only upon closing of the Business Combination.
The Company had engaged ICR LLC (“ICR”) to provide investor relations services in connection with the initial Business Combination for which ICR was entitled to a monthly fee of $10,400 for the period from November 2021 through December 2022 when the contract with ICR was terminated. A total of $145,600 is recorded by the Company and is due and payable to ICR upon either the termination of or the closing of the initial Business Combination. Under the contract, an additional $145,600 would be due and payable to ICR only upon the closing of the initial Business Combination.
The Company has engaged Bishop IR (“Bishop”) as an investor relations advisor in connection with the initial Business Combination for the period from June 21, 2023 through June 20, 2024 with a monthly fee of $8,000
,
which will increase to $12,000 upon the closing of the initial Business Combination. Either party can terminate the contract at any time upon thirty days prior notice to the other party. Upon completion of initial Business Combination, Bishop would be entitled to a success fee of $100,000 payable only upon closing of the initial Business Combination.
 
14
Business Combination Marketing Agreement
The Company engaged Northland Securities, Inc., the representative of the underwriters, as an advisor in connection with Business Combination to assist in holding meetings with the Company’s stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with the initial Business Combination and assist the Company with press releases and public filings in connection with the Business Combination. The Company will pay the representative a cash fee for such services only upon the consummation of the initial Business Combination in an amount equal to 2.25% of the gross proceeds of the IPO, or $3,375,000. The Company will also pay the representative a separate capital market advisory fee of $2,500,000 only upon the completion of the initial Business Combination. Additionally, the Company will pay the representative a cash fee equal to 1.0% of the total consideration payable in the proposed Business Combination if the representative introduces the Company to the target business with which the Company completes a Business Combination. On February 8, 2021, Northland purchased 87,500 shares of common stock at an average purchase price of approximately $0.0001 per share. On May 29, 2021, Northland returned these 87,500 shares of common stock to the Company, for no consideration, which were subsequently cancelled.
We also will pay to the representative only upon the closing of the initial Business Combination, $1,030,000 due under two separate engagement letters in connection with fairness opinions delivered to our Board of Directors. An aggregate of $120,000 has already been paid under these engagement letters and expensed in the Company’s statement of operations for the fiscal year ended September 30, 2022.
Non-Redemption
Agreements
On January 20, 2023, the Company and its Sponsor entered into ten agreements (the
“Non-Redemption
Agreements” ) with one or more third parties in exchange for them agreeing not to redeem shares of the Company’s common stock sold in its IPO in connection with the upcoming Annual Meeting at which a proposal to approve an extension of time for the Company to consummate an initial business combination from February 17, 2023 to August 17, 2023 had also been submitted to the stockholders. The
Non-Redemption
Agreements provide for the allocation of up to 75,000 Founder Shares held by the Sponsor in exchange for such investor and/or investors agreeing to hold and not redeem certain public shares at the Meeting. Certain of the parties to the
Non-Redemption
Agreements are also members of the Sponsor. The Company estimated the aggregate fair value of the 713,057 Founder Shares attributable to the
non-redeeming
stockholders to be $1,102,909 or on average $1.55 per share. The excess of the fair value of the Founder Shares was determined to be a contribution to the Company from the Sponsor in accordance with Staff Accounting Bulletin (“SAB”) Topic 5T and an offering cost in accordance with SAB Topic 5A. Accordingly, the offering cost was recorded against additional
paid-in
capital. Pursuant to the
Non-Redemption
Agreements, the Company agreed not to satisfy any of its excise tax obligations from the interest earned on the funds held in the Trust Account.
Right of First Refusal
If the Company determines to pursue any equity, equity-linked, debt or mezzanine financing relating to or in connection with an initial Business Combination, then Northland Securities, Inc. shall have the right, but not the obligation, to act as book running manager, placement agent and/or arranger, as the case may be, in any and all such financing or financings. This right of first refusal extends from the date of the IPO until the earlier of the consummation of an initial Business Combination or the liquidation of the Trust Account if the Company fails to consummate a Business Combination during the required time period.
Purchasing Agreement
On February 23, 2023, Armada, Rezolve and YA II PN, Ltd., a Cayman Islands exempted company (“YA”) entered into a Standby Equity Purchase Agreement (the “Purchase Agreement”), pursuant to which, among other things, upon the closing of the Business Combination, Rezolve shall have the right to issue and sell to YA up to
$250 million of the ordinary shares of Rezolve during the 36 month period following the closing of the Business Combination. Rezolve will not be obligated to draw any amount under the Agreement, will control both the timing and amount of all drawdowns, and will issue stock to YA on each drawn down from the facility. Subject to closing of the Business Combination, Rezolve must file and maintain a registration statement, or multiple registration statements, for resale by YA of the shares. If the Business Combination Agreement is terminated, other than in connection with the consummation of the Business Combination, then the Purchase Agreement shall be terminated and of no further effect, without any liability of any party thereunder. Other than making appropriate disclosure of the Purchase Agreement under the Federal securities laws, the Company has no obligations under the Purchase Agreement.
On February 2, 2024, Armada, Rezolve, Rezolve AI and YA amended and restated the Purchase Agreement, (the “Amended and Restated Purchase Agreement”) to, among other things, incorporate a prepaid advance arrangement, whereby YA committed to provide Rezolve with a prepaid advance in an original principal amount of
$2,500,000 
(the “Prepaid Advance”). Upon execution of the Amended and Restated Purchase Agreement,
$2,000,000
of the Prepaid Advance was funded to Rezolve. 
Note 6 — Stockholders’ Deficit
Preferred stock
The Company is authorized to issue 1,000,000 shares of preferred stock with apar value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2023 and September 30, 2023, there were no shares of preferred stock issued or outstanding.
Common stock
The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. At December 31, 2023 and September 30, 2023, there were 5,709,500 shares of common stock issued and outstanding, excluding 2,363,349 and 2,363,349 shares subject to redemption, respectively. On February 3, 2021, affiliates of the Sponsor paid $25,000, or approximately $0.006 per share, to cover certain offering costs in consideration for 4,312,500 Founder Shares. On February 8, 2021, EarlyBirdCapital, Inc. and Northland purchased 162,500 and 87,500 representative shares, respectively, at an average purchase price of approximately $0.0001 per share, or an aggregate purchase price of $25.00.
On May 29, 2021, Northland returned 87,500 shares of common stock to the Company, for no consideration, which were subsequently cancelled and on June 16, 2021, the Sponsor purchased an additional 700,000 shares of common stock at a purchase price of $0.006 per share, resulting in the Sponsor holding an aggregate of 5,012,500 shares of common stock. On June 16, 2021, the Sponsor transferred 50,000 shares to its Chief Executive Officer and
 
15

to its President and 35,000 shares to each of its three outside directors. The Founder Shares included an aggregate of up to 1,125,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part. On October 1, 2021 the underwriter’s over-allotment option expired unused resulting in 1,125,000 founder shares forfeited to the Company for no consideration.
Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. In connection with any vote held to approve the initial Business Combination, the Sponsor, as well as all of the Company’s officers and directors, have agreed to vote their respective shares of common stock owned by them immediately prior to the IPO and any shares purchased in the IPO or following the IPO in the open market in favor of the proposed Business Combination.
Warrants
Each whole warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment as discussed herein. The warrants will become exercisable 30 days after the completion of the Company’s initial Business Combination. However, no warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the public warrants is not effective within 90 days following the consummation of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. In the event of such cashless exercise, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose will mean the average reported last sale price of the shares of common stock for the 5 trading days ending on the trading day prior to the date of exercise. The warrants will expire on the fifth anniversary of the completion of an initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
The Company may call the warrants for redemption, in whole and not in part, at a price of $0.01 per warrant, in whole and not in part:
 
   
at any time after the warrants become exercisable,
 
   
upon not less than 30 days’ prior written notice of redemption to each warrant holder
 
   
if, and only if, the reported last sale price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations) for any 20 trading days within a
30-trading
day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and
 
   
if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants.
If the Company calls the warrants for redemption as described above, the Company’s management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the shares of common stock for the 5 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.
In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor, initial stockholders or their affiliates, without taking into account any founders’ shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the Market Value is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of common stock or equity-linked securities.
Note 7— Subsequent Events
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as disclosed below, the Company did not identify any subsequent events that would have required adjustment or disclosure in these financial statements.
On January 16, 2024, the Company borrowed an additional $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to February 17, 2024. The funds made available by the Sponsor to the Company under the Extension Note were attributable to a draw down under the Subscription Agreement with Polar described in Note 4 above.
On January 16, 2024, the Company borrowed $39,100 from the Sponsor to be used for working capital. The promissory note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. This promissory note was funded by the Sponsor pursuant to a draw down under the Subscription
Agreement with Polar (as described in Note 4 above).
On February 2, 2024, Armada, Rezolve, Rezolve AI and YA amended and restated the Purchase Agreement, (the “Amended and Restated Purchase Agreement”) to, among other things, incorporate a prepaid advance arrangement, whereby YA committed to provide Rezolve with a prepaid advance in an original principal amount of $2,500,000 (the “Prepaid Advance”). Upon execution of the Amended and Restated Purchase Agreement, $2,000,000 of the Prepaid Advance was funded to Rezolve.
On February 15, 2024 the Company held a special meeting of its stockholders to approve an amendment to its Charter (the “Charter Amendment”) to extend the date (the “Termination Date”) by which the Company has to consummate a Business Combination from February 17, 2024 (the “Termination Date”) to March 17, 2024 (the “Charter Extension Date”) and to allow the Company, without another stockholder vote, to elect to extend the Termination Date on a monthly basis up to five times by an additional one month each time after the Charter Extension Date, by resolution of the Company’s board of directors, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until August 17, 2024, or a total of
 
16

up to six months after the Termination Date, unless the closing of a Business Combination shall have occurred prior thereto (the “Third Extension Amendment Proposal”). The stockholders of the Company approved the Third Extension Amendment Proposal at the special meeting and on February 1
5
, 2024 the Company filed the Charter Amendment with the Delaware Secretary of State.
In connection with the vote to approve the Charter Amendment, the holders of
945,662
shares of Common Stock of the Company exercised their right to redeem their shares for cash at a redemption price of approximately $
10.98
per share, for an aggregate redemption amount of $10,384,496.

In connection with the approval of the Third Extension Amendment Proposal, the Company issued an unsecured promissory note in the principal amount of up to $297,714 (the “Second Extension Note”) to the Sponsor. The Second Extension Note does
not
bear interest and matures upon closing of the Business Combination. In the event that the Company does not consummate a Business Combination, the Second Extension Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The proceeds of the Second Extension Note will be deposited in the Trust Account in connection with the Charter Amendment as follows: $49,619
to be
deposited into the Trust Account within three business days following February 17, 2024, and up to
 
$
248,095
 
in five equal installments to be deposited into the Trust Account for each of the five
one-month
extensions.
On February 16, 2024, the Company borrowed $49,619 under the Second Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to March 17, 2024. The funds made available by the Sponsor to the Company under the Extension Note were attributable to a draw down under the Subscription Agreement with Polar described in Note 4 above.
On February 16, 2024, the Company borrowed $60,381 from the Sponsor to be used for working capital. The promissory note is non-interest bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. This promissory note was funded by the Sponsor pursuant to a draw down under the Subscription Agreement with Polar described in Note 4 above.
 
17


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this report. References to the “Company,” “us” or “we” refer to Armada Acquisition Corp. I.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings.

Overview

We are a blank check company incorporated in Delaware on November 5, 2020, for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses.

On August 17, 2021, we consummated our IPO of 15,000,000 units, at $10.00 per unit, generating gross proceeds of $150 million.

Simultaneously with the closing of the IPO, we consummated the private placement of 459,500 Private Shares for an aggregate purchase price of $4,595,000.

Upon the closing of the IPO on August 17, 2021, $150,000,000 ($10.00 per unit) from the net proceeds of the sale of the units in the IPO and the sale of Private Shares were placed in the Trust Account.

If we are unable to complete the initial Business Combination within the Combination Period, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us but net of taxes payable (and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, liquidate and dissolve, subject (in the case of (ii) and (iii) above) to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

On February 2, 2023, we held an annual meeting of our stockholders (the “Annual Meeting”). At the Annual Meeting, our stockholders approved an amendment to the Company’s Charter to extend the date by which the Company must consummate a business combination or, if it fails to do so, cease its operations and redeem or repurchase 100% of the shares of the Company’s Common Stock issued in the Company’s initial public offering, from February 17, 2023 for up to six additional months at the election of the Company, ultimately until as late as August 17, 2023 (the “Extension”). We filed an amendment to the Company’s Charter with the Secretary of State of the State of Delaware reflecting the Extension. In connection with the Extension, the holders of 11,491,148 shares of Common Stock elected to redeem their shares at a per share redemption price of approximately $10.19 As a result, we removed $117,079,879 to pay such holders.

On February 23, 2023, the Company, Rezolve and YA II PN, Ltd., a Cayman Islands exempted company (“YA”) entered into a Standby Equity Purchase Agreement (the “Purchase Agreement”), pursuant to which, among other things, upon the closing of the Business Combination, Rezolve shall have the right to issue and sell to YA up to $250 million of the ordinary shares of Rezolve during the 36 month period following the closing of the Business Combination. Rezolve will not be obligated to draw any amount under the Agreement, will control both the timing and amount of all drawdowns, and will issue stock to YA on each drawn down from the facility. Subject to closing of the Business Combination, Rezolve must file and maintain a registration statement, or multiple registration statements, for resale by YA of the shares. If the Business Combination Agreement is terminated, other than in connection with the consummation of the Business Combination, then the Purchase Agreement shall be terminated and of no further effect, without any liability of any party thereunder. Other than making appropriate disclosure of the Purchase Agreement under the Federal securities laws, the Company has no obligations under the Purchase Agreement.

 

18


Table of Contents

On May 9, 2022, the Sponsor loaned the Company the aggregate amount of $483,034 in order to assist the Company to fund its working capital needs and was evidenced by two promissory notes. During July 2022, the Company fully repaid one of the promissory notes in the amount of $187,034 which represented monies loaned to the Company for the payment of Delaware franchise taxes. The Company utilized the interest earned on the Trust Account to repay the promissory note. The Company also paid $4,300 and $44,246 on behalf of the Sponsor for tax services in fiscal years 2023 and 2022, respectively. These amounts were applied against the balance owing to the Sponsor under the remaining promissory note. As of September 30, 2023 and 2022, the net amount outstanding under the promissory note was $247,454 and $251,754, respectively. The promissory notes are non-interest bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time.

On November 10, 2022 the Sponsor loaned the Company $1,500,000 in order to cover the additional contribution to the Trust Account required in connection with the exercise by the Company of the extension of the Combination Period until February 17, 2023, and $450,000 to fund its working capital needs. These loans were evidenced by two promissory notes from the Company, as maker, to the Sponsor, as payee. The promissory notes are non-interest bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time.

On July 28, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $125,245. The promissory note is non-interest bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time.

On August 2, 2023, the Company held a special meeting of its stockholders to approve an amendment to its Charter (the “Charter Amendment”) to extend the date (the “Termination Date”) by which Armada has to consummate a Business Combination from August 17, 2023 (the “Original Termination Date”) to September 17, 2023 (the “Charter Extension Date”) and to allow Armada, without another stockholder vote, to elect to extend the Termination Date to consummate a Business Combination on a monthly basis up to five times by an additional one month each time after the Charter Extension Date, by resolution of Armada’s board of directors, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until February 17, 2024, or a total of up to six months after the Original Termination Date, unless the closing of a Business Combination shall have occurred prior thereto (the “Second Extension Amendment Proposal”). The stockholders of Armada approved the Second Extension Amendment Proposal at the special meeting and on August 3, 2023, Armada filed the Charter Amendment with the Delaware Secretary of State.

In connection with the vote to approve the Charter Amendment, the holders of 1,145,503 public shares of Common Stock of Armada exercised their right to redeem their shares for cash at a redemption price of approximately $10.56 per share, for an aggregate redemption amount of approximately $12,095,215.

In connection with the approval of the Second Extension Amendment Proposal, the Company issued an unsecured promissory note in the principal amount of up to $425,402 (the “Extension Note”) to the Sponsor. The Extension Note does not bear interest and matures upon closing of the Business Combination. In the event that Armada does not consummate a Business Combination, the Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. Notwithstanding the foregoing, in the event that Armada does not consummate a Business Combination, the total principal amount of the Extension Note may be converted, in whole or in part, at the option of the lender into common stock of the Company at a price of $10.00 per share, which shares will be identical to the private placement shares issued to Armada Sponsor LLC at the time of the initial public offering of the Company. The proceeds of the Extension Note will be deposited in the Trust Account in connection with the Charter Amendment as follows: $70,900 to be deposited into the Trust Account within five business days following approval of the Charter Amendment by the Company’s stockholders, and up to $354,502 in five equal installments to be deposited into the Trust Account for each of the five one-month extensions. As of February 14, 2024, the Extension Note was fully drawn.

On August 4, 2023, the Company, Rezolve, Rezolve AI, and Rezolve Merger Sub amended the Business Combination Agreement to remove the requirement that after giving effect to the transactions contemplated by the Business Combination Agreement, Rezolve shall have at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) immediately after the closing of the Business Combination.

On August 8, 2023, the Company borrowed $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to September 17, 2023.

On August 8, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $20,840 to be used for working capital. The promissory note is non-interest bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time.

On September 8, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $79,099 to be used for working capital. The promissory note is non-interest bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time.

On September 12, 2023, the Company borrowed $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to October 17, 2023.

On October 10, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $59,099 to be used for working capital. The promissory note is non-interest bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time.

On October 11, 2023, the Company borrowed $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to November 17, 2023.

 

19


Table of Contents

On November 9, 2023, the Company borrowed $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to December 17, 2023.

On November 20, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $12,510 to be used for working capital. The promissory note is non-interest bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time.

On December 19, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $39,100 to be used for working capital. The promissory note is non-interest bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. The funds made available by the Sponsor to the Company were attributable to a draw down under the Subscription Agreement with Polar described in Note 4 above.

On December 19, 2023, the Company borrowed an additional $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to January 17, 2024. The funds made available by the Sponsor to the Company under the Extension Note were attributable to a draw down under the Subscription Agreement with Polar described in Note 4 above.

The aggregate balance outstanding under all promissory notes from the Company to the Sponsor, including the Extension Note and Subscription Liability, was $2,783,352 and $2,564,439 as of December 31, 2023, and September 30, 2023, respectively.

On January 16, 2024, the Company borrowed $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to February 17, 2024. The funds made available by the Sponsor to the Company under the Extension Note were attributable to a draw down under the Subscription Agreement with Polar described in Note 4 above.

On January 16, 2024, the Company borrowed $39,100 from the Sponsor to be used for working capital. The promissory note is non-interest bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. The funds made available by the Sponsor to the Company were attributable to a draw down under the Subscription Agreement with Polar described in Note 4 above.

On February 2, 2024, Armada, Rezolve, Rezolve AI and YA amended and restated the Purchase Agreement (the “Amended and Restated Purchase Agreement”) to, among other things, incorporate a prepaid advance arrangement, whereby YA committed to provide Rezolve with a prepaid advance in an original principal amount of $2,500,000 (the “Prepaid Advance”). Upon execution of the Amended and Restated Purchase Agreement, $2,000,000 of the Prepaid Advance was funded to Rezolve.

On February 15, 2024 the Company held a special meeting of its stockholders to approve an amendment to its Charter (the “Charter Amendment”) to extend the date (the “Termination Date”) by which the Company has to consummate a Business Combination from February 17, 2024 (the “Termination Date”) to March 17, 2024 (the “Charter Extension Date”) and to allow the Company, without another stockholder vote, to elect to extend the Termination Date on a monthly basis up to five times by an additional one month each time after the Charter Extension Date, by resolution of the Company’s board of directors, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until August 17, 2024, or a total of up to six months after the Termination Date, unless the closing of a Business Combination shall have occurred prior thereto (the “Third Extension Amendment Proposal”). The stockholders of the Company approved the Third Extension Amendment Proposal at the special meeting and on February 15, 2024 the Company filed the Charter Amendment with the Delaware Secretary of State.

In connection with the vote to approve the Charter Amendment, the holders of 945,662 shares of Common Stock of the Company exercised their right to redeem their shares for cash at a redemption price of approximately $10.98 per share, for an aggregate redemption amount of $10,384,496.

In connection with the approval of the Third Extension Amendment Proposal, the Company issued an unsecured promissory note in the principal amount of up to $297,714 (the “Second Extension Note”) to the Sponsor. The Second Extension Note does not bear interest and matures upon closing of the Business Combination. In the event that the Company does not consummate a Business Combination, the Second Extension Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The proceeds of the Second Extension Note will be deposited in the Trust Account in connection with the Charter Amendment as follows: $49,619 to be deposited into the Trust Account within three business days following February 17, 2024, and up to $248,095 in five equal installments to be deposited into the Trust Account for each of the five one-month extensions.

On February 16, 2024, the Company borrowed $49,619 under the Second Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to March 17, 2024. The funds made available by the Sponsor to the Company under the Extension Note were attributable to a draw down under the Subscription Agreement with Polar described in Note 4 above.

On February 16, 2024, the Company borrowed $60,381 from the Sponsor to be used for working capital. The promissory note is non-interest bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. This promissory note was funded by the Sponsor pursuant to a draw down under the Subscription Agreement with Polar described in Note 4 above.

Business Combination Agreement

On December 17, 2021, we announced that we entered into a business combination agreement, dated as of December 17, 2021, with Rezolve Limited, a private limited liability company registered under the laws of England and Wales (“Rezolve”), Rezolve Group Limited, a Cayman Islands exempted company (“Cayman NewCo”), and Rezolve Merger Sub, Inc., a Delaware corporation (“Rezolve Merger Sub”) (such business combination agreement, the “Business Combination Agreement,” and such business combination, the “Business Combination”).

Pursuant to the terms of the Business Combination Agreement, we, Cayman NewCo, Rezolve and Rezolve Merger Sub will effect a series of transactions including, among other things:

 

   

a company reorganization pursuant to which Cayman NewCo will enter into a transfer and exchange agreement (the “Transfer and Exchange Agreement”), pursuant to which, each Key Company Shareholder (as defined in the Business Combination Agreement) will transfer to Cayman NewCo his, her or its respective shares of Rezolve in exchange for ordinary shares in Cayman NewCo, such that following the effectiveness of such transfers, the Key Company Shareholders will own the same proportionate equity interests of Cayman NewCo that such Key Company Shareholders owned immediately before such transfers (with the balance of the other shares of Rezolve to be transferred to Cayman NewCo in exchange for an equivalent number and class of shares in Cayman NewCo) and, immediately thereafter, each Key Company Shareholder will transfer to Cayman NewCo all of his, her or its respective shares of Cayman NewCo so received in exchange for his, her or its applicable pro rata portion of the aggregate stock consideration in accordance with the terms and conditions set forth in the Business Combination Agreement and in such Transfer and Exchange Agreement (with all other shareholders of Rezolve to transfer to Cayman NewCo all of his, her or its respective shares of Cayman NewCo received in exchange for his, her or its applicable pro rata portion of the aggregate stock consideration); and

 

   

following the Company Reorganization, but in no event earlier than ten (10) days following the effectiveness of each of the transactions contemplated by the Company Reorganization: (a) Rezolve Merger Sub shall be merged with and into Armada whereupon Rezolve Merger Sub will cease to exist and with Armada surviving the Merger as a subsidiary of Cayman NewCo; and (b) Armada shall loan all of its remaining cash in the Trust Account to Cayman NewCo in exchange for a promissory note, to enable Cayman NewCo to fund working capital and transaction expenses. Pursuant to the Merger, all of the outstanding securities of Armada will be converted into the right to receive an equivalent number of securities of Cayman NewCo of the same type and with the same terms.

As a result of the Business Combination (i) the shareholders of Rezolve will receive a number of Cayman NewCo ordinary shares equal to (A) the quotient obtained by dividing (x) $1,750,000,000 by (y) $10.00 minus (B) the Outstanding Warrant Number (as defined in the Business Combination Agreement) and minus (C) the Acquisition Shares (as defined in the Business Combination Agreement) (to the extent such Acquisition Shares are not already issued on or prior to the Company Reorganization Date), and (ii) the combined company will pay or cause to be paid all of the transaction expenses. As described below, in June 2023 the Business Combination Agreement was amended and restated, and the $1.75 billion number referred to in the prior sentence was changed to $1.60 billion.

The consummation of the Business Combination is subject to the satisfaction or waiver of certain customary closing conditions of the respective parties, including the completion of the Company Reorganization, the requisite approvals of our stockholders and Rezolve’s shareholders and regulatory approvals.

 

20


Table of Contents

In connection with the execution of the Business Combination Agreement, we and Cayman NewCo entered into certain subscription agreements, each dated December 17, 2021 (the “Subscription Agreements”), with certain investors, pursuant to which such investors have agreed to purchase an aggregate of 2,050,000 Ordinary Shares (the “PIPE Shares”) of Cayman NewCo (together, the “Subscriptions”), for a purchase price of $10.00 per share, for an aggregate purchase price of $20.5 million to be issued substantially concurrently with the consummation of the Business Combination. The obligations of each party to consummate the Subscriptions are conditioned upon, among other things, customary closing conditions. The Subscription Agreements terminated once the transactions contemplated by the Business Combination Agreement were not consummated on or prior to August 31, 2022.

On November 10, 2022 (the “Amendment Date”), Armada and Rezolve entered into a First Amendment to the Business Combination Agreement (the “Amendment”). Except as specifically set forth in the Amendment, all other terms and provisions of the original Business Combination Agreement remain unaffected and continue in full force and effect. Below is a summary of the key amendments:

Structure of the Business Combination

The Amendment amends the Business Combination Agreement so that Rezolve is substituted for Cayman Newco as applicable. As a result of this amendment, Cayman Newco is no longer a party to the Business Combination Agreement or the Business Combination, and Rezolve will be the listed entity upon the closing. As necessary, Armada and Rezolve have agreed to make any amendments to the Ancillary Documents as are necessary or appropriate to effect the substitution of Rezolve for Cayman Newco in the Business Combination.

Termination

The original Business Combination Agreement allowed the parties to terminate such agreement if certain conditions described therein are satisfied. One such condition allowed either Armada or Rezolve to terminate the Business Combination Agreement if the Business Combination is not consummated by August 31, 2022 (the “Termination Date”). The Amendment extended the Termination Date to the later of (i) January 31, 2023 or (ii) fifteen (15) days prior to the last date on which Armada may consummate a Business Combination, as defined in and pursuant to the Second Amended and Restated Certificate of Incorporation of Armada, as approved or extended by the stockholders of Armada from time to time.

The original Business Combination Agreement allowed either Armada or Rezolve to terminate the Business Combination Agreement in the event the aggregate transaction proceeds provided or committed to be provided are not more than fifty million dollars ($50,000,000). The Amendment deleted this provision in its entirety.

Incentive Plan

Under the Amendment, the Company and Rezolve agreed and acknowledged that following December 31, 2023, the Rezolve Board has the right to increase the number of Rezolve shares under the Rezolve Incentive Plan by up to 5% per annum for each calendar year commencing in and including 2023, subject to appropriate shareholder approval as required by applicable law or the NASDAQ rules and regulations.

Articles of Association

Pursuant to the Amendment, Armada and Rezolve agreed upon the form of the articles of association of Rezolve to be adopted and become effective upon closing of the Business Combination.

Amended and Restated Business Combination Agreement

On June 16, 2023, the Company, Rezolve, Rezolve AI Limited, a private limited liability company incorporated under the laws of England and Wales (“Rezolve AI”) and Rezolve Merger Sub amended and restated the Business Combination Agreement (the “Amended and Restated Business Combination Agreement”) by way of a Deed of Release, Amendment and Restatement to, among other things, amend (a) the enterprise value of Rezolve by which the aggregate stock consideration is calculated to $1.60 billion, and (b) provide for (i) a pre-Closing demerger (the “Pre-Closing Demerger”) of Rezolve pursuant to UK legislation under which (x) part of Rezolve’s business and assets (being all of its business and assets except for certain shares in Rezolve Information Technology (Shanghai) Co Ltd and its wholly owned subsidiary Nine Stone (Shanghai) Ltd and Rezolve Information Technology (Shanghai) Co Ltd Beijing Branch and certain other excluded assets) are to be transferred to Rezolve AI in exchange for the issue by Rezolve AI of shares of the same classes as in Rezolve for distribution among the original shareholders of Rezolve in proportion to their holdings of shares of each class in Rezolve as at immediately prior to the Pre-Closing Demerger, (y) Rezolve AI will be assigned, assume and/or reissue the secured convertible notes currently issued by Rezolve pursuant to the Loan Agreements (as defined in the Amended and Restated Business Combination Agreement) and (z) Rezolve will then be wound up, and (ii) the merger of the Company with and into Rezolve Merger Sub, with the Company continuing as the surviving entity (the “Merger”) such that after completion of the Pre-Closing Demerger and Merger, the Company will become a wholly owned subsidiary of Rezolve AI.

Concurrently with the execution and delivery of the Amended and Restated Business Combination Agreement, the Company and the Key Company Shareholders (as defined in the Amended and Restated Business Combination Agreement) have entered into the Transaction Support Agreement, pursuant to which, among other things, the Key Company Shareholders have agreed to (a) vote in favor of the Company Reorganization (b) vote in favor of the Amended and Restated Business Combination Agreement and the agreements contemplated thereby and the transactions contemplated thereby, (c) enter into the Investor Rights Agreement (as defined in the Amended and Restated Business Combination Agreement) at Closing and (d) the termination of certain agreements effective as of Closing.

On August 4, 2023, the Company, Rezolve, Rezolve AI, and Rezolve Merger Sub amended the Business Combination Agreement to remove the requirement that after giving effect to the transactions contemplated by the Business Combination Agreement, Rezolve shall have at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) immediately after the closing of the Business Combination.

We cannot assure you that our plans to complete our initial business combination will be successful.

 

21


Table of Contents

Purchasing Agreement

On February 23, 2023, Armada, Rezolve and YA II PN, Ltd., a Cayman Islands exempted company (“YA”) entered into a Standby Equity Purchase Agreement (the “Purchase Agreement”), pursuant to which, among other things, upon the closing of the Business Combination, Rezolve shall have the right to issue and sell to YA up to $250 million of the ordinary shares of Rezolve during the 36 month period following the closing of the Business Combination. Rezolve will not be obligated to draw any amount under the Agreement, will control both the timing and amount of all drawdowns, and will issue stock to YA on each drawn down from the facility. Subject to closing of the Business Combination, Rezolve must file and maintain a registration statement, or multiple registration statements, for resale by YA of the shares. If the Business Combination Agreement is terminated, other than in connection with the consummation of the Business Combination, then the Purchase Agreement shall be terminated and of no further effect, without any liability of any party thereunder. Other than making appropriate disclosure of the Purchase Agreement under the Federal securities laws, the Company has no obligations under the Purchase Agreement.

On February 2, 2024, Armada, Rezolve, Rezolve AI and YA amended and restated the Purchase Agreement, to, among other things, incorporate a prepaid advance arrangement, whereby YA committed to provide Rezolve with a prepaid advance in an original principal amount of $2,500,000 (the “Prepaid Advance”). Upon execution of the Amended and Restated Purchase Agreement, $2,000,000 of the Prepaid Advance was funded to Rezolve.

Results of Operations

For the three months ended December 31, 2023, we had a net loss of $360,314, which consisted of formation and operating costs of $571,529, stock-based compensation of $50,400, and income tax provision of $67,834, partially offset by trust interest income of $334,836 and interest expense of $5,387.

For the three months ended December 31, 2022, we had a net income of $607,027, which consisted of trust interest income of $1,289,673, offset by formation and operating costs of $394,352, stock-based compensation of $27,963, and income tax provision of $260,331.

Following the exercise by the Company on November 10, 2022 of the extension of the deadline for us to complete an initial business combination under our second amended and restated certificate of incorporation, we had until February 17, 2023 (or 18 months following the IPO) to consummate a Business Combination. On February 2, 2023, the stockholders approved an amendment to our certificate of incorporation to extend the Combination Period until August 17, 2023, and on August 2, 2023, the stockholders approved a further amendment to our certificate of incorporation to extend the Combination Period until no later than February 17, 2024. On August 8, 2023, the Company deposited $70,900 into the Trust Account thereby extending the Combination Period until September 17, 2023, and on each of September 12, 2023, October 11, 2023, November 9, 2023, December 15, 2023 and January 16, 2024, the Company deposited $70,900 into the Trust Account thereby extending the Combination Period for an additional five months or until February 17, 2024.

On February 15, 2024, the stockholders approved a third amendment to the Company’s certificate of incorporation to extend the Combination Period for up to six additional months or until no later than August 17, 2024.

However, if we are unable to complete the initial Business Combination within the Combination Period (unless such period is further extended pursuant to the approval of our stockholders), we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company but net of taxes payable (and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and the Company’s board of directors, liquidate and dissolve, subject (in the case of (ii) and (iii) above) to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. As of December 31, 2023, and September 30, 2023, the Trust Account has released $130,246,958 to the Company to pay tax obligations and for redemptions, including $129,175,094 for redemptions and $1,071,864 for tax obligations.

We have also agreed to reimburse the Sponsor for office space, secretarial and administrative services provided to members of our management team, in an amount not to exceed $10,000 per month. Upon completion of our initial business combination or our liquidation, we will cease paying these monthly fees. For the three months ended December 31, 2023 the Company did not pay these administrative fees and recorded an account payable to the Sponsor for $30,000 and for the three months ended December 31, 2022, the Company paid $30,000 under this agreement.

Liquidity and Going Concern

As of December 31, 2023, we had cash outside our Trust Account of $54,405, available for working capital needs. The amount of $25,871,565 as of December 31, 2023, held in the Trust Account is generally unavailable for our use, prior to an initial business combination.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account to complete our initial business combination. We may withdraw interest to pay our taxes and liquidation expenses if we are unsuccessful in completing a business combination. We estimate our 2023 annual franchise tax obligations to be $127,600, which we may pay from funds from the Public Offering held outside of the Trust Account or from interest earned on the funds held in the Trust Account and released to us for this purpose. Our 2021 Delaware franchise tax amounted to $182,069 and our 2022 Delaware franchise tax exclusive of interest and penalty amounted to $200,000. Our annual income tax obligations will depend on the amount of interest and other income earned on the amounts held in the Trust Account reduced by our operating expense and franchise taxes. We expect the interest earned on the amount in the Trust Account will be sufficient to pay our income taxes. To the extent that our equity or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies. The Trust Account has released $0 and $1,071,864 as of December 31, 2023 and September 30, 2023, respectively, to the Company to pay its income and franchise tax obligations.

Further, our Sponsor, officers and directors or their respective affiliates may, but are not obligated to, continue to loan us funds as may be required. If we complete a business combination, we would repay the loans to the extent funds are available. In the event that a business combination does not close, we may use a portion of proceeds held outside the Trust Account to repay the loans, but no proceeds held in the Trust Account would be used to repay the loans. Such loans would be evidenced by promissory notes and would be repaid upon consummation of a business combination, without interest. There was a balance due to the Sponsor of $2,776,600 and $2,564,439 under the loans (including the Extension Note) as of December 31, 2023 and September 30, 2023, respectively. The balance of subscription agreement liability (net of debt discount) was $6,752 as of December 31, 2023, and $0 as of September 30, 2023.

 

22


Table of Contents

However, if our estimates of the operating costs are less than the actual amount necessary to do so, or our Sponsor ceases to loan us sufficient funds, we may have insufficient funds available to operate our business prior to our business combination. Under the original Business Combination Agreement, either we or Rezolve could have terminated the Business Combination Agreement if the aggregate transaction proceeds (excluding certain amounts invested by the investors specified in the Business Combination Agreement) provided or committed to be provided was not more than $50 million. The Amendment entered into in November 2022 eliminated this provision in its entirety. If we are unable to complete a business combination (including the Business Combination) because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account.

In connection with our assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” our management has determined that we have and will continue to incur significant costs in pursuit of acquisition plans which, in addition to the possibility that we might not be able to close a business combination and be forced to liquidate after August 17, 2024 raises substantial doubt about our ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities that might be necessary if we are unable to continue as a going concern.

Critical Accounting Policies

The preparation of these financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. We have identified the following as our critical accounting policies:

Common Stock Subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity. The Company’s shares of common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 15,000,000 shares of common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheet.

The Company recognizes changes in redemption value as they occur. Immediately upon the closing of the IPO, the Company recognized the remeasurement adjustment from initial carrying amount to redemption book value. The change in the carrying value of common stock subject to possible redemptions resulted in charges against additional paid-in capital and accumulated deficit.

Net (Loss) Income Per Common Stock

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per common stock is computed by dividing net (loss) income by the weighted average number of common stock outstanding for the period. Remeasurement adjustments associated with the redeemable shares of common stock is excluded from earnings per share as the redemption value approximates fair value.

The calculation of diluted (loss) income per share does not consider the effect of the warrants issued in connection with the IPO because the warrants are contingently exercisable, and the contingencies have not yet been met. The warrants are exercisable to purchase 7,500,000 shares of common stock in the aggregate. As of December 31, 2023 and 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net (loss) income per common stock is the same as basic net (loss) income per common stock for the periods presented.

Accretion of the carrying value of common stock subject to redemption value is excluded from net (loss) income per common stock because the redemption value approximates fair value.

Recent Accounting Pronouncements

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its consolidated financial statements and disclosures.

Off-Balance Sheet Arrangements; Commitments and Contractual Obligations

We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements.

We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or entered into any non-financial agreements involving assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities other than an administrative agreement to reimburse our sponsor for office space, secretarial and administrative services not to exceed $10,000 per month from the date of closing of the Public Offering. Upon completion of a business combination or the Company’s liquidation, the Company will cease paying these monthly fees.

 

23


Table of Contents

Financial Advisory Fees

We engaged Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC (“CCM”), an affiliate of a member of the Sponsor, to provide consulting and advisory services in connection with the IPO, for which it received an advisory fee equal to one (1.0) percent of the aggregate proceeds of the IPO, or $1,500,000, upon closing of the IPO. Affiliates of CCM have and manage investment vehicles with a passive investment in the Sponsor. On August 18, 2021, we paid to CCM an aggregate of $1,500,000. CCM is engaged to represent our interests only. We have engaged CCM as a capital markets advisor in connection with the initial Business Combination for which it will earn an advisory fee of $3,000,000 payable only upon closing of the Business Combination. The Company also engaged CCM as a financial advisor in connection with the initial Business Combination for which it will earn an advisory fee of $8,750,000 payable only upon closing of the Business Combination.

We have engaged D.A. Davidson & Co. as a financial advisor and investment banker in connection with the initial Business Combination for which it will earn an advisory fee of $600,000, payable only upon closing of the Business Combination.

We have engaged Craig Hallum Capital Group LLC as a financial advisor in connection with the initial Business Combination for which it will earn an advisory fee of $500,000, payable only upon closing of the Business Combination.

We had engaged ICR LLC (“ICR”) to provide investor relations services in connection with the initial Business Combination for which ICR was entitled to a monthly fee of $10,400 for the period from November 2021 through December 2022 when the contract with ICR was terminated. A total of $145,600 is recorded by the Company and is due and payable to ICR upon either the termination of or the closing of the initial Business Combination. Under the contract, an additional $145,600 would be due and payable to ICR only upon the closing of the initial Business Combination.

We have engaged Bishop IR (“Bishop”) as an investor relations advisor in connection with the initial Business Combination for the period from June 21, 2023 through June 20, 2024 with a monthly fee of $8,000 which will increase to $12,000 upon the closing of the initial Business Combination. Either party can terminate the contract at any time upon thirty days prior notice to the other party. Upon completion of initial Business Combination, Bishop would be entitled to a success fee of $100,000 payable only upon closing of the initial Business Combination.

Business Combination Marketing Agreement

We engaged Northland Securities, Inc., the representative of the underwriter, as an advisor in connection with Business Combination to assist in holding meetings with our stockholders to discuss the potential Business Combination and the target business’ attributes, introduce us to potential investors that are interested in purchasing our securities in connection with the initial Business Combination and assist us with press releases and public filings in connection with the Business Combination. We will pay the representative a cash fee for such services only upon the consummation of the initial Business Combination in an amount equal to 2.25% of the gross proceeds of the IPO, or $3,375,000. We will also pay the representative a separate capital market advisory fee of $2,500,000 only upon completion of the initial Business Combination. Additionally, we will pay the representative a cash fee equal to 1.0% of the total consideration payable in the proposed Business Combination if the representative introduces us to the target business with which the Company completes a Business Combination. On February 8, 2021, Northland purchased 87,500 shares of common stock at an average purchase price of approximately $0.0001 per share. On May 29, 2021, Northland returned these 87,500 shares of common stock to the Company, for no consideration, which were subsequently cancelled.

We also will pay to the representative only upon the closing of the initial Business Combination, $1,030,000 due under two separate engagement letters in connection with fairness opinions delivered to our Board of Directors. An aggregate of $120,000 has already been paid under these engagement letters and expensed in the Company’s statement of operations for the fiscal year ended September 30, 2022.

Right of First Refusal

If we determine to pursue any equity, equity-linked, debt or mezzanine financing relating to or in connection with an initial Business Combination, then Northland Securities, Inc. shall have the right, but not the obligation, to act as book running manager, placement agent and/or arranger, as the case may be, in any and all such financing or financings.

This right of first refusal extends from the date of the IPO until the earlier of the consummation of an initial Business Combination or the liquidation of the Trust Account if the Company fails to consummate a Business Combination during the required time period.

Registration Rights

The holders of the Founder Shares issued and outstanding on the date of the IPO, as well as the holders of the representative shares, Private Shares and any shares the Sponsor may receive in payment of the Extension Note, will be entitled to registration rights pursuant to an agreement to be signed prior to or on the effective date of the IPO. The holders of a majority of these securities (other than the holders of the representative shares) are entitled to make up to two demands that we register such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private Shares and shares issued to the Sponsor in payment of the Extension Note can elect to exercise these registration rights at any time after we consummate a business combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a business combination. We will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The underwriters were paid a cash underwriting discount of 1.0% of the gross proceeds of the IPO, or $1,500,000 (and are entitled to an additional $225,000 of deferred underwriting commission payable at the time of an initial Business Combination if the underwriters’ over-allotment is exercised in full). On October 1, 2021 the underwriters’ over-allotment option expired unused resulting in the $225,000 deferred underwriting commission to be not payable to the underwriter.

 

24


Table of Contents

Business Combination Agreement

We are party to the Business Combination Agreement with Rezolve, Cayman NewCo and Rezolve Merger Sub, dated December 17, 2021. Completion of the proposed transaction pursuant to the Business Combination Agreement is subject to customary closing conditions, including the approval of the Company’s and Rezolve’s respective stockholders and regulatory approvals.

On November 10, 2022, Armada and Rezolve entered into a First Amendment to the Business Combination Agreement (the “Amendment”), to among other things, extend the date on which either party to the Business Combination Agreement had the right to terminate the Business Combination Agreement if the Business Combination had not been completed by such date, and change the structure of the Business Combination such that Cayman NewCo is no longer a party to the Business Combination Agreement or the Business Combination.

On June 16, 2023, the Company, Rezolve, Rezolve AI Limited, a private limited liability company incorporated under the laws of England and Wales (“Rezolve AI”) and Rezolve Merger Sub amended and restated the Business Combination Agreement (the “Amended and Restated Business Combination Agreement”) by way of a Deed of Release, Amendment and Restatement to, among other things, amend (a) the enterprise value of Rezolve by which the aggregate stock consideration is calculated to $1.60 billion, and (b) provide for (i) a pre-Closing demerger (the “Pre-Closing Demerger”) of Rezolve pursuant to UK legislation under which (x) part of Rezolve’s business and assets (being all of its business and assets except for certain shares in Rezolve Information Technology (Shanghai) Co Ltd and its wholly owned subsidiary Nine Stone (Shanghai) Ltd and Rezolve Information Technology (Shanghai) Co Ltd Beijing Branch and certain other excluded assets) are to be transferred to Rezolve AI in exchange for the issue by Rezolve AI of shares of the same classes as in Rezolve for distribution among the original shareholders of Rezolve in proportion to their holdings of shares of each class in Rezolve as at immediately prior to the Pre-Closing Demerger, (y) Rezolve AI will be assigned, assume and/or reissue the secured convertible notes currently issued by Rezolve pursuant to the Loan Agreements (as defined in the Amended and Restated Business Combination Agreement) and (z) Rezolve will then be wound up, and (ii) the merger of the Company with and into Rezolve Merger Sub, with the Company continuing as the surviving entity (the “Merger”) such that after completion of the Pre-Closing Demerger and Merger, the Company will become a wholly owned subsidiary of Rezolve AI.

Concurrently with the execution and delivery of the Amended and Restated Business Combination Agreement, Armada and the Key Company Shareholders (as defined in the Amended and Restated Business Combination Agreement) have entered into the Transaction Support Agreement, pursuant to which, among other things, the Key Company Shareholders have agreed to (a) vote in favor of the Company Reorganization (b) vote in favor of the Amended and Restated Business Combination Agreement and the agreements contemplated thereby and the transactions contemplated thereby, (c) enter into the Investor Rights Agreement (as defined in the Amended and Restated Business Combination Agreement) at Closing and (d) the termination of certain agreements effective as of Closing.

On August 4, 2023, Armada, Rezolve, Rezolve AI, and Rezolve Merger Sub amended the Business Combination Agreement to remove the requirement that after giving effect to the transactions contemplated by the Business Combination Agreement, Rezolve shall have at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) immediately after the closing of the Business Combination.

Subscription Agreement

Effective December 12, 2023, Armada and the Sponsor entered into an subscription agreement (the “Polar Subscription Agreement”) with Polar Multi-Strategy Master Fund (“Polar”), an unaffiliated third party of the Company, pursuant to which Polar agrees to make certain capital contributions (the “Investor Capital Contribution”) from time to time, at the request of the Sponsor, subject to the terms and conditions of the Polar Subscription Agreement, to the Sponsor to meet the Sponsor’s commitment to fund the Company’s working capital needs. In exchange for the commitment of Polar to provide the Investor Capital Contribution, (i) the Sponsor will transfer shares of common stock, par value $0.0001 per share, to Polar at the closing of its initial business combination, as further described below; and (ii) upon repayment of working capital loans by the Company, the Sponsor will return the Investor Capital Contribution at the closing of an initial business combination, as further described below.

The maximum aggregate Investor Capital Contribution is $440,000, with an initial Investor Capital Contribution of $110,000 available for drawdown within five (5) business days of the Polar Subscription Agreement and the balance available for drawdown in three equal monthly tranches of $110,000 during January, February and March 2024. The initial Investor Capital Contribution of $110,000 has been funded to the Sponsor, on January 16, 2024, the second Investor Capital Contribution of $110,000 was funded, and on February 13, 2024, the third Investor Capital Contribution of $110,000 was funded.

In exchange for the forgoing commitment of Polar to make capital contributions to the Sponsor, the Company agrees to, or cause the surviving entity following the closing of the Company’s initial business combination to, issue 880,000 shares of Armada common stock currently held by the Sponsor in consideration for the amount that has been funded by Polar as of or prior to the closing of an initial business combination. The Company or the surviving entity of the business combination shall promptly file a registration statement for resale to register the Subscription Shares after the closing of an initial business combination, but no later than 45 calendar days after the closing of business combination, and cause the registration statement to be declared effective by 150 calendar days after the closing of an initial business combination.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of December 31, 2023, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that as of December 31, 2023, our disclosure controls and procedures were effective.

 

25


Table of Contents

Changes in Internal Control over Financial Reporting

There were no changes to our internal control over financial reporting that occurred during our fiscal quarter ended December 31, 2023, that have materially affected or are reasonably likely to materially affect, our interna control over financial reporting.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

As of the date of this Quarterly Report, there have been no material changes with respect to those risk factors previously disclosed in our Annual Report on Form 10-K for the year ended September 30, 2023, as filed with SEC on December 4, 2023. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not Applicable.

Item 5. Other Information.

None.

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

Exhibit No.

  

Description

  

Incorporation by Reference

2.1    Subscription Agreement, dated December 12, 2023, by and among Armada Acquisition Corp. I, Armada Sponsor LLC and Polar Multi-Strategy Master Fund.    Previously filed as an exhibit to our Current Report on Form 8-K filed on January 19, 2024 and incorporated by reference herein.
31.1    Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)- 14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.    Filed herewith.
31.2    Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)- 14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.    Filed herewith.
32.1    Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.    Furnished herewith.
32.2    Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.    Furnished herewith.
101.INS    XBRL Instance Document    Filed herewith.
101.CAL    XBRL Taxonomy Extension Calculation Linkbase Document    Filed herewith.
101.SCH    XBRL Taxonomy Extension Schema Document    Filed herewith.

 

26


Table of Contents
101.DEF    XBRL Taxonomy Extension Definition Linkbase Document    Filed herewith.
101.LAB    XBRL Taxonomy Extension Labels Linkbase Document    Filed herewith.
101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document    Filed herewith.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).    Filed herewith.

 

27


Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    ARMADA ACQUISITION CORP. I
Date: February 16, 2024     By:   /s/ Stephen P. Herbert
    Name:   Stephen P. Herbert
    Title:   Chief Executive Officer
      (Principal Executive Officer)
Date: February 16, 2024     By:   /s/ Douglas M. Lurio
    Name:   Douglas M. Lurio
    Title:   President
      (Principal Accounting and Financial Officer)

 

28

EXHIBIT 31.1

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Stephen P. Herbert, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Armada Acquisition Corp. I;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: February 16, 2024     By:   /s/ Stephen P. Herbert
      Stephen P. Herbert
      Chief Executive Officer
      (Principal Executive Officer)

EXHIBIT 31.2

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Douglas M. Lurio, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Armada Acquisition Corp. I;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: February 16, 2024     By:   /s/ Douglas M. Lurio
      Douglas M. Lurio
      President
      (Principal Financial and Accounting Officer)

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Armada Acquisition Corp. I (the “Company”) on Form 10-Q for the quarterly period ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stephen P. Herbert, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 16, 2024

 

/s/ Stephen P. Herbert
Name:   Stephen P. Herbert
Title:   Chief Executive Officer
  (Principal Executive Officer)

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Armada Acquisition Corp. I (the “Company”) on Form 10-Q for the quarterly period ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Douglas M. Lurio, President of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 16, 2024

 

/s/ Douglas M. Lurio
Name:   Douglas M. Lurio
Title:   President
  (Principal Financial and Accounting Officer)
v3.24.0.1
Cover - shares
3 Months Ended
Dec. 31, 2023
Feb. 09, 2024
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Dec. 31, 2023  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 001-40742  
Entity Registrant Name Armada Acquisition Corp. I  
Entity Central Index Key 0001844817  
Entity Tax Identification Number 85-3810850  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 1760 Market Street  
Entity Address, Address Line Two Suite 602  
Entity Address, City or Town Philadelphia  
Entity Address, State or Province PA  
Entity Address, Postal Zip Code 19103  
City Area Code 215  
Local Phone Number 543-6886  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company true  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   8,072,849
Common stock trades seperately   8,058,884
Units Each Consisting Of One Share Of Common Stock And Onehalf Of One Redeemable Warrant [Member]    
Title of 12(b) Security Units, each consisting of one share of Common Stock and one-half of one Redeemable Warrant  
Trading Symbol AACIU  
Security Exchange Name NASDAQ  
Common Stock Par Value 0. 0001 Per Share [Member]    
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol AACI  
Security Exchange Name NASDAQ  
Warrants Each Exercisable For One Share Of Common Stock For 11. 50 Per Share [Member]    
Title of 12(b) Security Warrants, each exercisable for one share of Common Stock for $11.50 per share  
Trading Symbol AACIW  
Security Exchange Name NASDAQ  
v3.24.0.1
CONDENSED BALANCE SHEETS - USD ($)
Dec. 31, 2023
Sep. 30, 2023
Assets [Abstract]    
Cash $ 54,405 $ 60,284
Prepaid expenses 13,534 33,605
Total current assets 67,939 93,889
Investments held in Trust Account 25,871,565 25,324,028
Total Assets 25,939,504 25,417,917
Current liabilities:    
Accounts payable 5,132,351 4,708,050
Franchise tax payable 23,919 12,100
Income tax payable 78,617 10,783
Subscription agreement liability, net 6,752 0
Excise tax payable 1,291,751 1,291,751
Total current liabilities 9,309,990 8,587,123
Commitments and Contingencies (Note 5)
Common stock subject to possible redemption, 2,363,349 shares at redemption value of approximately $10.91 and $10.71 per share at December 31, 2023 and September 30, 2023, respectively 25,784,690 25,316,806
Stockholders' Deficit:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding 0 0
Common stock, $0.0001 par value; 100,000,000 shares authorized, 5,709,500 shares issued and outstanding (excluding 2,363,349 and 2,363,349 shares subject to possible redemption) at December 31, 2023 and September 30, 2023, respectively 570 570
Additional paid-in capital 159,034 0
Accumulated deficit (9,314,780) (8,486,582)
Total Stockholders' Deficit (9,155,176) (8,486,012)
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders' Deficit 25,939,504 25,417,917
Related Party [Member]    
Current liabilities:    
Promissory Notes-Related Party $ 2,776,600 $ 2,564,439
v3.24.0.1
CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 31, 2023
Sep. 30, 2023
Statement of Financial Position [Abstract]    
Common stock subject to possible redemption, shares 2,363,349 2,363,349
Common stock subject to possible redemption, redemption value per share $ 10.91 $ 10.71
Preferred Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Preferred Stock, Shares Authorized 1,000,000 1,000,000
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Common Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Common Stock, Shares Authorized 100,000,000 100,000,000
Common Stock, Shares, Issued 5,709,500 5,709,500
Common Stock, Shares, Outstanding 5,709,500 5,709,500
v3.24.0.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Formation and operating costs $ 571,529 $ 394,352
Stock-based compensation 50,400 27,963
Loss from operations (621,929) (422,315)
Other income    
Trust interest income 334,836 1,289,673
Interest expense (5,387) 0
Total other income 329,449 1,289,673
Income before provision for income taxes (292,480) 867,358
Provision for income taxes (67,834) (260,331)
Net (loss) income (360,314) $ 607,027
Common Stock [Member]    
Other income    
Net (loss) income $ 0  
Common Stock [Member] | Common stock subject to possible redemption [Member]    
Other income    
Basic weighted average shares outstanding 2,363,349 15,000,000
Diluted weighted average shares outstanding 2,363,349 15,000,000
Basic net (loss) income per share $ (0.04) $ 0.03
Diluted net (loss) income per share $ (0.04) $ 0.03
Common Stock [Member] | Non-redeemable common stock [Member]    
Other income    
Basic weighted average shares outstanding 5,709,500 5,709,500
Diluted weighted average shares outstanding 5,709,500 5,709,500
Basic net (loss) income per share $ (0.04) $ 0.03
Diluted net (loss) income per share $ (0.04) $ 0.03
v3.24.0.1
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Total
Subscription Agreement [Member]
Sponsor [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Subscription Agreement [Member]
Sponsor [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Subscription Agreement [Member]
Sponsor [Member]
Beginning balance, value at Sep. 30, 2022 $ (3,149,327)   $ 570 $ 941,796   $ (4,091,693)  
Beginning balance, shares at Sep. 30, 2022     5,709,500        
Stock-based compensation 27,963     27,963   0  
Subsequent remeasurement of common stock subject to possible redemption (2,479,343)     0   (2,479,343)  
Net (loss) income 607,027         607,027  
Ending balance, value at Dec. 31, 2022 (4,993,680)   $ 570 969,759   (5,964,009)  
Ending balance, shares at Dec. 31, 2022     5,709,500        
Beginning balance, value at Sep. 30, 2023 $ (8,486,012)   $ 570 0   (8,486,582)  
Beginning balance, shares at Sep. 30, 2023 5,709,500   5,709,500        
Stock-based compensation $ 50,400     50,400   0  
Proceeds allocated to Sponsor Shares for subscription agreement liability (see note 4)   $ 108,634     $ 108,634   $ 0
Subsequent remeasurement of common stock subject to possible redemption (467,884)     0   (467,884)  
Net (loss) income (360,314)   $ 0 0   (360,314)  
Ending balance, value at Dec. 31, 2023 $ (9,155,176)   $ 570 $ 159,036   $ (9,314,780)  
Ending balance, shares at Dec. 31, 2023 5,709,500   5,709,500        
v3.24.0.1
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash Flows from Operating Activities:    
Net (loss) income $ (360,314) $ 607,027
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Interest earned on investments held in Trust Account (334,836) (1,289,673)
Interest expense 5,387 0
Stock-based compensation 50,400 27,963
Changes in current assets and liabilities:    
Prepaid expenses 20,071 55,678
Accounts payable 424,300 24,344
Income tax payable 67,834 260,331
Franchise tax payable 11,819 50,000
Net cash used in operating activities (115,339) (264,331)
Cash Flows from Investing Activities:    
Principal deposited in Trust Account (212,701) 0
Net cash used in investing activities (212,701) (1,500,000)
Cash Flows from Financing Activities:    
Proceeds from issuance of promissory notes to related party 212,161 1,950,000
Proceeds from subscription agreement 110,000 0
Net cash provided by financing activities 322,161 1,950,000
Net change in cash (5,879) 185,669
Cash, beginning of the period 60,284 177,578
Cash, end of the period 54,405 363,247
Supplemental disclosure of noncash investing and financing activities    
Subsequent remeasurement of common stock subject to possible redemption 467,884 2,479,343
Cost of issuance of debt under Polar agreement $ 108,634 $ 0
v3.24.0.1
Organization, Business Operations and Going Concern
3 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization, Business Operations and Going Concern
Note–1 - Organization, Business Operations and Going Concern
Armada Acquisition Corp. I (the “Company”) is a blank check company incorporated as a Delaware corporation on November 5, 2020.
The Company was incorporated for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). As more fully described in this Note 1, on December 17, 2021 the Company entered into a business combination agreement with a target business which was amended and restated on June 16, 2023, and further amended on August 4, 2023. The Company concentrated its efforts in identifying businesses in the financial services industry with particular emphasis on businesses that are providing or changing technology for traditional financial services. 
As of December 31, 2023, the Company had not commenced any operations. All activity for the period from November 5, 2020 (inception) through December 31, 2023, relates to the Company’s formation and the initial public offering (the “IPO”) described below, and since the closing of the IPO, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO.
The Company’s sponsor is Armada Sponsor LLC (the “Sponsor”).
The registration statement for the Company’s IPO was declared effective on August 12, 2021 (the “Effective Date”). On August 17, 2021, the Company commenced the IPO of 15,000,000 units at $10.00 per unit (the “Units”).
Simultaneously with the consummation of the IPO, the Company consummated the private placement of 459,500 shares of common stock (“Private Shares”) at a price of $10.00 per share for an aggregate purchase price of $4,595,000.
Transaction costs amounted to $3,537,515, consisting of $1,500,000 of underwriting commissions, and $2,037,515 of other offering costs.
Following the closing of the IPO, a total of $150,000,000 ($10.00 per Unit) was held in the Trust Account (“Trust Account”). The funds held in the Trust Account are required to be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule
2a-7
promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the Investment Company Act, on August 10, 2023 we instructed the trustee to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in an interest bearing demand deposit account until the earlier of the consummation of a Business Combination or our liquidation. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay tax obligations and up to $100,000 to pay dissolution expenses, the proceeds from the IPO and the sale of the Private Shares will not be released from the Trust Account until the earlier of the completion of a Business Combination or the Company’s redemption of 100% of the outstanding public shares if it has not completed a Business Combination in the required time period. The proceeds held in the Trust Account may be used as consideration to pay the sellers of a target business with which the Company completes a Business Combination. Any amounts not paid as consideration to the sellers of the target business may be used to finance operations of the target business.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.
The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (excluding deferred underwriting commissions and taxes payable) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully.
In connection with any proposed Business Combination, the Company will either (1) seek stockholders approval of the initial Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against the proposed Business Combination or do not vote at all, into their pro rata share of the aggregate amount then on deposit in the Trust Account (net of taxes payable), or (2) provide its stockholders with the opportunity to sell their shares to the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the Trust Account (net of taxes payable and less up to $100,000 of interest to pay dissolution expenses), in each case subject to the limitations described herein. The decision as to whether the Company will seek stockholders approval of a proposed Business Combination or will allow stockholders to sell their shares to the Company in a tender offer will be made by the Company, solely in its discretion.
The shares of common stock subject to redemption are recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination (unless the proposal amending the Company charter to remove the net tangible assets requirement in connection with the Business Combination is approved and implemented at the special meeting approving the Business Combination) and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.
 
The Company had until February 17, 2023 (or 18 months following the IPO) to consummate a Business Combination (the “Combination Period”). As further described in Note 1, on February 2, 2023, the stockholders approved an amendment to our certificate of incorporation to extend the Combination Period until August 17, 2023. On August 2, 2023, the stockholders approved a second amendment to our certificate of incorporation to extend the Combination Period for six monthly periods or until no later than February 17, 2024. On February 1
5
, 2024, the stockholders approved a third amendment to the Company’s certificate of incorporation to extend the Combination Period for up to
six
additional monthly periods or until no later than August 17, 2024.
On August 8, 2023, the Company deposited $70,900 into the Trust Account thereby extending the Combination Period until September 17, 2023, and on each of September 12, 2023, October 11, 2023, November 9, 2023, December 15, 2023 and January 16, 2024, the Company deposited $70,900 
into the Trust Account, thereby extending the Combination Period for five additional months or until February17, 2024.
However, if the Company is unable to complete the initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding public shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company but net of taxes payable (and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, liquidate and dissolve, subject (in the case of (ii) and (iii) above) to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
The Sponsor, officers and directors have agreed (i) to vote any shares owned by them in favor of any proposed Business Combination, (ii) not to redeem any shares in connection with a stockholder vote to approve a proposed initial Business Combination or sell any shares to the Company in a tender offer in connection with a proposed initial Business Combination, (iii) that the founders’ shares will not participate in any liquidating distributions from the Company’s Trust Account upon winding up if a Business Combination is not consummated.
The Sponsor has agreed that it will be liable to ensure that the proceeds in the Trust Account are not reduced below $10.00 per share by the claims of target businesses or claims of vendors or other entities that are owed money by the Company for services rendered or contracted for or products sold to the Company. The agreement to be entered into by the Sponsor specifically provides for two exceptions to the indemnity it has given: it will have no liability (1) as to any claimed amounts owed to a target business or vendor or other entity, which has executed an agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account, or (2) as to any claims for indemnification by the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has it independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company believes it is unlikely that the Sponsor will be able to satisfy its indemnification obligations if it is required to do so.
On December 17, 2021, the Company entered into a business combination agreement as amended on November 10, 2022, June 16, 2023, and August 4, 2023 with Rezolve Limited, a private limited company incorporated under the laws of England and Wales (“Rezolve”), Rezolve Group Limited, a Cayman Islands exempted company (“Cayman NewCo”), and Rezolve Merger Sub, Inc., (“Rezolve Merger Sub”) (such business combination agreement, the “Business Combination Agreement,” and such business combination, the “Business Combination”).
On November 10, 2022, the Company and Rezolve entered into a First Amendment to the Business Combination Agreement (the “Amendment,” and together with the Original Business Combination Agreement, the “Business Combination Agreement” and the business combination contemplated thereby, the “Business Combination”), to among other things, extend the date on which either party to the Business Combination Agreement had the right to terminate the Business Combination Agreement if the Business Combination had not been completed by such date to the later of (i) January 31, 2023 or (ii) fifteen days prior to the last date on which the Company may consummate a Business Combination, and change the structure of the Business Combination such that Cayman NewCo is no longer a party to the Business Combination Agreement or the Business Combination.
On February 2, 2023, the Company held its Annual Meeting. At the Annual Meeting, the Company’s stockholders approved an amendment to the Company’s Charter to extend the date by which the Company must consummate a Business Combination or, if it fails to do so, cease its operations and redeem or repurchase 100% of the shares of the Company’s common stock issued in the Company’s IPO, from February 17, 2023 for up to six additional months at the election of the Company, ultimately until as late as August 17, 2023 (the “Extension”). In connection with the Extension, the holders of 11,491,148 shares of Common Stock elected to redeem their shares at a per share redemption price of approximately $10.19. As a result, $117,079,879 was removed from the Company’s Trust Account to pay such holders.
On June 16, 2023, the Company, Rezolve, Rezolve AI Limited, a private limited liability company incorporated under the laws of England and Wales (“Rezolve AI”) and Rezolve Merger Sub amended and restated the Business Combination Agreement (the “Amended and Restated Business Combination Agreement”) by way of a Deed of Release, Amendment and Restatement to, among other things, amend (a) the enterprise value of Rezolve by which the aggregate stock consideration is calculated to $1.60 billion, and (b) provide for (i) a
pre-Closing
demerger (the
“Pre-Closing
Demerger”) of Rezolve pursuant to UK legislation under which (x) part of Rezolve’s business and assets (being all of its business and assets except for certain shares in Rezolve Information Technology (Shanghai) Co Ltd and its wholly owned subsidiary Nine Stone (Shanghai) Ltd and Rezolve Information Technology (Shanghai) Co Ltd Beijing Branch and certain other excluded assets) are to be transferred to Rezolve AI in exchange for the issue by Rezolve AI of shares of the same classes of capital stock as in Rezolve for distribution among the original shareholders of Rezolve in proportion to their holdings of shares of each class of capital stock in Rezolve as at immediately prior to the
Pre-Closing
Demerger, (y) Rezolve AI will be assigned, assume and/or reissue the secured convertible notes currently issued by Rezolve pursuant to the Loan Agreements (as defined in the Amended and Restated Business Combination Agreement) and (z) Rezolve will then be wound up, and (ii) the merger of the Company with and into Rezolve Merger Sub, with the Company continuing as the surviving entity (the “Merger”) such that after completion of the
Pre-Closing
Demerger and Merger, the Company will become a wholly owned subsidiary of Rezolve AI.
Concurrently with the execution and delivery of the Amended and Restated Business Combination Agreement, the Company and the Key Company Shareholders (as defined in the Amended and Restated Business Combination Agreement) have entered into the Transaction Support Agreement, pursuant to which, among other things, the Key Company Shareholders have agreed to (a) vote in favor of the Company Reorganization (b) vote in favor of the
Amended and Restated Business Combination Agreement and the agreements contemplated thereby and the transactions contemplated thereby, (c) enter into the Investor Rights Agreement (as defined in the Amended and Restated Business Combination Agreement) at Closing and (d) the termination of certain agreements effective as of Closing.
On August 2, 2023, the Company held a special meeting of its stockholders to approve an amendment to its Charter (the “Charter Amendment”) to extend the date (the “Termination Date”) by which Armada has to consummate a Business Combination from August 17, 2023 (the “Original Termination Date”) to September 17, 2023 (the “Charter Extension Date”) and to allow Armada, without another stockholder vote, to elect to extend the Termination Date to consummate a Business Combination on a monthly basis up to five times by an additional one month each time after the Charter Extension Date, by resolution of Armada’s board of directors, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until February 17, 2024, or a total of up to six months after the Original Termination Date, unless the closing of a Business Combination shall have occurred prior thereto (the “Second Extension Amendment Proposal”). The stockholders of Armada approved the Second Extension Amendment Proposal at the special meeting and on August 3, 2023, Armada filed the Charter Amendment with the Delaware Secretary of State.
In connection with the vote to approve the Charter Amendment, the holders of 1,145,503 public shares of Common Stock of Armada exercised their right to redeem their shares for cash at a redemption price of approximately $10.56 per share, for an aggregate redemption amount of approximately $12,095,215.
In connection with the approval of the Second Extension Amendment Proposal, the Company issued an unsecured promissory note in the principal amount of up to $425,402 (the “Extension Note”) to the Sponsor. The Extension Note does not bear interest and matures upon closing of the Business Combination. In the event that Armada does not consummate a Business Combination, the Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The proceeds of the Extension Note will be deposited in the Trust Account in connection with the Charter Amendment as follows: $70,900 to be deposited into the Trust Account within five business days following approval of the Charter Amendment by the Company’s stockholders, and up to $354,502 in five equal installments to be deposited into the Trust Account for each of the five
one-month
extensions. On August 8, 2023, the Company borrowed $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to September 17, 2023, and on September 12, 2023, October 11, 2023, November 9, 2023, December 19, 2023 and January 16, 2024 the Company borrowed $70,900 under the Extension Note on each such date and deposited the funds into the Trust Account thereby extending the Combination Period for five additional months or until February 17, 2024. Payments made on December 19, 2023 and January 16, 2024 were funded under the terms of the Subscription Agreement with Polar (see Note 4 below).
On August 4, 2023, the Company, Rezolve, Rezolve AI, and Rezolve Merger Sub amended the Business Combination Agreement to remove the requirement that after giving effect to the transactions contemplated by the Business Combination Agreement, Rezolve shall have at least
$5,000,001 of net tangible assets (as determined in accordance with
Rule 3a51-1(g)(1)
of the Exchange Act) immediately after the closing of the Business Combination.
On February 15, 2024, the Company held a special meeting of its stockholders to approve an amendment to its Charter (the “Charter Amendment”) to extend the date (the “Termination Date”) by which the Company has to consummate a Business Combination from February 17, 2024 (the “Termination Date”) to March 17, 2024 (the “Charter Extension Date”) and to allow the Company, without another stockholder vote, to elect to extend the Termination Date to consummate a Business Combination on a monthly basis up to five times by an additional one month each time after the Charter Extension Date, by resolution of the Company’s board of directors, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until August 17, 2024, or a total of up to six months after the Original Termination Date, unless the closing of a Business Combination shall have occurred prior thereto (the “Third Extension Amendment Proposal”). The stockholders of the Company approved the Third Extension Amendment Proposal at the special meeting and on February 15, 2024 the Company filed the Charter Amendment with the Delaware Secretary of State.
In connection with the vote to approve the Charter Amendment, the holders of
945,662
shares of Common Stock of the Company exercised their right to redeem their shares for cash at a redemption price of approximately
 $10.98
per share, for an aggregate redemption amount of $10,384,496.
In connection with the approval of the Third Extension Amendment Proposal, the Company issued an unsecured promissory note in the principal amount of up to $297,714 (the “Second Extension Note”) to the Sponsor. The Second Extension Note does not bear interest and matures upon closing of the Business Combination. In the event that the Company does not consummate a Business Combination, the Second Extension Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The proceeds of the Second Extension Note will be deposited in the Trust Account in connection with the Charter Amendment as follows: $49,619
to be deposited into the Trust Account within three business days following February 17, 2024, and up to
 $
248,095
 
in five equal installments to be deposited into the Trust Account for each of the five
one-month
extensions.
Liquidity and Going Concern
The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business.
As of December 31, 2023, the Company had approximately $54,000 of cash in its bank operating account and a working capital deficiency of approximately $9.1 million (excluding income tax payable and franchise tax payable).
Following the completion of our IPO, the Sponsor has from time to time provided loans to the Company in order to assist the Company to fund its working capital needs and to provide funds to pay for the extensions of the Combination Period, all as more fully described in Note 3.
The aggregate balance outstanding under all promissory notes, including the Extension Note,
 
was $
2,776,600
 and $
2,564,439
as of December 31, 2023
,
and September 30, 2023, respectively.
 
The
 
balance of subscription agreement liability
 
(net of debt discount)
was $6,752 as of December 31, 2023, and $0 as of September 30, 2023.
In connection with the Company’s assessment of going concern considerations in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management determined that the liquidity condition and date for mandatory liquidation and dissolution raise substantial doubt about the Company’s ability to continue as a going concern through August 17, 2024, the scheduled liquidation date of the Company if it does not complete a Business Combination prior to such date. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
 
Risks and Uncertainties
Management is continuing to evaluate the impact of the
COVID-19
pandemic on the industry, the geopolitical conditions resulting from the recent invasion of Ukraine by Russia and subsequent sanctions against Russia, Belarus and related individuals and entities, as well as the war between Israel and Hamas, and the possibility of these conflicts spreading in the surrounding region, the status of debt and equity markets, and protectionist legislation in our target markets. Management has concluded that while it is reasonably possible that any of the foregoing could have a negative effect on the Company’s financial position, results of its operations and/or that of Rezolve’s or any other target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.
Inflation Reduction Act of 2022
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.
Any redemption or other repurchase that occurs on or after January 1, 2023, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of the Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with the Business Combination (or otherwise issued not in connection with the Business Combination but issued within the same taxable year of the Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. The Company has agreed that any such excise taxes shall not be paid from the interest earned on the funds held in the Trust Account.
As discussed above, during February 2023, holders of 11,491,148 shares of Common Stock elected to redeem their shares in connection with the Extension. As a result, $117,079,879 was removed from the Company’s Trust Account to pay such holders. During August 2023, holders of 1,145,503 shares of Common Stock elected to redeem their shares in connection with the Second Amendment Extension Proposal. As a result, $12,095,215 was removed from the Company’s Trust Account to pay such holders. During February 2024, holders of 945,662
shares of Common Stock elected to redeem their shares in connection with the Third Amendment Extension Proposal at a redemption price of approximately
 $10.98
per share, for an aggregate redemption amount of $10,384,496.
Management has evaluated the requirements of the IR Act and the Company’s operations, and has determined that $1,291,751 is required to be recorded as a liability on the Company’s balance sheet as of December 31, 2023. This liability will be reevaluated and remeasured at the end of each quarterly period.
v3.24.0.1
Significant Accounting Policies
3 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Significant Accounting Policies
Note 2 — Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by US GAAP. In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows for the period presented in the unaudited condensed financial statements. Operating results for the three months ended December 31, 2023, are not necessarily indicative of the results that may be expected through September 30, 2024.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on
Form10-K,
as filed with SEC on December 4, 2023.
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart the Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any
 
such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This
may
make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $54,405 and $60,284 in cash as of December 31, 2023 and September 30, 2023, respectively.
Investments Held in Trust Account
As of both December 31, 2023 and September 30, 2023, the assets held in the Trust Account were held in an interest bearing demand deposit account. To mitigate the risk that the Company may be deemed an investment company for purposes of the Investment Company Act, on August 10, 2023, the Company instructed the trustee of the Trust Account to liquidate the investments held in the Trust Account and thereafter to hold all funds in the Trust Account in an interest bearing demand deposit account until the earlier of consummation of a Business Combination or liquidation. Furthermore, such cash is held in bank accounts which exceed federally insured limits as guaranteed by the Federal Deposit Insurance Corporation.
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
   
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
   
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
   
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
The fair value of certain of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheets.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At December 31, 2023 and September 30, 2023, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Offering Costs Associated with IPO
The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A— “Expenses of Offering”. Offering costs consist of legal, accounting, underwriting and other costs incurred through the balance sheet date that are related to the IPO. The Company incurred offering costs amounting to
 
$3,537,515 as a result of the IPO consisting of a $1,500,000 underwriting commissions and $2,037,515 of other offering costs.
Common Stock Subject to Possible Redemption
The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ deficit. The Company’s shares of common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly,
2,363,349 shares of common stock as of September 30, 2023 and December 31, 2023 subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.
 
The Company recognizes changes in redemption value as they occur. Immediately upon the closing of the IPO, the Company recognized the remeasurement adjustment from initial carrying amount to redemption book value. The change in the carrying value
of
common stock subject to possible redemption resulted in charges against additional
paid-in
capital and accumulated deficit.
At December 31, 2023 and September 30, 2023, the common stock reflected in the balance sheets are reconciled in the following table:
 
 
 
 
 
 
Gross Proceeds
   $ 150,000,000  
Proceeds allocated to Public Warrants
     (11,700,000
Issuance costs related to common stock
     (3,261,589
Remeasurement of carrying value to redemption value
     14,961,589  
Subsequent remeasurement of carrying value to redemption value – Trust interest income (excluding the amount that can be withdrawn from Trust Account for taxes)
     548,862  
Common stock subject to possible redemption – September 30, 2022
  
 
150,548,862
 
Redemptions
     (129,175,094
Remeasurement of carrying value to redemption value
     3,943,038  
Common stock subject to possible redemption – September 30, 2023
  
$
25,316,806
 
Remeasurement of carrying value to redemption value
     467,884  
Common stock subject to possible redemption – December 31, 2023
  
$
25,784,690
 
 
Net (Loss) Income Per Common Stock
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per common stock is computed by dividing net (loss) income by the weighted average number of common stock outstanding for the period. Remeasurement adjustments associated with the redeemable shares of common stock are excluded from earnings per share as the redemption value approximates fair value.
The calculation of diluted (loss) income per share does not consider the effect of the warrants issued in connection with the IPO because the warrants are contingently exercisable, and the contingencies have not yet been met. The warrants are exercisable to purchase 7,500,000 shares of common stock in the aggregate. As of December 31, 2023 and 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net (loss) income per common stock is the same as basic net loss per common stock for the periods presented.
Accretion of the carrying value of common stock subject to redemption value is excluded from net (loss) income per common stock because the redemption value approximates fair value.
 
 
  
For the Three Months Ended December 31,
 
 
  
2023
 
  
2022
 
 
  
Common
Stock
Subject to
Possible
Redemption
 
  
Non-Redeemable
Common
Stock
 
  
Common
Stock
Subject to
Possible
Redemption
 
  
Non-Redeemable
Common
Stock
 
Basic and diluted net (loss) income per share
                                   
Numerator:
                                   
Allocation of net (loss) income
   $ (105,483    $ (254,831    $ 439,673      $ 167,354  
Denominator
                                   
Weighted-average shares outstanding
     2,363,349        5,709,500        15,000,000        5,709,500  
Basic and diluted net (loss) income per share
   $ (0.04    $ (0.04    $ 0.03      $ 0.03  
Stock-Based Compensation
The Company accounts for share-based payments in accordance with FASB ASC Topic 718, “Compensation—Stock Compensation,” (“ASC 718”), which requires that all equity awards be accounted for at their “fair value.” The Company measures and recognizes compensation expense for all share-based payments on their estimated fair values measured as of the grant date. These costs are recognized as an expense in the statements of operations upon vesting, once the applicable performance conditions are met, with an offsetting increase to additional
paid-in
capital. Forfeitures are recognized as they occur.
On June 16, 2021, the Sponsor transferred 50,000 shares to each of its Chief Executive Officer and to its President and 35,000 shares to each of its three independent directors. The aforementioned transfer is
with
in the scope of ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The aggregate fair value of these shares was $509,552 at issuance. A total of 100,000 shares vested upon consummation of the Initial Public Offering. The remaining 105,000 shares vest in equal quarterly installments until the second anniversary of the consummation of the Company’s Initial Public Offering, or August 17, 2023. At December 31, 2023, all shares under the June 16, 2021 grant were vested.
On June 26, 2023, the Sponsor allocated 270,000 shares to its three independent directors (90,000 each) and 100,000 shares to an executive officer. The aforementioned transfer is
with
in the scope of ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the transfer date. The aggregate fair value of these shares was $207,200 at the date of the transfer. A total of 190,000 shares vested upon the transfer date. The remaining 180,000 shares will vest as follows: 90,000 upon the 6 month anniversary of the transfer date; and 90,000 upon the one year anniversary of the transfer date
,
provided that all unvested shares would become vested upon consummation of initial business combination. The Company recognized $50,400 of stock-based compensation related to this grant for the three months ended December 31, 2023.
The Company recognized $50,400 and $27,963
of stock-based compensation for the three-month periods ended December 31, 2023 and December 31, 2022, respectively. 
Income Taxes
The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
 
As of December 31, 2023, and September 30, 2023, the Company’s deferred tax asset had a full
valuation
allowance recorded against it. Our effective tax
 
rate
 
was 23.19%
 
and 30.01% for the three months ended December 31, 2023 and 2022. The effective tax rate differs from the statutory tax rate of 21% for three months ended December 31, 2023, and 2022, due to the valuation allowance on the deferred tax assets and permanent differences related to the business acquisition and stock-based compensation expenses.
Debt discounts
Debt discounts relate to the issuance costs of some of the promissory notes to related parties, and are included in the condensed consolidated balance sheets as a direct deduction from the face amount of the promissory notes. Debt discounts are amortized over the term of the related promissory notes and included in the interest expense.
Recent Accounting Pronouncements
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its consolidated financial statements and disclosures.
v3.24.0.1
Related Party Transactions
3 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
Related Party Transactions
Note 3 — Related Party Transactions
Founder Shares
On February 3, 2021, the Sponsor paid $
25,000
, approximately $
0.006
per share, to cover certain offering costs in consideration for
4,312,500
shares of common stock, par value $
0.0001
. On June 16, 2021, the Sponsor purchased an additional
700,000
shares of common stock at a purchase price of $
0.006
per share, or an aggregate $
4,070
, and transferred
50,000
shares to its Chief Executive Officer and to its President and
35,000
shares to each of its
three
independent directors. On July 23, 2021, the Sponsor purchased an additional
1,200,000
shares of common stock at a purchase price of $
0.006
per share, or an aggregate $
6,975
, resulting in the Sponsor holding an aggregate of
6,007,500
shares of common stock and the Chief Executive Officer, President and independent directors holding an aggregate of
205,000
shares of common stock (such shares, collectively, the “Founder Shares”). The Founder Shares included an aggregate of up to
1,125,000
shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part. On October 1, 2021 the underwriters’ over-allotment option expired unused resulting in
1,125,000
Founder Shares forfeited to the Company for no consideration.
The Sponsor, officers and directors have agreed not to transfer, assign or sell any Founder Shares held by them until the earliest of (A)180 days after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, the date on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the public stockholders having the right to exchange their public shares for cash, securities or other property (except with respect to permitted transferees). Any permitted transferees would be subject to the same restrictions and other agreements of the Sponsor, officers, and directors with respect to any Founder Shares.
Additionally, upon consummation of the IPO, the Sponsor sold membership interests in the Sponsor to 10 anchor investors that purchased 9.9% of the units sold in the IPO. The Sponsor sold membership interests in the Sponsor entity reflecting an allocation of 131,250 Founder Shares to each anchor investor, or an aggregate of 1,312,500 Founder Shares to all 10 anchor investors, at a purchase price of approximately $0.006 per share. The Company estimated the aggregate fair value of these founder shares attributable to each anchor investor to be $424,491, or $3.23 per share. The Company has offset the excess of the fair value against the gross proceeds from these anchor investors as a reduction in its additional
paid-in
capital in accordance with Staff Accounting Bulletin Topic 5A.
Representative Common Stock
On February 8, 2021, EarlyBirdCapital, Inc. and Northland Securities, Inc. (“Northland”) purchased 162,500 and 87,500 shares of common stock (“representative shares”), respectively, at an average purchase price of approximately $0.0001 per share, or an aggregate purchase price of $25.00. On May 29, 2021, Northland returned 87,500 shares of common stock to the Company, for no consideration, which were subsequently cancelled.
The representative shares are identical to the public shares included in the Units being sold in the IPO, except that the representative shares are subject to certain transfer restrictions, as described in more detail below.
The holders of the representative shares have agreed not to transfer, assign or sell any such shares until 30 days after the completion of an initial Business Combination. In addition, the holders of the representative shares have agreed (i) to waive their redemption rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of an initial Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete an initial Business Combination.
Promissory
Notes-to
Related Party
On May 9, 2022, the Sponsor loaned the Company the aggregate amount of $483,034 in order to assist the Company to fund its working capital needs. The loan is evidenced by two promissory notes in the aggregate principal amount of $483,034 from the Company, as maker, to the Sponsor, as payee. During July 2022, the Company fully repaid one of the promissory notes in the amount of $187,034, which represented monies loaned to the Company for the payment of Delaware franchise taxes. The Company utilized the interest earned on the Trust Account to repay the promissory note. The Company also paid $0 and $4,300 on behalf of the Sponsor for tax services in period ended December 31, 2023 and September 30, 2023, respectively. These amounts were applied against the balance owing to the Sponsor under the remaining promissory note. As of December 31, 2023 and September 30, 2023, the net amount outstanding under the promissory note was $247,454 and $247,454, respectively.
On November 10, 2022, the Sponsor loaned the Company $1,500,000 in order to cover the additional contribution to the Trust Account in connection with the Company’s exercise of the extension of the Combination Period until February 17, 2023, and $450,000 to fund its working capital needs. The promissory notes are
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time.
 
On July 28, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $125,245. The promissory note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. The amount outstanding under this promissory note was $125,245 as of December 31, 2023.
On August 2, 2023, the Company entered into a promissory note to the Sponsor in the amount of up to $425,402. The Extension Note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. Upon consummation of a Business Combination, the Sponsor shall have the option, but not the obligation, to convert up to $425,402 of the total principal amount of this note, in whole or in part at the option of the Sponsor, into common stock of the Company at a price of $10.00 per share (the “Common Stock”). The Common Stock shall be identical to the private placement shares issued to the Sponsor at the time of the Company’s IPO. On August 8, 2023, the Company borrowed $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to September 17, 2023. On September 12, 2023, the Company borrowed an additional $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to October 17, 2023. On October 10, 2023, the Company borrowed an additional $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to November 17, 2023. On November 9, 2023, the Company borrowed an additional $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to December 17, 2023. On December 19, 2023, the Company borrowed an additional $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to January 17, 2024. As of December 31, 2023, $354,502 was drawn and outstanding under this note. Management has determined that the conversion feature described above should not be accounted for separately from its host instrument. The December 19, 2023 draw of $70,900 under the Extension Note was attributable to a draw down under the Subscription Agreement with Polar as described in the Note 4 below.
On August 8, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $20,840 to be used for working capital. The promissory note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. The amount outstanding under this promissory note was $20,840 as of December 31, 2023.
On September 8, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $79,099 to be used for working capital. The promissory note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. The amount outstanding under this promissory note was $79,099 as of December 31, 2023.
On October 10, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $59,099 to be used for working capital. The promissory note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. The amount outstanding under this promissory note was $59,099 as of December 31, 2023.
On November 20, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $12,510 to be used for working capital. The promissory note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. The amount outstanding under this promissory note was $12,510 as of December 31, 2023.
On December 19, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $39,100 to be used for working capital. The promissory note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. This promissory note is attributable to a draw down under the Subscription Agreement with Polar as described in the Note 4 below.
The aggregate balance outstanding under all promissory notes, excluding the funding under the Subscription Agreement with Polar (as described in the Not 4 below) was $2,776,600 and $2,564,439 as of December 31, 2023 and September 30, 2023, respectively.
Administrative Service Fee
Commencing on the date of the IPO, the Company will pay the Sponsor $10,000 per month for office space, utilities and secretarial support. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the three months ended December 31, 2023, the Company incurred $30,000 in administrative service fees which were not paid and which were recorded in the accounts payable and accrued liabilities in the Company’s balance sheet, and for the three months ended December 31, 2022, the Company incurred and paid $30,000 in administrative service fees.
v3.24.0.1
Subscription agreement liability
3 Months Ended
Dec. 31, 2023
Subscription Liability [Abstract]  
Subscription agreement liability
Note 4 — Subscription Agreement Liability
Effective December 12, 2023, the Company and the Sponsor, entered into a subscription agreement (the “Subscription Agreement”) with Polar Multi-Strategy Master Fund (“Polar”), an unaffiliated third party of the Company, pursuant to which Polar agreed to make certain capital contributions (the “Investor Capital Contribution”) from time to time, at the request of the Sponsor, subject to the terms and conditions of the Subscription Agreement, to the Sponsor to meet the Sponsor’s commitment to fund the Company’s working capital needs and extension payments. In exchange for the commitment of Polar to provide the Investor Capital Contribution, (i) the Sponsor will transfer shares of common stock, par value $0.0001 per share, to Polar at the closing of its initial business combination, as further described below; and (ii)
 
the
Company and the Sponsor have agreed jointly and severally to return the Investor Capital Contribution to the Investor at the closing of an initial business combination. The maximum aggregate Investor Capital Contribution is $440,000, with an initial Investor Capital Contribution of $110,000 available for drawdown within five (5) business days of the Subscription Agreement and the remaining amount to be available for drawdown in three equal tranches of $110,000 during January, February and March 2024. The initial Investor Capital Contribution of $110,000 has been funded to the Sponsor
,
 on January 16, 2024, the second Investor Capital Contribution of $110,000
was funded to the Sponsor, and on February 13, 2024, the third Investor Capital Contribution of $110,000 was funded to the Sponsor. In exchange for the foregoing commitment of Polar to make the Investor Capital Contributions to the Sponsor, the Company agrees to, or cause the surviving entity following the closing of the Company’s initial business combination to, issue
 
880,000
shares of Company common stock
 
currently held by the Sponsor in consideration for the amount that has been funded by Polar as of or prior to the closing of an initial business combination (the “Subscription Shares”). The Company or the surviving entity of the business combination shall promptly file a registration statement for resale to register the Subscription Shares after the closing of an initial business combination, but no later than 45 calendar days after the closing of business combination, and cause the registration statement to be declared effective by 150 calendar days after the closing of an initial business combination. The Subscription Shares shall be free from the lockup provisions currently applicable to these shares (for a period of 180 days following the closing of the business combination), provided that the stockholders of the Company shall have approved a proposal to such effect at the stockholders meeting held to approve the initial business combination.
In the event that Sponsor or the Company defaults in its obligations under the terms of the Subscription Agreement and in the event that such default continues for a period of five (5) business days following written notice to the Sponsor and Company (the “Default Date”), the Company (or the surviving entity following the
De-SPAC
Closing) shall immediately issue to Investor 220,000 shares of Company’s Common Stock (the “Default Shares” and together with the Subscription Shares, the “Investor Shares”) on the Default Date and shall issue an additional 220,000 Default Shares on each monthly anniversary of the Default Date thereafter, until the default is cured.
If the Company liquidates without consummating an initial business combination, neither the Company nor the Sponsor shall have any further obligation under the Subscription Agreement other than distributing to the Investor any available cash balances in their operating accounts up to the amount of the Investor Capital Contribution (subject to applicable law) excluding any funds held in the Trust Account.
The Company accounts for the subscription agreement liability as a bundled transaction with allocation of individual items based on their relative fair values. The fair value of shares issuable under the Subscription Agreement is considered cost of borrowing of the funds lent by the Sponsor upon receipt of the Contributions from the Investor and the net amount is recorded as subscription agreement liability in the Company’s balance sheet. The Company recognized $108,634 of cost of borrowing attributable to the draw under the Subscription Agreement in December 2023. Such cost of borrowing is amortized over the term of the Subscription Agreement and is included in the Company’s statement of operations as interest expense. For the three months ended December 31, 2023, the Company recorded $5,384 of interest expense attributable to the previously recognized cost of borrowing. The net amount of subscription liability is presented as a separate line item in the Company’s balance sheet as of December 31, 2023.
v3.24.0.1
Commitments and Contingencies
3 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note 5 — Commitments and Contingencies
Registration Rights
The holders of the Founder Shares issued and outstanding on the date of the IPO, as well as the holders of the representative shares, Private Shares and any shares the Sponsor may receive in payment of the Extension Note, will be entitled to registration rights pursuant to an agreement signed on the effective date of the IPO. The holders of a majority of these securities (other than the holders of the representative shares) are entitled to make up to two demands that the Company registers such securities.
The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private Shares and shares issued to the Sponsor in payment of the Extension Note can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The underwriters were paid a cash underwriting discount of 1.0% of the gross proceeds of the IPO, or $1,500,000 (and are entitled to an additional $225,000 of deferred underwriting commission payable at the time of an initial Business Combination if the underwriters’ over-allotment is exercised in full). On October 1, 2021 the underwriters’ over-allotment option expired unused resulting in the $225,000 deferred underwriting commission to be not payable to the underwriter.
Financial Advisory Fee
The Company has engaged Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC (“CCM”), an affiliate of a member of the Sponsor, to provide consulting and advisory services in connection with the IPO, for which it received an advisory fee equal to one (1.0) percent of the aggregate proceeds of the IPO, or $1,500,000, upon closing of the IPO. Affiliates of CCM have and manage investment vehicles with a passive investment in the Sponsor. On August 18, 2021, the Company paid to CCM
a
n aggregate of $1,500,000. The Company engaged CCM as a capital markets advisor in connection with the initial Business Combination for which it will earn an advisory fee of $3,000,000 payable only upon closing of the Business Combination. The Company also engaged CCM as a financial advisor in connection with the initial Business Combination for which it will earn an advisory fee of $8,750,000 payable only upon closing of the Business Combination.
The Company has engaged D.A. Davidson & Co. as a financial advisor and investment banker in connection with the initial Business Combination for which it will earn an advisory fee of $600,000, payable only upon closing of the Business Combination.
The Company has engaged Craig Hallum Capital Group LLC as a financial advisor in connection with the initial Business Combination for which it will earn an advisory fee of $500,000, payable only upon closing of the Business Combination.
The Company had engaged ICR LLC (“ICR”) to provide investor relations services in connection with the initial Business Combination for which ICR was entitled to a monthly fee of $10,400 for the period from November 2021 through December 2022 when the contract with ICR was terminated. A total of $145,600 is recorded by the Company and is due and payable to ICR upon either the termination of or the closing of the initial Business Combination. Under the contract, an additional $145,600 would be due and payable to ICR only upon the closing of the initial Business Combination.
The Company has engaged Bishop IR (“Bishop”) as an investor relations advisor in connection with the initial Business Combination for the period from June 21, 2023 through June 20, 2024 with a monthly fee of $8,000
,
which will increase to $12,000 upon the closing of the initial Business Combination. Either party can terminate the contract at any time upon thirty days prior notice to the other party. Upon completion of initial Business Combination, Bishop would be entitled to a success fee of $100,000 payable only upon closing of the initial Business Combination.
 
Business Combination Marketing Agreement
The Company engaged Northland Securities, Inc., the representative of the underwriters, as an advisor in connection with Business Combination to assist in holding meetings with the Company’s stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with the initial Business Combination and assist the Company with press releases and public filings in connection with the Business Combination. The Company will pay the representative a cash fee for such services only upon the consummation of the initial Business Combination in an amount equal to 2.25% of the gross proceeds of the IPO, or $3,375,000. The Company will also pay the representative a separate capital market advisory fee of $2,500,000 only upon the completion of the initial Business Combination. Additionally, the Company will pay the representative a cash fee equal to 1.0% of the total consideration payable in the proposed Business Combination if the representative introduces the Company to the target business with which the Company completes a Business Combination. On February 8, 2021, Northland purchased 87,500 shares of common stock at an average purchase price of approximately $0.0001 per share. On May 29, 2021, Northland returned these 87,500 shares of common stock to the Company, for no consideration, which were subsequently cancelled.
We also will pay to the representative only upon the closing of the initial Business Combination, $1,030,000 due under two separate engagement letters in connection with fairness opinions delivered to our Board of Directors. An aggregate of $120,000 has already been paid under these engagement letters and expensed in the Company’s statement of operations for the fiscal year ended September 30, 2022.
Non-Redemption
Agreements
On January 20, 2023, the Company and its Sponsor entered into ten agreements (the
“Non-Redemption
Agreements” ) with one or more third parties in exchange for them agreeing not to redeem shares of the Company’s common stock sold in its IPO in connection with the upcoming Annual Meeting at which a proposal to approve an extension of time for the Company to consummate an initial business combination from February 17, 2023 to August 17, 2023 had also been submitted to the stockholders. The
Non-Redemption
Agreements provide for the allocation of up to 75,000 Founder Shares held by the Sponsor in exchange for such investor and/or investors agreeing to hold and not redeem certain public shares at the Meeting. Certain of the parties to the
Non-Redemption
Agreements are also members of the Sponsor. The Company estimated the aggregate fair value of the 713,057 Founder Shares attributable to the
non-redeeming
stockholders to be $1,102,909 or on average $1.55 per share. The excess of the fair value of the Founder Shares was determined to be a contribution to the Company from the Sponsor in accordance with Staff Accounting Bulletin (“SAB”) Topic 5T and an offering cost in accordance with SAB Topic 5A. Accordingly, the offering cost was recorded against additional
paid-in
capital. Pursuant to the
Non-Redemption
Agreements, the Company agreed not to satisfy any of its excise tax obligations from the interest earned on the funds held in the Trust Account.
Right of First Refusal
If the Company determines to pursue any equity, equity-linked, debt or mezzanine financing relating to or in connection with an initial Business Combination, then Northland Securities, Inc. shall have the right, but not the obligation, to act as book running manager, placement agent and/or arranger, as the case may be, in any and all such financing or financings. This right of first refusal extends from the date of the IPO until the earlier of the consummation of an initial Business Combination or the liquidation of the Trust Account if the Company fails to consummate a Business Combination during the required time period.
Purchasing Agreement
On February 23, 2023, Armada, Rezolve and YA II PN, Ltd., a Cayman Islands exempted company (“YA”) entered into a Standby Equity Purchase Agreement (the “Purchase Agreement”), pursuant to which, among other things, upon the closing of the Business Combination, Rezolve shall have the right to issue and sell to YA up to
$250 million of the ordinary shares of Rezolve during the 36 month period following the closing of the Business Combination. Rezolve will not be obligated to draw any amount under the Agreement, will control both the timing and amount of all drawdowns, and will issue stock to YA on each drawn down from the facility. Subject to closing of the Business Combination, Rezolve must file and maintain a registration statement, or multiple registration statements, for resale by YA of the shares. If the Business Combination Agreement is terminated, other than in connection with the consummation of the Business Combination, then the Purchase Agreement shall be terminated and of no further effect, without any liability of any party thereunder. Other than making appropriate disclosure of the Purchase Agreement under the Federal securities laws, the Company has no obligations under the Purchase Agreement.
On February 2, 2024, Armada, Rezolve, Rezolve AI and YA amended and restated the Purchase Agreement, (the “Amended and Restated Purchase Agreement”) to, among other things, incorporate a prepaid advance arrangement, whereby YA committed to provide Rezolve with a prepaid advance in an original principal amount of
$2,500,000 
(the “Prepaid Advance”). Upon execution of the Amended and Restated Purchase Agreement,
$2,000,000
of the Prepaid Advance was funded to Rezolve. 
v3.24.0.1
Stockholders' Equity
3 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
Note 6 — Stockholders’ Deficit
Preferred stock
The Company is authorized to issue 1,000,000 shares of preferred stock with apar value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2023 and September 30, 2023, there were no shares of preferred stock issued or outstanding.
Common stock
The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. At December 31, 2023 and September 30, 2023, there were 5,709,500 shares of common stock issued and outstanding, excluding 2,363,349 and 2,363,349 shares subject to redemption, respectively. On February 3, 2021, affiliates of the Sponsor paid $25,000, or approximately $0.006 per share, to cover certain offering costs in consideration for 4,312,500 Founder Shares. On February 8, 2021, EarlyBirdCapital, Inc. and Northland purchased 162,500 and 87,500 representative shares, respectively, at an average purchase price of approximately $0.0001 per share, or an aggregate purchase price of $25.00.
On May 29, 2021, Northland returned 87,500 shares of common stock to the Company, for no consideration, which were subsequently cancelled and on June 16, 2021, the Sponsor purchased an additional 700,000 shares of common stock at a purchase price of $0.006 per share, resulting in the Sponsor holding an aggregate of 5,012,500 shares of common stock. On June 16, 2021, the Sponsor transferred 50,000 shares to its Chief Executive Officer and
 
to its President and 35,000 shares to each of its three outside directors. The Founder Shares included an aggregate of up to 1,125,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part. On October 1, 2021 the underwriter’s over-allotment option expired unused resulting in 1,125,000 founder shares forfeited to the Company for no consideration.
Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. In connection with any vote held to approve the initial Business Combination, the Sponsor, as well as all of the Company’s officers and directors, have agreed to vote their respective shares of common stock owned by them immediately prior to the IPO and any shares purchased in the IPO or following the IPO in the open market in favor of the proposed Business Combination.
Warrants
Each whole warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment as discussed herein. The warrants will become exercisable 30 days after the completion of the Company’s initial Business Combination. However, no warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the public warrants is not effective within 90 days following the consummation of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. In the event of such cashless exercise, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose will mean the average reported last sale price of the shares of common stock for the 5 trading days ending on the trading day prior to the date of exercise. The warrants will expire on the fifth anniversary of the completion of an initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
The Company may call the warrants for redemption, in whole and not in part, at a price of $0.01 per warrant, in whole and not in part:
 
   
at any time after the warrants become exercisable,
 
   
upon not less than 30 days’ prior written notice of redemption to each warrant holder
 
   
if, and only if, the reported last sale price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations) for any 20 trading days within a
30-trading
day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and
 
   
if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants.
If the Company calls the warrants for redemption as described above, the Company’s management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the shares of common stock for the 5 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.
In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor, initial stockholders or their affiliates, without taking into account any founders’ shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the Market Value is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of common stock or equity-linked securities.
v3.24.0.1
Subsequent Events
3 Months Ended
Dec. 31, 2023
Subsequent Events [Abstract]  
Subsequent Events
Note 7— Subsequent Events
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as disclosed below, the Company did not identify any subsequent events that would have required adjustment or disclosure in these financial statements.
On January 16, 2024, the Company borrowed an additional $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to February 17, 2024. The funds made available by the Sponsor to the Company under the Extension Note were attributable to a draw down under the Subscription Agreement with Polar described in Note 4 above.
On January 16, 2024, the Company borrowed $39,100 from the Sponsor to be used for working capital. The promissory note is
non-interest
bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. This promissory note was funded by the Sponsor pursuant to a draw down under the Subscription
Agreement with Polar (as described in Note 4 above).
On February 2, 2024, Armada, Rezolve, Rezolve AI and YA amended and restated the Purchase Agreement, (the “Amended and Restated Purchase Agreement”) to, among other things, incorporate a prepaid advance arrangement, whereby YA committed to provide Rezolve with a prepaid advance in an original principal amount of $2,500,000 (the “Prepaid Advance”). Upon execution of the Amended and Restated Purchase Agreement, $2,000,000 of the Prepaid Advance was funded to Rezolve.
On February 15, 2024 the Company held a special meeting of its stockholders to approve an amendment to its Charter (the “Charter Amendment”) to extend the date (the “Termination Date”) by which the Company has to consummate a Business Combination from February 17, 2024 (the “Termination Date”) to March 17, 2024 (the “Charter Extension Date”) and to allow the Company, without another stockholder vote, to elect to extend the Termination Date on a monthly basis up to five times by an additional one month each time after the Charter Extension Date, by resolution of the Company’s board of directors, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until August 17, 2024, or a total of
up to six months after the Termination Date, unless the closing of a Business Combination shall have occurred prior thereto (the “Third Extension Amendment Proposal”). The stockholders of the Company approved the Third Extension Amendment Proposal at the special meeting and on February 1
5
, 2024 the Company filed the Charter Amendment with the Delaware Secretary of State.
In connection with the vote to approve the Charter Amendment, the holders of
945,662
shares of Common Stock of the Company exercised their right to redeem their shares for cash at a redemption price of approximately $
10.98
per share, for an aggregate redemption amount of $10,384,496.

In connection with the approval of the Third Extension Amendment Proposal, the Company issued an unsecured promissory note in the principal amount of up to $297,714 (the “Second Extension Note”) to the Sponsor. The Second Extension Note does
not
bear interest and matures upon closing of the Business Combination. In the event that the Company does not consummate a Business Combination, the Second Extension Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The proceeds of the Second Extension Note will be deposited in the Trust Account in connection with the Charter Amendment as follows: $49,619
to be
deposited into the Trust Account within three business days following February 17, 2024, and up to
 
$
248,095
 
in five equal installments to be deposited into the Trust Account for each of the five
one-month
extensions.
On February 16, 2024, the Company borrowed $49,619 under the Second Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to March 17, 2024. The funds made available by the Sponsor to the Company under the Extension Note were attributable to a draw down under the Subscription Agreement with Polar described in Note 4 above.
On February 16, 2024, the Company borrowed $60,381 from the Sponsor to be used for working capital. The promissory note is non-interest bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. This promissory note was funded by the Sponsor pursuant to a draw down under the Subscription Agreement with Polar described in Note 4 above.
v3.24.0.1
Significant Accounting Policies (Policies)
3 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by US GAAP. In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows for the period presented in the unaudited condensed financial statements. Operating results for the three months ended December 31, 2023, are not necessarily indicative of the results that may be expected through September 30, 2024.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on
Form10-K,
as filed with SEC on December 4, 2023.
Emerging Growth Company Status
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart the Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any
 
such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This
may
make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash
Cash
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $54,405 and $60,284 in cash as of December 31, 2023 and September 30, 2023, respectively.
Investments Held in Trust Account
Investments Held in Trust Account
As of both December 31, 2023 and September 30, 2023, the assets held in the Trust Account were held in an interest bearing demand deposit account. To mitigate the risk that the Company may be deemed an investment company for purposes of the Investment Company Act, on August 10, 2023, the Company instructed the trustee of the Trust Account to liquidate the investments held in the Trust Account and thereafter to hold all funds in the Trust Account in an interest bearing demand deposit account until the earlier of consummation of a Business Combination or liquidation. Furthermore, such cash is held in bank accounts which exceed federally insured limits as guaranteed by the Federal Deposit Insurance Corporation.
Fair Value Measurements
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
   
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
   
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
   
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
The fair value of certain of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheets.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At December 31, 2023 and September 30, 2023, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Offering Costs Associated with IPO
Offering Costs Associated with IPO
The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A— “Expenses of Offering”. Offering costs consist of legal, accounting, underwriting and other costs incurred through the balance sheet date that are related to the IPO. The Company incurred offering costs amounting to
 
$3,537,515 as a result of the IPO consisting of a $1,500,000 underwriting commissions and $2,037,515 of other offering costs.
Common Stock Subject to Possible Redemption
Common Stock Subject to Possible Redemption
The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ deficit. The Company’s shares of common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly,
2,363,349 shares of common stock as of September 30, 2023 and December 31, 2023 subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.
 
The Company recognizes changes in redemption value as they occur. Immediately upon the closing of the IPO, the Company recognized the remeasurement adjustment from initial carrying amount to redemption book value. The change in the carrying value
of
common stock subject to possible redemption resulted in charges against additional
paid-in
capital and accumulated deficit.
At December 31, 2023 and September 30, 2023, the common stock reflected in the balance sheets are reconciled in the following table:
 
 
 
 
 
 
Gross Proceeds
   $ 150,000,000  
Proceeds allocated to Public Warrants
     (11,700,000
Issuance costs related to common stock
     (3,261,589
Remeasurement of carrying value to redemption value
     14,961,589  
Subsequent remeasurement of carrying value to redemption value – Trust interest income (excluding the amount that can be withdrawn from Trust Account for taxes)
     548,862  
Common stock subject to possible redemption – September 30, 2022
  
 
150,548,862
 
Redemptions
     (129,175,094
Remeasurement of carrying value to redemption value
     3,943,038  
Common stock subject to possible redemption – September 30, 2023
  
$
25,316,806
 
Remeasurement of carrying value to redemption value
     467,884  
Common stock subject to possible redemption – December 31, 2023
  
$
25,784,690
 
Net (Loss) Income Per Common Stock
Net (Loss) Income Per Common Stock
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per common stock is computed by dividing net (loss) income by the weighted average number of common stock outstanding for the period. Remeasurement adjustments associated with the redeemable shares of common stock are excluded from earnings per share as the redemption value approximates fair value.
The calculation of diluted (loss) income per share does not consider the effect of the warrants issued in connection with the IPO because the warrants are contingently exercisable, and the contingencies have not yet been met. The warrants are exercisable to purchase 7,500,000 shares of common stock in the aggregate. As of December 31, 2023 and 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net (loss) income per common stock is the same as basic net loss per common stock for the periods presented.
Accretion of the carrying value of common stock subject to redemption value is excluded from net (loss) income per common stock because the redemption value approximates fair value.
 
 
  
For the Three Months Ended December 31,
 
 
  
2023
 
  
2022
 
 
  
Common
Stock
Subject to
Possible
Redemption
 
  
Non-Redeemable
Common
Stock
 
  
Common
Stock
Subject to
Possible
Redemption
 
  
Non-Redeemable
Common
Stock
 
Basic and diluted net (loss) income per share
                                   
Numerator:
                                   
Allocation of net (loss) income
   $ (105,483    $ (254,831    $ 439,673      $ 167,354  
Denominator
                                   
Weighted-average shares outstanding
     2,363,349        5,709,500        15,000,000        5,709,500  
Basic and diluted net (loss) income per share
   $ (0.04    $ (0.04    $ 0.03      $ 0.03  
Stock-Based Compensation
Stock-Based Compensation
The Company accounts for share-based payments in accordance with FASB ASC Topic 718, “Compensation—Stock Compensation,” (“ASC 718”), which requires that all equity awards be accounted for at their “fair value.” The Company measures and recognizes compensation expense for all share-based payments on their estimated fair values measured as of the grant date. These costs are recognized as an expense in the statements of operations upon vesting, once the applicable performance conditions are met, with an offsetting increase to additional
paid-in
capital. Forfeitures are recognized as they occur.
On June 16, 2021, the Sponsor transferred 50,000 shares to each of its Chief Executive Officer and to its President and 35,000 shares to each of its three independent directors. The aforementioned transfer is
with
in the scope of ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The aggregate fair value of these shares was $509,552 at issuance. A total of 100,000 shares vested upon consummation of the Initial Public Offering. The remaining 105,000 shares vest in equal quarterly installments until the second anniversary of the consummation of the Company’s Initial Public Offering, or August 17, 2023. At December 31, 2023, all shares under the June 16, 2021 grant were vested.
On June 26, 2023, the Sponsor allocated 270,000 shares to its three independent directors (90,000 each) and 100,000 shares to an executive officer. The aforementioned transfer is
with
in the scope of ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the transfer date. The aggregate fair value of these shares was $207,200 at the date of the transfer. A total of 190,000 shares vested upon the transfer date. The remaining 180,000 shares will vest as follows: 90,000 upon the 6 month anniversary of the transfer date; and 90,000 upon the one year anniversary of the transfer date
,
provided that all unvested shares would become vested upon consummation of initial business combination. The Company recognized $50,400 of stock-based compensation related to this grant for the three months ended December 31, 2023.
The Company recognized $50,400 and $27,963
of stock-based compensation for the three-month periods ended December 31, 2023 and December 31, 2022, respectively. 
Income Taxes
Income Taxes
The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
 
As of December 31, 2023, and September 30, 2023, the Company’s deferred tax asset had a full
valuation
allowance recorded against it. Our effective tax
 
rate
 
was 23.19%
 
and 30.01% for the three months ended December 31, 2023 and 2022. The effective tax rate differs from the statutory tax rate of 21% for three months ended December 31, 2023, and 2022, due to the valuation allowance on the deferred tax assets and permanent differences related to the business acquisition and stock-based compensation expenses.
Debt discounts
Debt discounts
Debt discounts relate to the issuance costs of some of the promissory notes to related parties, and are included in the condensed consolidated balance sheets as a direct deduction from the face amount of the promissory notes. Debt discounts are amortized over the term of the related promissory notes and included in the interest expense.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its consolidated financial statements and disclosures.
v3.24.0.1
Significant Accounting Policies (Tables)
3 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Summary of common stock reflected in the balance sheets are reconciled
At December 31, 2023 and September 30, 2023, the common stock reflected in the balance sheets are reconciled in the following table:
 
 
 
 
 
 
Gross Proceeds
   $ 150,000,000  
Proceeds allocated to Public Warrants
     (11,700,000
Issuance costs related to common stock
     (3,261,589
Remeasurement of carrying value to redemption value
     14,961,589  
Subsequent remeasurement of carrying value to redemption value – Trust interest income (excluding the amount that can be withdrawn from Trust Account for taxes)
     548,862  
Common stock subject to possible redemption – September 30, 2022
  
 
150,548,862
 
Redemptions
     (129,175,094
Remeasurement of carrying value to redemption value
     3,943,038  
Common stock subject to possible redemption – September 30, 2023
  
$
25,316,806
 
Remeasurement of carrying value to redemption value
     467,884  
Common stock subject to possible redemption – December 31, 2023
  
$
25,784,690
 
Schedule of basic and diluted net loss per share
Accretion of the carrying value of common stock subject to redemption value is excluded from net (loss) income per common stock because the redemption value approximates fair value.
 
 
  
For the Three Months Ended December 31,
 
 
  
2023
 
  
2022
 
 
  
Common
Stock
Subject to
Possible
Redemption
 
  
Non-Redeemable
Common
Stock
 
  
Common
Stock
Subject to
Possible
Redemption
 
  
Non-Redeemable
Common
Stock
 
Basic and diluted net (loss) income per share
                                   
Numerator:
                                   
Allocation of net (loss) income
   $ (105,483    $ (254,831    $ 439,673      $ 167,354  
Denominator
                                   
Weighted-average shares outstanding
     2,363,349        5,709,500        15,000,000        5,709,500  
Basic and diluted net (loss) income per share
   $ (0.04    $ (0.04    $ 0.03      $ 0.03  
v3.24.0.1
Organization, Business Operations and Going Concern (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 17, 2024
Feb. 16, 2024
Feb. 15, 2024
Feb. 13, 2024
Feb. 09, 2024
Jan. 16, 2024
Dec. 19, 2023
Dec. 15, 2023
Nov. 09, 2023
Oct. 11, 2023
Oct. 10, 2023
Sep. 12, 2023
Aug. 08, 2023
Aug. 02, 2023
Jun. 16, 2023
Feb. 02, 2023
Jan. 20, 2023
Nov. 10, 2022
Aug. 17, 2021
Aug. 31, 2023
Dec. 31, 2023
Sep. 30, 2023
Sep. 30, 2022
Aug. 04, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Date of incorporation                                         Nov. 05, 2020      
Transaction costs                                     $ 3,537,515          
Underwriting commissions                                     1,500,000          
Other offering costs                                     2,037,515          
Proceeds held in trust account                                     $ 150,000,000   $ 25,871,565 $ 25,324,028    
Trust assets value per unit                                     $ 10          
Maturity period of government securities                                     185 days          
Redemption outstanding public shares                                     100.00%          
Percentage of trust assets for acquisition                                     80.00%          
Percentage of ownership for acquisition                                     50.00%          
Net tangible assets for acquisition                                     $ 5,000,001          
Extended period from IPO closing to complete acquisition                                     18 months          
Percentage of public shares to be redeemed                                     100.00%          
Interest amount to pay dissolution expenses                                     $ 100,000          
Minimum trust proceeds per share                                     $ 10          
Operating account                                         54,000      
Proceeds from sale of restricted investments                           $ 70,900                    
Minimum net worth required for compliance                                               $ 5,000,001
Amount deposited into trust account                           $ 354,502                    
Temporary equity, accretion to redemption value                                         $ 467,884 $ 3,943,038 $ 14,961,589  
Threshold date for consummation of business combination                           Feb. 17, 2024   Aug. 17, 2023     Feb. 17, 2023   Feb. 17, 2023      
Number of days prior to the threhold date of completion of business combination in which the business combination agreement could be terminated                                   15 days            
Net working capital excluding income tax and franchise tax payable                                         $ 9,100,000      
Redemption price                                         $ 10.91 $ 10.71    
Excise tax payable                                         $ 1,291,751 $ 1,291,751    
First Amendment To The Business Combination Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Threshold date for termination of business combination agreement                                   Jan. 31, 2023            
Common Stock [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Temporary equity, accretion to redemption value                           $ 12,095,215           $ 12,095,215        
Temporary equity shares redeemed during the period share                           1,145,503           1,145,503        
Redemption price                           $ 10.56                    
Unsecured Promissory Note [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Aggregate loaned amount                           $ 425,402                    
Debt instrument, interest rate, stated percentage                           0.00%                    
Tranche One [Member] | Subscription Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Proceeds from sale of restricted investments             $ 70,900                                  
Payment to acquire restricted investments             $ 70,900 $ 70,900                                
Tranche One [Member] | Extension Note [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Proceeds from sale of restricted investments                         $ 70,900                      
Payment to acquire restricted investments                         $ 70,900                      
Tranche Two [Member] | Extension Note [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Proceeds from sale of restricted investments                       $ 70,900                        
Payment to acquire restricted investments                       $ 70,900                        
Tranche Four [Member] | Extension Note [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Proceeds from sale of restricted investments                   $ 70,900 $ 70,900                          
Payment to acquire restricted investments                   $ 70,900 $ 70,900                          
Tranche Five [Member] | Extension Note [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Proceeds from sale of restricted investments                 $ 70,900                              
Payment to acquire restricted investments                 $ 70,900                              
Subsequent Event [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Proceeds from sale of restricted investments $ 49,619                                              
Amount deposited into trust account $ 248,095                                              
Subsequent Event [Member] | Common Stock [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Temporary equity, accretion to redemption value     $ 10,384,496   $ 10,384,496                                      
Temporary equity shares redeemed during the period share     945,662   945,662                                      
Redemption price     $ 10.98   $ 10.98                                      
Subsequent Event [Member] | Unsecured Promissory Note [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Aggregate loaned amount     $ 297,714                                          
Debt instrument, interest rate, stated percentage     0.00%                                          
Subsequent Event [Member] | Tranche Two [Member] | Subscription Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Proceeds from sale of restricted investments           $ 70,900                                    
Payment to acquire restricted investments   $ 49,619       $ 70,900                                    
Subsequent Event [Member] | Approval To Extend The Last Date Prior To Which Business Combination Shall Be Consummated [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Extended date for consummation of business combination     Aug. 17, 2024                                          
Additional extension period granted to consummate the business combination     6 months 6 months                                        
Related Party [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Note payable to related parties                                         2,776,600 2,564,439    
Subscription agreement liability                                         6,752 $ 0    
Amended and Restated Business Combination Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Aggregate Stock Consideration                             $ 1,600,000,000                  
Non Redemption Agreements [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Proceeds from sale of restricted investments                                         117,079,879      
Threshold date for consummation of business combination                                 Aug. 17, 2023              
Percentage of redeemption of public shares                               100.00%                
Temporary equity shares redeemed during the period share                               11,491,148                
Redemption price                               $ 10.19                
Excise tax payable                                         $ 1,291,751      
IPO [Member] | Units [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Number of shares issued                                     15,000,000          
Price per share                                     $ 10          
Private Placement [Member] | Private Shares [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Number of shares issued                                     459,500          
Price per share                                     $ 10          
Private Placement [Member] | Private [Member] | Purchase Aggregate [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Aggregate purchase price                                     $ 4,595,000          
v3.24.0.1
Significant Accounting Policies - Summary of common stock reflected in the balance sheets are reconciled (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Sep. 30, 2022
Accounting Policies [Abstract]      
Gross Proceeds     $ 150,000,000
Proceeds allocated to Public Warrants     (11,700,000)
Issuance costs related to common stock     (3,261,589)
Remeasurement of carrying value to redemption value $ 467,884 $ 3,943,038 14,961,589
Subsequent remeasurement of carrying value to redemption value – Trust interest income (excluding the amount that can be withdrawn from Trust Account for taxes)     548,862
Common stock subject to possible redemption $ 25,784,690 25,316,806 $ 150,548,862
Redemptions   $ (129,175,094)  
v3.24.0.1
Schedule of basic and diluted net loss per share (Details) - USD ($)
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Allocation of net (loss) income $ (360,314) $ 607,027
Redeemable Common Stock [Member]    
Allocation of net (loss) income $ (105,483) $ 439,673
Weighted-average shares outstanding 2,363,349 15,000,000
Weighted-average shares outstanding 2,363,349 15,000,000
Basic and diluted net (loss) income per share $ (0.04) $ 0.03
Basic and diluted net (loss) income per share $ (0.04) $ 0.03
Non-Redeemable Common Stock [Member]    
Allocation of net (loss) income $ (254,831) $ 167,354
Weighted-average shares outstanding 5,709,500 5,709,500
Weighted-average shares outstanding 5,709,500 5,709,500
Basic and diluted net (loss) income per share $ (0.04) $ 0.03
Basic and diluted net (loss) income per share $ (0.04) $ 0.03
v3.24.0.1
Significant Accounting Policies (Details Narrative)
3 Months Ended
Jun. 26, 2023
USD ($)
shares
Aug. 17, 2021
USD ($)
Jun. 16, 2021
USD ($)
Director
shares
Dec. 31, 2023
USD ($)
Director
shares
Dec. 31, 2022
USD ($)
Sep. 30, 2023
USD ($)
shares
Cash and cash equivalents | $       $ 54,405   $ 60,284
Exceed limit | $       $ 250,000    
Shares of common stock subject to possible redemption       2,363,349   2,363,349
Fair value of converted shares | $ $ 207,200   $ 509,552      
Compensation expense | $ $ 50,400          
Share-Based Payment Expense | $       $ 50,400 $ 27,963  
Offering costs | $   $ 3,537,515        
Underwriting commissions | $   1,500,000        
Other offering costs | $   $ 2,037,515        
Effective income tax reconciliation percentage       23.19% 30.01%  
Statutory tax rate percentage       21.00% 21.00%  
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested 190,000          
Share-Based Payment Arrangement, Tranche Two [Member]            
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested 90,000          
Share-Based Payment Arrangement, Tranche One [Member]            
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested 90,000          
Sponsor [Member]            
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested 180,000          
President [Member]            
Shares of common stock transferred     50,000      
Director [Member]            
Shares of common stock transferred 90,000   35,000      
Number of independent directors | Director     3 3    
Three Independent Directors [Member]            
Shares of common stock transferred 270,000          
Executive Officer [Member]            
Shares of common stock transferred 100,000          
IPO [Member]            
Share-based compensation arrangement by share-based payment award, options, vested, number of shares       100,000    
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested       105,000    
Warrant [Member]            
Warrants exercise to purchase common stock       7,500,000    
v3.24.0.1
Related Party Transactions (Details Narrative)
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 17, 2024
USD ($)
Feb. 16, 2024
USD ($)
Jan. 16, 2024
USD ($)
Dec. 19, 2023
USD ($)
Dec. 15, 2023
USD ($)
Nov. 09, 2023
USD ($)
Oct. 11, 2023
USD ($)
Oct. 10, 2023
USD ($)
Sep. 12, 2023
USD ($)
Aug. 08, 2023
USD ($)
Aug. 02, 2023
USD ($)
$ / shares
Jul. 28, 2023
USD ($)
Jun. 26, 2023
shares
Nov. 10, 2022
USD ($)
Oct. 02, 2021
shares
Aug. 17, 2021
USD ($)
Investor
$ / shares
shares
Jul. 23, 2021
USD ($)
$ / shares
shares
Jun. 16, 2021
USD ($)
Director
$ / shares
shares
May 29, 2021
shares
May 29, 2021
shares
Feb. 08, 2021
USD ($)
$ / shares
shares
Feb. 03, 2021
USD ($)
$ / shares
shares
Jul. 31, 2022
USD ($)
Dec. 31, 2023
USD ($)
Director
$ / shares
shares
Dec. 31, 2022
USD ($)
Sep. 30, 2023
USD ($)
$ / shares
Nov. 20, 2023
USD ($)
Sep. 08, 2023
USD ($)
May 09, 2022
USD ($)
Oct. 01, 2021
shares
Related Party Transaction [Line Items]                                                            
Common stock, par value | $ / shares                                               $ 0.0001   $ 0.0001        
Underwriters over-allotment option expired | shares                                               1,125,000            
Proceeds from sale of restricted investments                     $ 70,900                                      
Administrative fees expense                                               $ 30,000 $ 30,000          
Tranche One [Member] | Subscription Agreement [Member]                                                            
Related Party Transaction [Line Items]                                                            
Proceeds from sale of restricted investments       $ 70,900                                                    
Payment to acquire restricted investments       70,900 $ 70,900                                                  
Tranche One [Member] | Extension Note [Member]                                                            
Related Party Transaction [Line Items]                                                            
Proceeds from sale of restricted investments                   $ 70,900                                        
Payment to acquire restricted investments                   70,900                                        
Tranche Two [Member] | Extension Note [Member]                                                            
Related Party Transaction [Line Items]                                                            
Proceeds from sale of restricted investments                 $ 70,900                                          
Payment to acquire restricted investments                 $ 70,900                                          
Tranche Four [Member] | Extension Note [Member]                                                            
Related Party Transaction [Line Items]                                                            
Proceeds from sale of restricted investments             $ 70,900 $ 70,900                                            
Payment to acquire restricted investments             $ 70,900 70,900                                            
Tranche Five [Member] | Extension Note [Member]                                                            
Related Party Transaction [Line Items]                                                            
Proceeds from sale of restricted investments           $ 70,900                                                
Payment to acquire restricted investments           $ 70,900                                                
Subsequent Event [Member]                                                            
Related Party Transaction [Line Items]                                                            
Proceeds from sale of restricted investments $ 49,619                                                          
Subsequent Event [Member] | Tranche Two [Member] | Subscription Agreement [Member]                                                            
Related Party Transaction [Line Items]                                                            
Proceeds from sale of restricted investments     $ 70,900                                                      
Payment to acquire restricted investments   $ 49,619 $ 70,900                                                      
Trust Account Contribution [Member]                                                            
Related Party Transaction [Line Items]                                                            
Proceeds from related party debt                           $ 1,500,000                                
Working Capital Needs Funding [Member]                                                            
Related Party Transaction [Line Items]                                                            
Proceeds from related party debt                           $ 450,000                                
Polar Multi Strategy Master Fund [Member] | Extension Note [Member]                                                            
Related Party Transaction [Line Items]                                                            
Aggregate loaned amount       70,900                                                    
Sponsor [Member]                                                            
Related Party Transaction [Line Items]                                                            
Notes payable current                                               2,776,600   $ 2,564,439        
Aggregate loaned amount                                                         $ 483,034  
Payment for services                                               0   4,300        
Sponsor [Member] | Extension Note [Member]                                                            
Related Party Transaction [Line Items]                                                            
Line of Credit Facility, Maximum Amount Outstanding During Period                                               354,502            
Sponsor [Member] | Subscription Agreement With Polar [Member]                                                            
Related Party Transaction [Line Items]                                                            
Notes payable current                                               39,100            
Aggregate loaned amount       $ 39,100                                                    
Sponsor [Member] | Promissory Notes [Member]                                                            
Related Party Transaction [Line Items]                                                            
Notes payable current                                               247,454   247,454        
Aggregate loaned amount                     $ 425,402 $ 125,245                                    
Repayments of debt                                             $ 187,034              
Promissory note outstanding                                               125,245            
Debt instrument interest rate during period                       0.00%                                    
Sponsor [Member] | Promissory Notes [Member] | Working Capital Loan Tranche August Two Thousand And Twenty Three [Member]                                                            
Related Party Transaction [Line Items]                                                            
Notes payable current                                               20,840            
Aggregate loaned amount                   $ 20,840                                        
Sponsor [Member] | Promissory Notes [Member] | Working Capital Loan Tranche September Two Thousand And Twenty Three [Member]                                                            
Related Party Transaction [Line Items]                                                            
Notes payable current                                               79,099            
Aggregate loaned amount                                                       $ 79,099    
Sponsor [Member] | Promissory Notes [Member] | Working Capital Loan Tranche October Two Thousand And Twenty Three [Member]                                                            
Related Party Transaction [Line Items]                                                            
Notes payable current                                               59,099            
Aggregate loaned amount               $ 59,099                                            
Sponsor [Member] | Promissory Notes [Member] | Working Capital Loan Tranche November Two Thousand And Twenty Three [Member]                                                            
Related Party Transaction [Line Items]                                                            
Notes payable current                                               12,510            
Aggregate loaned amount                                                     $ 12,510      
Sponsor [Member] | Promissory Notes [Member] | Common Stock [Member] | Extension Note [Member]                                                            
Related Party Transaction [Line Items]                                                            
Loan conversion price | $ / shares                     $ 10                                      
Debt conversion converted instrument amount                     $ 425,402                                      
Related Party [Member]                                                            
Related Party Transaction [Line Items]                                                            
Notes payable current                                               2,776,600   $ 2,564,439        
Monthly fee                                               $ 10,000            
Related Party [Member] | Promissory Notes [Member]                                                            
Related Party Transaction [Line Items]                                                            
Notes payable current                                                         $ 483,034  
President [Member]                                                            
Related Party Transaction [Line Items]                                                            
Conversion of Stock, Shares Converted | shares                                   50,000                        
Director [Member]                                                            
Related Party Transaction [Line Items]                                                            
Conversion of Stock, Shares Converted | shares                         90,000         35,000                        
Number of independent directors | Director                                   3           3            
Chief Executive Officer [Member]                                                            
Related Party Transaction [Line Items]                                                            
Shares subject to forfeiture | shares                                 6,007,500                          
Founder Shares [Member]                                                            
Related Party Transaction [Line Items]                                                            
Value of shares issued                                           $ 25,000                
Price per share | $ / shares                               $ 0.006 $ 0.006 $ 0.006       $ 0.006                
Number of shares issued | shares                                 1,200,000 700,000       4,312,500                
Common stock, par value | $ / shares                                           $ 0.0001                
Aggregate purchase price                                 $ 6,975 $ 4,070                        
Period after business combination for transfer of shares                                               180 days            
Stock allocated to each anchor investor, shares | shares                               131,250                            
Stock allocated to anchor investors, shares | shares                               1,312,500                            
Stock allocated to each anchor investor, value                               $ 424,491                            
Stock allocated to each anchor investor, value per share | $ / shares                               $ 3.23                            
Founder Shares [Member] | Over-Allotment Option [Member]                                                            
Related Party Transaction [Line Items]                                                            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares                                                           1,125,000
Underwriters over-allotment option expired | shares                             1,125,000                              
Founder Shares [Member] | Chief Executive Officer President and Independent Directors [Member]                                                            
Related Party Transaction [Line Items]                                                            
Shares subject to forfeiture | shares                                 205,000                          
Units [Member]                                                            
Related Party Transaction [Line Items]                                                            
Number of anchor investors | Investor                               10                            
Units [Member] | IPO [Member]                                                            
Related Party Transaction [Line Items]                                                            
Price per share | $ / shares                               $ 10                            
Number of shares issued | shares                               15,000,000                            
Percentage of units purchased by anchor investors                               9.90%                            
Representative Shares [Member]                                                            
Related Party Transaction [Line Items]                                                            
Price per share | $ / shares                                         $ 0.0001                  
Period after business combination for transfer of shares                                               30 days            
Issuance of representative                                         $ 25                  
Representative Shares [Member] | EarlyBirdCapital, Inc. [Member]                                                            
Related Party Transaction [Line Items]                                                            
Issuance of representative shares, shares | shares                                         162,500                  
Representative Shares [Member] | Northland Securities, Inc. [Member]                                                            
Related Party Transaction [Line Items]                                                            
Issuance of representative shares, shares | shares                                     87,500 87,500 87,500                  
v3.24.0.1
Subscription agreement liability (Details Narrative) - USD ($)
3 Months Ended
Dec. 12, 2023
Dec. 31, 2023
Feb. 13, 2024
Sep. 30, 2023
Subscription Liability [Line Items]        
Common stock par or stated value per share   $ 0.0001   $ 0.0001
Cost of borrowing   $ 108,634    
Interest expense   $ 5,384    
Subscription Agreement [Member] | Polar Multi Strategy Master Fund [Member]        
Subscription Liability [Line Items]        
Common stock par or stated value per share $ 0.0001      
Common stock subscribed but not issued value $ 440,000      
Common stock subscribed but not issued shares 880,000      
Time limit from the date of consummation of business combination within which the shares shall be registered 45 days      
Time limit for the registration statement to become effective from the date of consummation of business combination 150 days      
Lock in period of shares 180 days      
Maximum time period for default to be rectified 5 days      
Subscription Agreement [Member] | Polar Multi Strategy Master Fund [Member] | December Two Thousand And Twenty Three [Member]        
Subscription Liability [Line Items]        
Common stock subscribed but not issued value $ 110,000      
Number of days within which investor shall contribute capital 5 days      
Subscription Agreement [Member] | Polar Multi Strategy Master Fund [Member] | January Two Thousand And Twenty Four [Member]        
Subscription Liability [Line Items]        
Common stock subscribed but not issued value $ 110,000      
Subscription Agreement [Member] | Polar Multi Strategy Master Fund [Member] | February Two Thousand And Twenty Four [Member]        
Subscription Liability [Line Items]        
Common stock subscribed but not issued value 110,000      
Subscription Agreement [Member] | Polar Multi Strategy Master Fund [Member] | March Two Thousand And Twenty Four [Member]        
Subscription Liability [Line Items]        
Common stock subscribed but not issued value $ 110,000   $ 110,000  
Subscription Agreement [Member] | Polar Multi Strategy Master Fund [Member] | Default Shares [Member]        
Subscription Liability [Line Items]        
Common stock subscribed but not issued shares 220,000      
Subscription Agreement [Member] | Polar Multi Strategy Master Fund [Member] | Additional Default Shares [Member]        
Subscription Liability [Line Items]        
Common stock subscribed but not issued shares 220,000      
v3.24.0.1
Commitments and Contingencies (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended 14 Months Ended
Feb. 02, 2024
Aug. 02, 2023
Feb. 23, 2023
Feb. 02, 2023
Jan. 20, 2023
Oct. 02, 2021
Aug. 18, 2021
Aug. 17, 2021
May 29, 2021
May 29, 2021
Feb. 08, 2021
Dec. 31, 2023
Jun. 20, 2024
Sep. 30, 2022
Dec. 31, 2022
Sep. 30, 2023
Underwriting discount percentage               1.00%                
Underwriting commissions               $ 1,500,000                
Deferred underwriting commission payable               $ 225,000                
Deferred underwriting commission expired           $ 225,000                    
Advisory fee percentage for initial public offering               1.00%                
Advisory fee for IPO amount if underwriters' option is not exercised               $ 1,500,000                
Advisory fee paid             $ 1,500,000                  
Advisory fee for business combination amount if underwriters' option is not exercised               $ 3,000,000                
Marketing agreement fee percentage for business combination               2.25%                
Marketing agreement fee for business combination amount if underwriters' option is not exercised               $ 3,375,000                
Capital market advisory fee for business combination               $ 2,500,000                
Cash fee percentage for target business introduction in business combination               1.00%                
Long term purchase commitment amount paid                           $ 120,000    
Long-Term Purchase Commitment, Amount                       $ 1,030,000        
Threshold Date For Consummation Of Business Combination   Feb. 17, 2024   Aug. 17, 2023       Feb. 17, 2023       Feb. 17, 2023        
Redemption price                       $ 10.91       $ 10.71
ICR LLC [Member]                                
Related party transaction, amounts of transaction monthly fee                             $ 10,400  
Representative Shares [Member]                                
Shares Issued, Price Per Share                     $ 0.0001          
Northland Securities, Inc. [Member] | Representative Shares [Member]                                
Stock Issued During Period, Shares, Other                 87,500 87,500 87,500          
Hallum Capital Group LLC [Member]                                
Advisory fee payable on consummation of business combination                       $ 500,000        
D A Davidson And Co [Member]                                
Advisory fee payable on consummation of business combination                       600,000        
Termination or Closing of Initial Business Combination [Member] | ICR LLC [Member]                                
Other liabilities                       145,600        
Additional Liabilities Upon the Closing of the Initial Business Combination [Member] | ICR LLC [Member]                                
Other liabilities                       145,600        
Initial Business Combination [Member] | Bishop IR [Member]                                
Success Fee Payable                       $ 100,000        
Initial Business Combination [Member] | Subsequent Event [Member] | Bishop IR [Member]                                
Related party transaction, amounts of transaction monthly fee                         $ 8,000      
Maximum [Member] | Initial Business Combination [Member] | Subsequent Event [Member] | Bishop IR [Member]                                
Related party transaction, amounts of transaction monthly fee                         $ 12,000      
Prepaid Advance Agreement [Member] | Subsequent Event [Member]                                
Proceeds from other debts $ 2,000,000                              
Other commitement $ 2,500,000                              
Amended and Restated Business Combination Agreement [Member]                                
Advisory fee for business combination amount if underwriters' option is not exercised               $ 8,750,000                
Purchase Agreement [Member] | YA II PN, Ltd. [Member]                                
Value of ordinary shares expected to issue     $ 250,000,000                          
Non Redemption Agreements [Member]                                
Threshold Date For Consummation Of Business Combination         Aug. 17, 2023                      
Redemption price       $ 10.19                        
Temporary equity shares redeemed during the period shares       11,491,148                        
Number of Shares Allocated in Exchange for Non Redeemption of Public Shares         75,000                      
Non Redemption Agreements [Member] | Sponsor [Member]                                
Redemption price         $ 1.55                      
Temporary Equity Shares Redeemed During the Period Value         $ 1,102,909                      
Temporary equity shares redeemed during the period shares         713,057                      
v3.24.0.1
Stockholders' Equity (Details Narrative)
3 Months Ended
Jun. 26, 2023
shares
Oct. 02, 2021
shares
Jul. 23, 2021
$ / shares
shares
Jun. 16, 2021
Director
$ / shares
shares
May 29, 2021
shares
May 29, 2021
shares
Feb. 08, 2021
$ / shares
shares
Feb. 08, 2021
$ / shares
shares
Feb. 03, 2021
USD ($)
$ / shares
shares
Feb. 03, 2021
USD ($)
$ / shares
shares
Dec. 31, 2023
Director
$ / shares
shares
Sep. 30, 2023
$ / shares
shares
Aug. 17, 2021
$ / shares
Class of Stock [Line Items]                          
Preferred stock, shares authorized                     1,000,000 1,000,000  
Preferred stock, par value | $ / shares                     $ 0.0001 $ 0.0001  
Preferred stock, shares issued                     0 0  
Preferred stock, shares outstanding                     0 0  
Common stock, shares authorized                     100,000,000 100,000,000  
Common stock, par value | $ / shares                     $ 0.0001 $ 0.0001  
Common stock, shares issued                     5,709,500 5,709,500  
Common stock, shares outstanding                     5,709,500 5,709,500  
Shares subject to redemption                     2,363,349 2,363,349  
Number of Shares Forfeited                     1,125,000    
Common Stock, Voting Rights                     one vote for each share    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares                     $ 11.5    
Warrant exercisable period after business combination                     30 days    
Warrant cashless exercise period after business combination                     90 days    
Period of trading days to determine fair market value of common stock                     5 days    
Warrants redemption price per share | $ / shares                     $ 0.01    
Notice period for warrants redemption                     30 days    
Common stock share price per share for warrants redemption | $ / shares                     $ 18    
Period of trading days within specified window for minimum common stock price for warrants redemption                     20 days    
Trading days specified window for minimum common stock price for warrants redemption                     30 days    
Common stock issue price per share below which triggers warrant adjustment | $ / shares                     $ 9.2    
Percentage of available equity proceeds below specified price which triggers warrant adjustment                     60.00%    
Common stock market value per share below which triggers warrant adjustment | $ / shares                     $ 9.2    
Percentage of Market Value for warrant exercise price adjustment                     115.00%    
President [Member]                          
Class of Stock [Line Items]                          
Conversion of Stock, Shares Converted       50,000                  
Director [Member]                          
Class of Stock [Line Items]                          
Conversion of Stock, Shares Converted 90,000     35,000                  
Number of independent directors | Director       3             3    
Founder Shares [Member]                          
Class of Stock [Line Items]                          
Common stock, par value | $ / shares                 $ 0.0001 $ 0.0001      
Value of shares issued | $                   $ 25,000      
Price per share | $ / shares     $ 0.006 $ 0.006         $ 0.006 $ 0.006     $ 0.006
Number of shares issued     1,200,000 700,000           4,312,500      
Founder Shares [Member] | Over-Allotment Option [Member]                          
Class of Stock [Line Items]                          
Number of Shares Forfeited   1,125,000                      
Founder Shares [Member] | Sponsor [Member]                          
Class of Stock [Line Items]                          
Common stock, shares outstanding       5,012,500                  
Founder Shares 1 [Member]                          
Class of Stock [Line Items]                          
Value of shares issued | $                 $ 25,000        
Price per share | $ / shares                 $ 0.006 $ 0.006      
Number of shares issued                 4,312,500        
Representative Shares [Member]                          
Class of Stock [Line Items]                          
Price per share | $ / shares             $ 0.0001 $ 0.0001          
Stock Repurchased and Retired During Period, Shares               25          
Representative Shares [Member] | EarlyBirdCapital, Inc. [Member]                          
Class of Stock [Line Items]                          
Issuance of Representative shares, shares             162,500            
Representative Shares [Member] | Northland Securities, Inc. [Member]                          
Class of Stock [Line Items]                          
Issuance of Representative shares, shares         87,500 87,500 87,500            
Stock Repurchased and Retired During Period, Shares         87,500                
v3.24.0.1
Subsequent Events (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 17, 2024
Feb. 16, 2024
Feb. 15, 2024
Feb. 13, 2024
Feb. 09, 2024
Feb. 02, 2024
Jan. 16, 2024
Aug. 02, 2023
Aug. 31, 2023
Dec. 31, 2023
Sep. 30, 2023
Sep. 30, 2022
May 09, 2022
Subsequent Event [Line Items]                          
Amount deposited into trust account               $ 354,502          
Proceeds from sale of restricted investments               70,900          
Temporary equity, accretion to redemption value                   $ 467,884 $ 3,943,038 $ 14,961,589  
Temporary equity redemption price per share                   $ 10.91 $ 10.71    
Common Stock [Member]                          
Subsequent Event [Line Items]                          
Temporary equity, accretion to redemption value               $ 12,095,215 $ 12,095,215        
Temporary equity shares redeemed during the period shares               1,145,503 1,145,503        
Temporary equity redemption price per share               $ 10.56          
Sponsor [Member]                          
Subsequent Event [Line Items]                          
Debt instrument, face amount                         $ 483,034
Subsequent Event [Member]                          
Subsequent Event [Line Items]                          
Amount deposited into trust account $ 248,095                        
Proceeds from sale of restricted investments 49,619                        
Subsequent Event [Member] | Common Stock [Member]                          
Subsequent Event [Line Items]                          
Temporary equity, accretion to redemption value     $ 10,384,496   $ 10,384,496                
Temporary equity shares redeemed during the period shares     945,662   945,662                
Temporary equity redemption price per share     $ 10.98   $ 10.98                
Subsequent Event [Member] | Approval To Extend The Last Date Prior To Which Business Combination Shall Be Consummated [Member]                          
Subsequent Event [Line Items]                          
Additional extension period granted to consummate the business combination     6 months 6 months                  
Subsequent Event [Member] | Subscription Agreement [Member] | Tranche Two [Member]                          
Subsequent Event [Line Items]                          
Payment to acquire restricted investments   $ 49,619         $ 70,900            
Proceeds from sale of restricted investments             70,900            
Subsequent Event [Member] | Prepaid Advance Agreement [Member]                          
Subsequent Event [Line Items]                          
Proceeds from other debts           $ 2,000,000              
Other commitement           $ 2,500,000              
Subsequent Event [Member] | Sponsor [Member] | Working Capital Loan [Member]                          
Subsequent Event [Line Items]                          
Debt instrument, face amount   $ 60,381         $ 39,100            
Subsequent Event [Member] | Second Extension Note [Member]                          
Subsequent Event [Line Items]                          
Debt instrument, interest rate, stated percentage         0.00%                
Subsequent Event [Member] | Second Extension Note [Member] | Sponsor [Member]                          
Subsequent Event [Line Items]                          
Debt instrument, face amount         $ 297,714                
Amount deposited into trust account 248,095                        
Proceeds from sale of restricted investments $ 49,619                        

Armada Acquisition Corpo... (NASDAQ:AACIU)
過去 株価チャート
から 12 2024 まで 12 2024 Armada Acquisition Corpo...のチャートをもっと見るにはこちらをクリック
Armada Acquisition Corpo... (NASDAQ:AACIU)
過去 株価チャート
から 12 2023 まで 12 2024 Armada Acquisition Corpo...のチャートをもっと見るにはこちらをクリック